FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Santana, MF
   Borba, MGS
   Baia-da-Silva, DC
   Val, F
   Alexandre, MAA
   Brito-Sousa, JD
   Melo, GC
   Queiroga, MVO
   Farias, MEL
   Camilo, CC
   Naveca, FG
   Xavier, MS
   Monteiro, WM
   Joao, GAP
   Hajjar, LA
   Ordi, J
   Lacerda, MVG
   Ferreira, LCL
AF Santana, Monique Freire
   Silva Borba, Mayla Gabriela
   Baia-da-Silva, Djane Clarys
   Val, Fernando
   Araujo Alexandre, Marcia Almeida
   Brito-Sousa, Jose Diego
   Melo, Gisely Cardoso
   Oliveira Queiroga, Marcos Vinicius
   Leao Farias, Maria Eduarda
   Camilo, Cecilia Cunha
   Naveca, Felipe Gomes
   Xavier, Mariana Simao
   Monteiro, Wuelton Marcelo
   Pivoto Joao, Guilherme Augusto
   Hajjar, Ludhmila Abrahao
   Ordi, Jaume
   Guimaraes Lacerda, Marcus Vinicius
   Lima Ferreira, Luiz Carlos
TI Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy
   Study
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MANAGEMENT
AB Although high mortality has been reported in many COVID-19 studies, very limited postmortem information from complete autopsies is available. We report the findings in the adrenal glands in 28 autopsies with confirmed SARS-CoV-2 infection. Microscopic lesions were identified in the adrenal glands in 12/28 patients (46%). Seven cases showed necrosis, generally ischemic; four showed cortical lipid degeneration; two showed hemorrhage; and one unspecific focal adrenalitis. Vascular thrombosis in one patient and focal inflammation in association with other findings in three patients were observed. No case presented adrenal insufficiency. In conclusion, adrenal lesions are frequent in patients with severe COVID-19. The lesions are mild but could contribute to the lethal outcome.
C1 [Santana, Monique Freire; Baia-da-Silva, Djane Clarys; Val, Fernando; Araujo Alexandre, Marcia Almeida; Brito-Sousa, Jose Diego; Melo, Gisely Cardoso; Monteiro, Wuelton Marcelo; Pivoto Joao, Guilherme Augusto; Guimaraes Lacerda, Marcus Vinicius; Lima Ferreira, Luiz Carlos] Fundacao Med Trop Dr Heitor Vieira Dourado, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil.
   [Santana, Monique Freire; Silva Borba, Mayla Gabriela; Baia-da-Silva, Djane Clarys; Val, Fernando; Brito-Sousa, Jose Diego; Melo, Gisely Cardoso; Xavier, Mariana Simao; Monteiro, Wuelton Marcelo; Lima Ferreira, Luiz Carlos] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.
   [Santana, Monique Freire] Fundacao Ctr Controle Oncol Estado Amazonas FCECO, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil.
   [Silva Borba, Mayla Gabriela; Oliveira Queiroga, Marcos Vinicius] Hosp & Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas, Brazil.
   [Leao Farias, Maria Eduarda; Naveca, Felipe Gomes; Guimaraes Lacerda, Marcus Vinicius] Fundacao Oswaldo Cruz, Inst Pesquisas Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Camilo, Cecilia Cunha] CDL Labs Santos & Vidal, Manaus, Amazonas, Brazil.
   [Hajjar, Ludhmila Abrahao] Univ Sao Paulo, Sao Paulo, Brazil.
   [Ordi, Jaume] Hosp Clin Barcelona, Barcelona, Spain.
   [Araujo Alexandre, Marcia Almeida] Fundacao Med Trop Dr Heitor Vieira Dourado, Ave Pedro Teixeira 25, BR-69040000 Manaus, Amazonas, Brazil.
RP Lacerda, MVG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Ave Pedro Teixeira 25, BR-69040000 Manaus, Amazonas, Brazil.
EM monique.freire20@gmail.com; maylagsborba@gmail.com;
   djane.claryss@gmail.com; ffaval@gmail.com; marcialexandre@gmail.com;
   sousajdb@live.com; cardosogisely@gmail.com;
   marcosqueirogaresearch@gmail.com; meduardaleaof@gmail.com;
   ceciliacamilo@yahoo.com.br; naveca.felipe@gmail.com;
   marianasimaoxavier@gmail.com; wueltonmm@gmail.com;
   guilhermepivoto@hotmail.com; ludhmilah@gmail.com;
   jaume.ordi@isglobal.org; marcuslacerda.br@gmail.com;
   ferreira.luiz@gmail.com
OI Abrahao Hajjar, Ludhmila/0000-0001-5645-2055
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Departamento de Ciencia e Tecnologia/Ministerio da Saude
   (DECIT); Ministerio da Ciencia, Tecnologia e Inovacoes (MCTI); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [403253/2020-9]; Fundacao de Amparo a Pesquisa do Estado do Amazonas
   (FAPEAM) [PAPAC 005/2019]; Fundacao de Amparo a Pesquisa do Estado do
   Amazonas (FAPEAM) (Pro-Estado public calls)
FX This study was funded by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Departamento de Ciencia e Tecnologia/Ministerio
   da Saude (DECIT), Ministerio da Ciencia, Tecnologia e Inovacoes (MCTI),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   grant 403253/2020-9), Fundacao de Amparo a Pesquisa do Estado do
   Amazonas (FAPEAM) (PAPAC 005/2019 and Pro-Estado public calls).
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Adôrno Isa Félix, 2019, Radiol Bras, V52, P12, DOI 10.1590/0100-3984.2018.0041
   Monteiro RAA, 2020, INTENS CARE MED, V46, P1766, DOI 10.1007/s00134-020-06125-z
   Annane D, 2017, CRIT CARE MED, V45, P2078, DOI 10.1097/CCM.0000000000002737
   Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635
   Centers for Disease Control and Prevention, 2020, CDC 2019 NOV COR 201
   Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844
   FOX B, 1976, J PATHOL, V119, P65, DOI 10.1002/path.1711190202
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guarner J, 2008, MODERN PATHOL, V21, P1113, DOI 10.1038/modpathol.2008.98
   Hui DS, 2013, ANTIVIR RES, V98, P410, DOI 10.1016/j.antiviral.2013.03.019
   Iuga A.C., 2020, ARCH PATHOL LAB MED
   Khwaja Jahanzaib, 2017, J Med Case Rep, V11, P72, DOI 10.1186/s13256-017-1236-0
   Nambiar VK, 2019, THROMBOTIC TENDENCIE
   National Toxicology Program U.S. Department of Health and Hu- man Services, 2020, ADR GLAND CORT VAC C
   RECOVERY Collaborative Group, 2020, N Engl J Med, DOI 10.1056/NEJMoa2021436
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   Whyte CS, 2020, J THROMB HAEMOST, V18, P1548, DOI 10.1111/jth.14872
   Xing YW, 2011, J ENDOCRINOL, V209, P327, DOI 10.1530/JOE-10-0493
   Yao XH, 2020, ZHONGHUA BING LI XUE, V49, P411, DOI [10.3760/cma.j.cn112151-20200312-00193, DOI 10.3760/CMA.J.CN112151-20200312-00193]
NR 20
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2020
VL 103
IS 4
BP 1604
EP 1607
DI 10.4269/ajtmh.20-0787
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA OE9CC
UT WOS:000580818500052
PM 32876012
OA Other Gold, Green Published
DA 2020-12-17
ER

PT J
AU Neto, TAP
   Goncalves-Pereiral, MH
   de Queiroz, CP
   Ramose, MF
   de Oliveira, FDS
   Oliveira-Prado, R
   do Nascimento, VA
   Abdalla, LF
   Santos, JHA
   Martins, OA
   Naveca, FG
   Teixeira-Carvalho, A
   Santiago, HD
AF Pereira Neto, Tertuliano Alves
   Goncalves-Pereiral, Marcela Helena
   de Queiroz, Camila Pereira
   Ramose, Michele Faria
   Souza de Oliveira, Fernanda de Fatima
   Oliveira-Prado, Roberta
   do Nascimento, Valdinete Alves
   Abdalla, Ligia Fernandes
   Abdalla Santos, Joao Hugo
   Martins-Filho, Olindo Assis
   Naveca, Felipe Gomes
   Teixeira-Carvalho, Andrea
   Santiago, Helton da Costa
TI Multifunctional T cell response in convalescent patients two years after
   ZIKV infection
SO JOURNAL OF LEUKOCYTE BIOLOGY
LA English
DT Article
DE immunity; multifunctional T cells; Zika; ZIKV
ID TETRAVALENT DENGUE VACCINE; VIRUS-INFECTION; TC17 CELLS; IFN-GAMMA;
   CD8(+); PROTECTION; SUBSET; IMMUNIZATION; INDIVIDUALS; EFFICACY
AB Zika is an important emerging infectious disease in which the role of T cells remains elusive. This study aimed to evaluate the phenotype of multifunctional T cells in individuals 2 yr after exposure to Zika virus (ZIKV). We used a library of 671 synthetic peptides covering the whole polyprotein of ZIKV in pools corresponding to each viral protein (i.e., capsid, membrane precursor or prM, envelope, NS1 [nonstructural protein], NS2A + NS2B, NS3, NS4A + NS4B, and NS5) to stimulate PBMCs from individuals previously exposed to ZIKV. We observed an increased frequency of ZIKV-specific IFN gamma, IL-17A, TNF, and IL-10 production by T cell populations. IFN gamma and TNF production were especially stimulated by prM, capsid, or NS1 in CD8+ T cells and by capsid or prM in CD4+ T cells. In addition, there was an increase in the frequency of IL-10+ CD8+ T cells after stimulation with prM, capsid, NS1, NS3, or NS5. Multifunctional properties were observed in ZIKV-specific T cells responding especially to prM, capsid, NS1 or, to a smaller extent, NS3 antigens. For example, we found a consistent IFN gamma + TNF+ CD8+ T cell population in response to most virus antigens and CD4+ and CD8+ T cells that were IFN gamma + IL-17A+ and IL-17A+IL-10+, which could also produce TNF, in response to capsid, prM, NS1, or NS3 stimulation. Interestingly, CD8+ T cells were more prone to a multifunctional phenotype than CD4+ T cells, and multifunctional T cells were more efficient at producing cytokines than single-function cells. This work provides relevant insights into the quality of ZIKV-specific T cell responses and ZIKV immunity.
C1 [Pereira Neto, Tertuliano Alves; Goncalves-Pereiral, Marcela Helena; de Queiroz, Camila Pereira; Ramose, Michele Faria; Santiago, Helton da Costa] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Souza de Oliveira, Fernanda de Fatima] Univ Fed Minas Gerais, Dept Clin Anal & Toxicol, Belo Horizonte, MG, Brazil.
   [Oliveira-Prado, Roberta; Martins-Filho, Olindo Assis; Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz, Rene Rachou Inst, Belo Horizonte, MG, Brazil.
   [do Nascimento, Valdinete Alves; Abdalla, Ligia Fernandes; Abdalla Santos, Joao Hugo; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Leonidas & Maria Deane Inst, Manaus, Amazonas, Brazil.
RP Santiago, HD (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Av Antonio Carlos 6627,ICB Sala Q4-172, BR-31270901 Belo Horizonte, MG, Brazil.
EM heltonsantiago@icb.ufmg.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   FinepCiencia Tecnologia e Inovacao (FINEP); Program for Technological
   Development in Tools for Health-PDTIS-FIOCRUZ (Flow Cytometry Platform
   of Instituto Rene Rachou); flow cytometry core facility of the Pharmacy
   School of Universidade Federal de Minas Gerais
FX This work was supported by the CNPq, FAPEMIG, Finep, and the Program for
   Technological Development in Tools for Health-PDTIS-FIOCRUZ (Flow
   Cytometry Platform of Instituto Rene Rachou) and flow cytometry core
   facility of the Pharmacy School of Universidade Federal de Minas Gerais.
CR Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Arroyo L, 2016, CLIN VACCINE IMMUNOL, V23, P813, DOI 10.1128/CVI.00217-16
   Badolato-Correa J, 2017, IMMUN INFLAMM DIS
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Boyd A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128714
   Branche E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46291-9
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Chu HY, 2015, J INFECT DIS, V212, P1618, DOI 10.1093/infdis/jiv258
   Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336
   Cong Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004709
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flores-Garcia Y, 2011, INT J BIOL SCI, V7, P1093, DOI 10.7150/ijbs.7.1093
   Pereira MHG, 2020, IMMUNOLOGY, V160, P90, DOI 10.1111/imm.13185
   Grifoni A, 2017, J VIROL
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814
   Hassert M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01678
   Henein S, 2017, J INFECT DIS, V215, P351, DOI 10.1093/infdis/jiw576
   Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935
   Holmgren J, 2017, VACCINE, V35, P3355, DOI 10.1016/j.vaccine.2017.05.005
   Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681
   Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412
   Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175
   Javed F, 2018, J BASIC MICROB, V58, P3, DOI 10.1002/jobm.201700398
   Khetarpal N, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6803098
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lam JH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94500
   Lindow JC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001742
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014
   Moodie Z, 2018, J INFECT DIS, V217, P742, DOI 10.1093/infdis/jix609
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/JLB.0109046, 10.1189/jlb.0109046]
   Panagioti E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00276
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Pardy RD, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080820
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rakshit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10773-5
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Roffe E, 2012, J IMMUNOL, V188, P649, DOI 10.4049/jimmunol.1003845
   Sahly El MH, 2019, OPEN FORUM INFECT DI, V6
   Saxena A, 2012, J IMMUNOL, V189, P3140, DOI 10.4049/jimmunol.1103111
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   Siefker DT, 2019, AM J RESP CRIT CARE
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Srenathan U, 2016, IMMUNOL LETT, V178, P20, DOI 10.1016/j.imlet.2016.05.001
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929
   Tajima M, 2011, INT IMMUNOL, V23, P751, DOI 10.1093/intimm/dxr086
   Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292
   Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wu XY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01112
   Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368
   Zhang GL, 2018, THER CLIN RISK MANAG, V14, P2127, DOI 10.2147/TCRM.S184809
   Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957
NR 81
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0741-5400
EI 1938-3673
J9 J LEUKOCYTE BIOL
JI J. Leukoc. Biol.
PD OCT
PY 2020
VL 108
IS 4
BP 1265
EP 1277
DI 10.1002/JLB.4MA0520-708R
EA JUL 2020
PG 13
WC Cell Biology; Hematology; Immunology
SC Cell Biology; Hematology; Immunology
GA NU0EX
UT WOS:000553225900001
PM 32726884
DA 2020-12-17
ER

PT J
AU da Silva, GAV
   Mesquita, TG
   Souza, VC
   Santo, JD
   de Souza, MLG
   Talhari, AC
   Talhari, S
   Naveca, FG
   Ramasawmy, R
AF da Silva, George A., V
   Mesquita, Tirza G.
   Souza, Victor C.
   Santo Junior, Jose do Espirito
   Gomes de Souza, Mara Lucia
   Talhari, Anette Chrusciak
   Talhari, Sinesio
   Naveca, Felipe G.
   Ramasawmy, Rajendranath
TI A Single Haplotype of IFNG Correlating With Low Circulating Levels of
   Interferon-gamma Is Associated With Susceptibility to Cutaneous
   Leishmaniasis Caused by Leishmania guyanensis
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE polymorphisms; haplotype; interferon-gamma; Leishmania guyanensis;
   cutaneous leishmaniasis
ID CD8(+) T-CELLS; NUCLEOTIDE POLYMORPHISM; MALARIA SUSCEPTIBILITY; GENE
   POLYMORPHISMS; INFECTION; RESPONSES; EFFECTOR; INTERLEUKIN-12;
   PROTECTION; RESISTANCE
AB Background. Interferon-gamma (IFN-gamma) plays an important role in the control of Leishmania infection. Blockade of IFN-gamma signaling in mice increases lesion size and parasite load. In endemic areas of Leishmaniasis, only a fraction of the population develop the disease. This suggest that host genetics may play a role in this response. We investigated whether single nucleotide polymorphisms (SNPs) in IFNG may be associated with elevated or decrease risk in the development of cutaneous leishmaniasis (CL).
   Methods. We assessed 9 SNP and cytosine-adenine (CA) repeats in IFNG by nucleotide sequencing in 647 patients with CL caused by Leishmania guyanensis and 629 controls. Circulating plasma IFN-gamma levels were also assayed in 400 patients with CL and 400 controls.
   Results. The rs2069705TT genotype is associated with elevated risk of developing CL compared with the rs2069705CC genotype (OR, 1.7; 95% CI, 1.3-2.4; P = .0008). There is a 70% chance that this genotype raises the risk of developing CL. In a dominant model, carriers of the rs2069705T allele compared with the rs2069705CC genotype showed a 50% (range, 20-100%) increased risk of developing CL (OR, 1.5; 95% CI, 1.2-2.0; P = .0004). Haplotype analysis showed 1 haplotype (H1) associated with low levels of IFN-gamma presented an increased risk of 60% of developing CL (OR, 1.6; 95% CI, 1.3-1.9; P = 5 x 10(-5)) compared with non-H1.
   Conclusions. IFNG variant rs2069705 seems to be a genetic modifier of clinical outcome of Leishmania infection; individuals with the H1 haplotype, associated with low levels of IFN-gamma, have a 60% risk of developing CL.
C1 [da Silva, George A., V; Santo Junior, Jose do Espirito; Ramasawmy, Rajendranath] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Mesquita, Tirza G.] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.
   [Souza, Victor C.; Naveca, Felipe G.] FIOCRUZ Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Gomes de Souza, Mara Lucia; Talhari, Anette Chrusciak; Talhari, Sinesio; Ramasawmy, Rajendranath] Fundacao Med Trop Doutor Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Talhari, Sinesio; Ramasawmy, Rajendranath] Univ Nilton Lins, Fac Med, Manaus, Amazonas, Brazil.
RP Ramasawmy, R (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Av Pedro Teixeira 25, Manaus, Amazonas, Brazil.
EM ramsawm@gmail.com
FU Brazilian Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [404181/2012-0]; Fundacao de Amparo a Pesquisa do Estado do
   Amazonas [06201954/2015]
FX This work was supported by the Brazilian Council for Scientific and
   Technological Development (CNPq) (grant number 404181/2012-0) to R. R.
   and the Fundacao de Amparo a Pesquisa do Estado do Amazonas to R. R.
   (grant number 06201954/2015).
CR Bittar RC, 2007, MEM I OSWALDO CRUZ, V102, P625, DOI 10.1590/S0074-02762007005000069
   Bourreau E, 2003, INFECT IMMUN, V71, P2244, DOI 10.1128/IAI.71.4.2244-2246.2003
   Bourreau E, 2001, J INFECT DIS, V183, P953, DOI 10.1086/319249
   Bourreau E, 2007, MICROBES INFECT, V9, P1034, DOI 10.1016/j.micinf.2007.04.009
   Dutra WO, 2011, DRUG DEVELOP RES, V72, P430, DOI 10.1002/ddr.20449
   Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x
   Furini AAC, 2016, MEDIAT INFLAMM, V2016, P1
   GALLIN JI, 1995, ANN INTERN MED, V123, P216, DOI 10.7326/0003-4819-123-3-199508010-00009
   Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004
   Gonsky R, 2014, INFLAMM BOWEL DIS, V20, P1794, DOI 10.1097/MIB.0000000000000172
   Henri S, 2002, INFECT IMMUN, V70, P3874, DOI 10.1128/IAI.70.7.3874-3880.2002
   Matos GI, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-33
   Kak Gunjan, 2018, BioMolecular Concepts, V9, P64, DOI 10.1515/bmc-2018-0007
   Kamali-Sarvestani E, 2006, CYTOKINE, V35, P159, DOI 10.1016/j.cyto.2006.07.016
   Kanchan K, 2015, INFECT GENET EVOL, V29, P6, DOI 10.1016/j.meegid.2014.10.030
   Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318
   Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881
   Koch O, 2005, GENES IMMUN, V6, P312, DOI 10.1038/sj.gene.6364214
   Lis J T, 1980, Methods Enzymol, V65, P347
   Marfurt J, 2003, J CLIN MICROBIOL, V41, P3147, DOI 10.1128/JCM.41.7.3147-3153.2003
   Medina TS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-264
   Nasr A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-314
   PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346
   Peixe RG, 2014, MEM I OSWALDO CRUZ, V109, P99, DOI 10.1590/0074-0276140539
   Pereira VA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0548-z
   Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x
   Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1
   Pravica V, 1999, EUR J IMMUNOGENET, V26, P1, DOI 10.1046/j.1365-2370.1999.00122.x
   Salih MA, 2007, GENES IMMUN, V8, P75, DOI 10.1038/sj.gene.6364353
   Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x
   Scott P, 2016, NAT REV IMMUNOL, V16, P581, DOI 10.1038/nri.2016.72
   Silva GAV, 2012, CYTOKINE, V60, P493, DOI 10.1016/j.cyto.2012.04.043
   Sousa-Franco J, 2006, MICROBES INFECT, V8, P390, DOI 10.1016/j.micinf.2005.07.007
   SWIHART K, 1995, J EXP MED, V181, P961, DOI 10.1084/jem.181.3.961
   Taylor AP, 1997, J EXP MED, V185, P1231, DOI 10.1084/jem.185.7.1231
   Tomiotto-Pellissier F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02529
   Torres OA, 2010, INFECT GENET EVOL, V10, P682, DOI 10.1016/j.meegid.2010.03.009
   WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367
   Weirather JL, 2017, ANN HUM GENET, V81, P41, DOI 10.1111/ahg.12180
NR 39
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 15
PY 2020
VL 71
IS 2
BP 274
EP 281
DI 10.1093/cid/ciz810
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA NZ5TN
UT WOS:000577168200005
PM 31722386
DA 2020-12-17
ER

PT J
AU Borba, MGS
   Val, FFA
   Sampaio, VS
   Alexandre, MAA
   Melo, GC
   Brito, M
   Mourao, MPG
   Brito-Sousa, JD
   Baia-da-Silva, D
   Guerra, MVF
   Hajjar, LA
   Pinto, RC
   Balieiro, AAS
   Pacheco, AGF
   Santos, JDO
   Naveca, FG
   Xavier, MS
   Siqueira, AM
   Schwarzbold, A
   Croda, J
   Nogueira, ML
   Romero, GAS
   Bassat, Q
   Fontes, CJ
   Albuquerque, BC
   Daniel-Ribeiro, CT
   Monteiro, WM
   Lacerda, MVG
AF Borba, Mayla Gabriela Silva
   Val, Fernando Fonseca Almeida
   Sampaio, Vanderson Souza
   Alexandre, Marcia Almeida Araujo
   Melo, Gisely Cardoso
   Brito, Marcelo
   Mourao, Maria Paula Gomes
   Brito-Sousa, Jose Diego
   Baia-da-Silva, Djane
   Guerra, Marcus Vinitius Farias
   Hajjar, Ludhmila Abrahao
   Pinto, Rosemary Costa
   Balieiro, Antonio Alcirley Silva
   Pacheco, Antonio Guilherme Fonseca
   Santos, James Dean Oliveira, Jr.
   Naveca, Felipe Gomes
   Xavier, Mariana Simao
   Siqueira, Andre Machado
   Schwarzbold, Alexandre
   Croda, Julio
   Nogueira, Mauricio Lacerda
   Romero, Gustavo Adolfo Sierra
   Bassat, Quique
   Fontes, Cor Jesus
   Albuquerque, Bernardino Claudio
   Daniel-Ribeiro, Claudio-Tadeu
   Monteiro, Wuelton Marcelo
   Lacerda, Marcus Vinicius Guimaraes
CA CloroCovid 19 Team
TI Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive
   Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome
   Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
SO JAMA NETWORK OPEN
LA English
DT Article
ID IN-VITRO; HYDROXYCHLOROQUINE; COVID-19
AB Importance There is no specific antiviral therapy recommended for coronavirus disease 2019 (COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ) requires a high concentration of the drug. Objective To evaluate the safety and efficacy of 2 CQ dosages in patients with severe COVID-19. Design, Setting, and Participants This parallel, double-masked, randomized, phase IIb clinical trial with 81 adult patients who were hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was conducted from March 23 to April 5, 2020, at a tertiary care facility in Manaus, Brazilian Amazon. Interventions Patients were allocated to receive high-dosage CQ (ie, 600 mg CQ twice daily for 10 days) or low-dosage CQ (ie, 450 mg twice daily on day 1 and once daily for 4 days). Main Outcomes and Measures Primary outcome was reduction in lethality by at least 50% in the high-dosage group compared with the low-dosage group. Data presented here refer primarily to safety and lethality outcomes during treatment on day 13. Secondary end points included participant clinical status, laboratory examinations, and electrocardiogram results. Outcomes will be presented to day 28. Viral respiratory secretion RNA detection was performed on days 0 and 4. Results Out of a predefined sample size of 440 patients, 81 were enrolled (41 [50.6%] to high-dosage group and 40 [49.4%] to low-dosage group). Enrolled patients had a mean (SD) age of 51.1 (13.9) years, and most (60 [75.3%]) were men. Older age (mean [SD] age, 54.7 [13.7] years vs 47.4 [13.3] years) and more heart disease (5 of 28 [17.9%] vs 0) were seen in the high-dose group. Viral RNA was detected in 31 of 40 (77.5%) and 31 of 41 (75.6%) patients in the low-dosage and high-dosage groups, respectively. Lethality until day 13 was 39.0% in the high-dosage group (16 of 41) and 15.0% in the low-dosage group (6 of 40). The high-dosage group presented more instance of QTc interval greater than 500 milliseconds (7 of 37 [18.9%]) compared with the low-dosage group (4 of 36 [11.1%]). Respiratory secretion at day 4 was negative in only 6 of 27 patients (22.2%). Conclusions and Relevance The preliminary findings of this study suggest that the higher CQ dosage should not be recommended for critically ill patients with COVID-19 because of its potential safety hazards, especially when taken concurrently with azithromycin and oseltamivir. These findings cannot be extrapolated to patients with nonsevere COVID-19.
C1 [Borba, Mayla Gabriela Silva; Val, Fernando Fonseca Almeida; Sampaio, Vanderson Souza; Alexandre, Marcia Almeida Araujo; Melo, Gisely Cardoso; Brito, Marcelo; Mourao, Maria Paula Gomes; Brito-Sousa, Jose Diego; Baia-da-Silva, Djane; Guerra, Marcus Vinitius Farias; Monteiro, Wuelton Marcelo; Lacerda, Marcus Vinicius Guimaraes] Fundacao Med Trop Dr Heitor Vieira Dourado, Av Pedro Teixeira,25 Dom Pedro, BR-69040000 Manaus, Amazonas, Brazil.
   [Borba, Mayla Gabriela Silva; Val, Fernando Fonseca Almeida; Sampaio, Vanderson Souza; Melo, Gisely Cardoso; Brito, Marcelo; Mourao, Maria Paula Gomes; Brito-Sousa, Jose Diego; Baia-da-Silva, Djane; Monteiro, Wuelton Marcelo; Lacerda, Marcus Vinicius Guimaraes] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Sampaio, Vanderson Souza; Pinto, Rosemary Costa] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [Hajjar, Ludhmila Abrahao] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Balieiro, Antonio Alcirley Silva; Naveca, Felipe Gomes; Lacerda, Marcus Vinicius Guimaraes] Fiocruz Amazonas, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Pacheco, Antonio Guilherme Fonseca] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Santos, James Dean Oliveira, Jr.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Xavier, Mariana Simao; Siqueira, Andre Machado] Inst Nacl Infectol Carlos Chagas Fiocruz, Rio De Janeiro, Brazil.
   [Schwarzbold, Alexandre] Univ Fed Santa Maria, Santa Maria, RS, Brazil.
   [Croda, Julio] Univ Fed Mato Grosso Do Sul, Fac Med, Campo Grande, MS, Brazil.
   [Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose Do Rio Preto, Sao Paulo, Brazil.
   [Romero, Gustavo Adolfo Sierra] Univ Brasilia, Brasilia, DF, Brazil.
   [Bassat, Quique] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.
   [Bassat, Quique] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Bassat, Quique] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain.
   [Bassat, Quique] Univ Barcelona, Hosp St Joan Deu, Pediat Dept, Pediat Infect Dis Unit, Barcelona, Spain.
   [Bassat, Quique] Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain.
   [Fontes, Cor Jesus] Univ Fed Mato Grosso, Cuiaba, Mato Grosso, Brazil.
   [Albuquerque, Bernardino Claudio] Univ Fed Amazonas, Fac Med, Manaus, Amazonas, Brazil.
   [Daniel-Ribeiro, Claudio-Tadeu] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Lacerda, MVG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Av Pedro Teixeira,25 Dom Pedro, BR-69040000 Manaus, Amazonas, Brazil.
EM marcuslacerda.br@gmail.com
RI Sampaio, Vanderson/AAQ-1418-2020; Pacheco, Antonio
   Guilherme/E-6378-2013; Nogueira, Mauricio L/B-7599-2012
OI Sampaio, Vanderson/0000-0001-7307-8851; Pacheco, Antonio
   Guilherme/0000-0003-3095-1774; Nogueira, Mauricio L/0000-0003-1102-2419;
   Santos, James/0000-0002-0627-6126; Val, Fernando/0000-0001-9995-0249;
   Brito-Sousa, Jose Diego/0000-0003-1659-3763
FU Coordination for the Improvement of Higher Education Personnel; Spanish
   Ministry of Science and Innovation through Centro de Excelencia Severo
   Ochoa 2019-2023 Program [CEX2018-000806-S]; Generalitat de Catalunya
   through the Centres de Recerca de Catalunya Program; Government of
   Mozambique; Spanish Agency for International Development; Fundacao de
   Amparo a Pesquisa do Estado do Amazonas; Government of the Amazonas
   State; Farmanguinhos (Fiocruz); Superintendencia da Zona Franca de
   Manaus; Brazilian Senate
FX Many members of the CloroCovid-19 Team are funded by Fundacao de Amparo
   a Pesquisa do Estado do Amazonas and Coordination for the Improvement of
   Higher Education Personnel. ISGlobal receives support from the Spanish
   Ministry of Science and Innovation through Centro de Excelencia Severo
   Ochoa 20192023 Program (grant, CEX2018-000806-S) and from Generalitat de
   Catalunya through the Centres de Recerca de Catalunya Program. Centro de
   Investigacao em Saude de Manhica is supported by the Government of
   Mozambique and the Spanish Agency for International Development. This
   study was funded by the Government of the Amazonas State, Farmanguinhos
   (Fiocruz), Superintendencia da Zona Franca de Manaus, Coordination for
   the Improvement of Higher Education Personnel, Fundacao de Amparo a
   Pesquisa do Estado do Amazonas, and federal funds facilitated by the
   Brazilian Senate.
CR Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Chorin E, 2020, QT INTERVAL PATIENTS
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   INGLOT AD, 1969, J GEN VIROL, V4, P203, DOI 10.1099/0022-1317-4-2-203
   Karasic TB, 2019, JAMA ONCOL, V5, P993, DOI 10.1001/jamaoncol.2019.0684
   Kazi M.S., 2013, J OPHTHALMOL, V20, P89
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   Lim HS, 2009, ANTIMICROB AGENTS CH, V53, P1468, DOI 10.1128/AAC.00339-08
   Ling ZK, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108956
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Mavrikakis I, 2003, OPHTHALMOLOGY, V110, P1321, DOI 10.1016/S0161-6420(03)00409-3
   MILLER DK, 1981, P NATL ACAD SCI-BIOL, V78, P3605, DOI 10.1073/pnas.78.6.3605
   multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI 10.3760/cma.j.issn.1001-0939.2020.0019
   Nti AA, 2019, RETINA-J RET VIT DIS, V39, P502, DOI 10.1097/IAE.0000000000002027
   Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101613
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Science Direct, CHLOR RET
   Shi Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2833-7
   Silva JA, 2007, CLIN EXP RHEUMATOL, V25, P795
   US Centers for Disease Control and Prevention, CDC 2019 NOV COR 201
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 29
TC 254
Z9 256
U1 20
U2 28
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD APR 24
PY 2020
VL 3
IS 4
AR e208857
DI 10.1001/jamanetworkopen.2020.8857
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA LJ1VI
UT WOS:000529959400001
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Hayd, RLN
   Moreno, MR
   Naveca, F
   Amdur, R
   Suchowiecki, K
   Watson, H
   Firestein, GS
   Simon, G
   Chang, AY
AF Hayd, Ramao Luciano Nogueira
   Moreno, Maony Rodrigues
   Naveca, Felipe
   Amdur, Richard
   Suchowiecki, Karol
   Watson, Hugh
   Firestein, Gary S.
   Simon, Gary
   Chang, Aileen Y.
TI Persistent chikungunya arthritis in Roraima, Brazil
SO CLINICAL RHEUMATOLOGY
LA English
DT Article
DE Amazon region; Chikungunya; Rheumatoid arthritis
ID REGULATORY T-CELLS; DISEASE
AB Background The Amazon region of Brazil experienced a large epidemic of East Central South African (ECSA) chikungunya virus (CHIKV) in 2017 and continuous transmission of CHIKV persists. The impact of chronic arthritis caused by ECSA CHIKV is unknown. Objective The study aim was to describe the duration, severity, and characteristics of CHIKV arthritis in Roraima, Brazil, in comparison with local controls to further understand the long-term rheumatologic impact of ECSA CHIKV infection. Methods We performed a cross-sectional analysis comparing clinical arthritis outcomes among 40 cases with chronic (> 3 months) arthritis attributed to their CHIKV disease (n = 40) with control participants who were exposed to CHIKV but did not develop chronic arthritis (n = 40), rheumatoid arthritis controls (n = 40), and healthy controls lacking CHIKV exposure and arthritis (n = 40). Findings Our primary finding is that over 2 years post-infection, patients report moderate arthritis disease severity comparable with rheumatoid arthritis with the most significant impact on decreased quality of life from pain. Main conclusions These findings suggest that chronic arthritis caused by ECSA CHIKV infection has had a moderate impact in the Americas.
C1 [Hayd, Ramao Luciano Nogueira; Moreno, Maony Rodrigues] Univ Fed Roraima, Lab Parasitol & Vetores Amazonia, Curso Enfermagem, Ctr Ciencias Saude, Boa Vista, RR, Brazil.
   [Naveca, Felipe] Fiocruz MS, Lab Ecol Doencas Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Amdur, Richard] George Washington Univ, Dept Surg, Washington, DC USA.
   [Suchowiecki, Karol; Simon, Gary; Chang, Aileen Y.] George Washington Univ, Dept Med, 2150 Penn Ave Suite 5-416, Washington, DC 20037 USA.
   [Watson, Hugh] Evotec ID, Lyon, France.
   [Firestein, Gary S.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.
RP Chang, AY (corresponding author), George Washington Univ, Dept Med, 2150 Penn Ave Suite 5-416, Washington, DC 20037 USA.
EM chang@email.gwu.edu
RI Watson, Hugh/AAL-5353-2020
OI Hayd, Ramao/0000-0002-9079-1111
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [KL2-TR-001877, KL2-TR-001877] Funding
   Source: Medline
CR Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584
   BARBOSA Reinaldo Imbrosio, 1993, B MUSEU PARAENSE EMI, V9, P123
   Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P578, DOI 10.1002/art.40384
   Gatis-Carrazzoni ASSG, 2019, N-S ARCH PHARMACOL, V392, P55, DOI 10.1007/s00210-018-1561-x
   Gopalan SS, 2009, J VECTOR DIS, V46, P57
   Hayd R, 2019, THESIS
   Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Jaffar-Bandjee MC, 2009, MICROBES INFECT, V11, P1206, DOI 10.1016/j.micinf.2009.10.001
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   Kulkarni SP, 2017, EUR J CLIN MICROBIOL, V36, P2475, DOI 10.1007/s10096-017-3087-4
   Lee WWL, 2015, J VIROL, V89, P7893, DOI 10.1128/JVI.00998-15
   Meneses CAR, 2013, THESIS
   Naveca FG, 2018, CHIKUNGUNYA VIRUS OU
   Pan American Health Organization, CHIK DAT MAPS STAT
   PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107
   Relatorio anual de Epidemiologia de Roraima, 2018, GOV EST ROR COORD GE
   SESAU-CGVS, 2017, B EP VIG ENT
   SINAN/NSIS/DVE/CGVS/SESAU/RR, 2017, SIST NAC AGR NOT GVS
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Tritsch SR, 2020, J RHEUMATOL, V47, P1267, DOI 10.3899/jrheum.190162
   Vasconcelos MAL, 2006, Z NATURFORSCH C, V61, P477, DOI 10.1515/znc-2006-7-803
   Vora Neil, 2008, Medscape J Med, V10, P238
   Watson H, 2020, CLIN RHEUMATOL, V39, P1679, DOI 10.1007/s10067-019-04919-1
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 26
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD SEP
PY 2020
VL 39
IS 9
BP 2781
EP 2787
DI 10.1007/s10067-020-05011-9
EA MAR 2020
PG 7
WC Rheumatology
SC Rheumatology
GA NB8UO
UT WOS:000519830300003
PM 32170487
DA 2020-12-17
ER

PT J
AU Giovanetti, M
   Faria, NR
   Lourenco, J
   de Jesus, JG
   Xavier, J
   Claro, IM
   Kraemer, MUG
   Fonseca, V
   Dellicour, S
   Theze, J
   Salles, FD
   Graf, T
   Silveira, PP
   do Nascimento, VA
   de Souza, VC
   Iani, FCD
   Castilho-Martins, EA
   Cruz, LN
   Wallau, G
   Fabri, A
   Levy, F
   Quick, J
   de Azevedo, V
   Aguiar, RS
   de Oliveira, T
   de Menezes, CB
   Castilho, MD
   Terra, TM
   da Silva, MS
   de Filippis, AMB
   de Abreu, AL
   Oliveira, WK
   Croda, J
   de Albuquerque, CFC
   Nunes, MRT
   Sabino, EC
   Loman, N
   Naveca, FG
   Pybus, OG
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Lourenco, Jose
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   Claro, Ingra Morales
   Kraemer, Moritz U. G.
   Fonseca, Vagner
   Dellicour, Simon
   Theze, Julien
   Salles, Flavia da Silva
   Graf, Tiago
   Silveira, Paola Paz
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   de Melo Iani, Felipe Campos
   Castilho-Martins, Emerson Augusto
   Cruz, Laura Nogueira
   Wallau, Gabriel
   Fabri, Allison
   Levy, Flavia
   Quick, Joshua
   de Azevedo, Vasco
   Aguiar, Renato Santana
   de Oliveira, Tulio
   de Menezes, Camila Botto
   Castilho, Marcia da Costa
   Terra, Tirza Matos
   da Silva, Marineide Souza
   Bispo de Filippis, Ana Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Croda, Julio
   Campelo de Albuquerque, Carlos F.
   Nunes, Marcio R. T.
   Sabino, Ester Cerdeira
   Loman, Nicholas
   Naveca, Felipe Gomes
   Pybus, Oliver G.
   Alcantara, Luiz Carlos
TI Genomic and Epidemiological Surveillance of Zika Virus in the Amazon
   Region
SO CELL REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; TRANSMISSION; OUTBREAK; SPREAD; BRAZIL;
   OROPOUCHE; REVEALS; MODELS; ANGOLA; FEVER
AB Zika virus (ZIKV) has caused an explosive epidemic linked to severe clinical outcomes in the Americas. As of June 2018, 4,929 ZIKV suspected infections and 46 congenital syndrome cases had been reported in Manaus, Amazonas, Brazil. Although Manaus is a key demographic hub in the Amazon region, little is known about the ZIKV epidemic there, in terms of both transmission and viral genetic diversity. Using portable virus genome sequencing, we generated 59 ZIKV genomes in Manaus. Phylogenetic analyses indicated multiple introductions of ZIKV from northeastern Brazil to Manaus. Spatial genomic analysis of virus movement among six areas in Manaus suggested that populous northern neighborhoods acted as sources of virus transmission to other neighborhoods. Our study revealed how the ZIKV epidemic was ignited and maintained within the largest urban metropolis in the Amazon. These results might contribute to improving the public health response to outbreaks in Brazil.
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Fabri, Allison; Levy, Flavia; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Faria, Nuno Rodrigues; Xavier, Joilson; Fonseca, Vagner; de Melo Iani, Felipe Campos; de Azevedo, Vasco; Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Kraemer, Moritz U. G.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Claro, Ingra Morales; Salles, Flavia da Silva; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, ZA-4001 Durban, South Africa.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium.
   [Dellicour, Simon] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Graf, Tiago; Silveira, Paola Paz; Aguiar, Renato Santana] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [de Melo Iani, Felipe Campos] Fundacao Ezequiel Dias, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Castilho-Martins, Emerson Augusto] Univ Fed Amapa, Fac Med, Macapa, Brazil.
   [Cruz, Laura Nogueira; de Abreu, Andre Luiz] Minist Saude CGLAB SVS MS, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, Brasilia, DF, Brazil.
   [Wallau, Gabriel] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Quick, Joshua; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [de Menezes, Camila Botto] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tirza Matos; da Silva, Marineide Souza] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Oliveira, Wanderson Kleber] MS, SVS, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil.
RP Alcantara, LC (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Faria, NR; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.; Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM nuno.faria@zoo.ox.ac.uk; oliver.pybus@zoo.ox.ac.uk;
   luiz.alcantara@ioc.fiocruz.br
RI Graf, Tiago/S-8535-2019; Nascimento, Valdinete Alves do/AAV-1879-2020;
   Wallau, Gabriel Luz/B-5911-2008; Fonseca, Vagner/R-5813-2019; Pybus,
   Oliver G/B-2640-2012; Dellicour, Simon/AAE-9054-2020; Faria, Nuno
   R/I-2975-2012; Castilho-Martins, Emerson Augusto/I-2094-2014; Oliveira,
   Wanderson/D-7140-2016
OI Graf, Tiago/0000-0003-4921-7975; Nascimento, Valdinete Alves
   do/0000-0002-7786-4718; Wallau, Gabriel Luz/0000-0002-1419-5713;
   Fonseca, Vagner/0000-0001-5521-6448; Pybus, Oliver
   G/0000-0002-8797-2667; Dellicour, Simon/0000-0001-9558-1052; Faria, Nuno
   R/0000-0001-8839-2798; Theze, Julien/0000-0001-8188-9494; da Silva
   Sales, Flavia Cristina/0000-0002-9048-0030; Castilho-Martins, Emerson
   Augusto/0000-0003-0542-4294; Alcantara, Luiz/0000-0002-6769-9931;
   Xavier, Joilson/0000-0003-3916-2018; /0000-0002-8529-4022; Oliveira,
   Wanderson/0000-0002-9662-1930
FU Decit/SCTIE/MoH; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/2016-00, 88881.130825/2016-00, 88887.130823/201600];
   European Union (EU) Horizon 2020 Programme through ZIKAllianceEuropean
   Union (EU) [PRES-005-FEX-17-4-2-33]; Oxford Martin School; Branco Weiss
   Fellowship - Society in Science; Google Faculty Award; Training Grant
   from the National Institute of Child Health and Human Development
   [T32HD040128]; Fonds National de la Recherche Scientifique (FNRS;
   Belgium)Fonds de la Recherche Scientifique - FNRS; FaperjCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/2002.930/2016]; International Development Research Centre
   (IDRC) Canada [108411-001]; EU Horizon 2020 Programme through ZikaPlan
   and ZikAction [734584, 734857]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX We thank Oxford Nanopore Technologies for technical support and QIAGEN
   for support of the ZIBRA-2 (Zika in Brazil Real Time Analyses-Second
   Round) project with reagents and equipment. This work was supported by
   Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7); by CAPES
   (88887.130716/2016-00, 88881.130825/2016-00, and 88887.130823/201600);
   by the European Union (EU) Horizon 2020 Programme through ZIKAlliance
   (PRES-005-FEX-17-4-2-33); and by the Oxford Martin School. M.U.G.K. is
   supported by The Branco Weiss Fellowship - Society in Science,
   administered by ETH Zurich, and acknowledges funding from a Google
   Faculty Award and a Training Grant from the National Institute of Child
   Health and Human Development (T32HD040128). S.D. is supported by Fonds
   National de la Recherche Scientifique (FNRS; Belgium). The activities of
   the A.M.B.F. laboratory were supported by the Faperj under the grant no.
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada under the grant 108411-001) and the EU Horizon 2020
   Programme through ZikaPlan and ZikAction (grants 734584 and 734857).
   M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ).
CR Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chaves BA, 2019, J MED ENTOMOL, V56, P1739, DOI 10.1093/jme/tjz110
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Fonseca V., 2019, PLOS NEGLECT TROP D, V213, P72
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Izquierdo-Suzan M, 2019, EMERG INFECT DIS, V25, P1477, DOI 10.3201/eid2508.181533
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kraemer MUG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41192-3
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Lourenco J., 2017, ELIFE, V6, P290
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Oboist U, 2019, METHODS ECOL EVOL, V10, P1357, DOI 10.1111/2041-210X.13205
   Perez-Guzman P.N., 2018, PLOS CURR, V10, P16
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2019, B EPIDEMIOLOGICO
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Vasconcelos L., 2001, P 1 WORLD PLANN C AC, V32, P11
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Wickham H, 2016, ELEGANT GRAPHICS DAT
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 64
TC 2
Z9 2
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 18
PY 2020
VL 30
IS 7
BP 2275
EP 2283
DI 10.1016/j.celrep.2020.01.085
PG 9
WC Cell Biology
SC Cell Biology
GA KN4QZ
UT WOS:000514824500019
PM 32075736
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU do Nascimento, VA
   Corado, ADG
   do Nascimento, FO
   da Costa, AKA
   Duarte, DCG
   Luz, SLB
   Goncalves, LMF
   de Jesus, MS
   da Costa, CF
   Delatorre, E
   Naveca, FG
AF do Nascimento, Valdinete Alves
   Guerra Corado, Andre de Lima
   do Nascimento, Fernanda Oliveira
   Araujo da Costa, Agatha Kelly
   Gomes Duarte, Debora Camila
   Bessa Luz, Sergio Luiz
   Fe Goncalves, Luciana Mara
   de Jesus, Michele Silva
   da Costa, Cristiano Fernandes
   Delatorre, Edson
   Naveca, Felipe Gomes
TI Genomic and phylogenetic characterisation of an imported case of
   SARS-CoV-2 in Amazonas State, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE coronavirus; SARS-CoV-2; COVID-19; Brazil; Amazon Region; genome
ID CORONAVIRUS; PATHOGENESIS; PNEUMONIA
AB A new coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] is currently causing a life-threatening pandemic. In this study, we report the complete genome sequencing and genetic characterisation of a SARS-CoV-2 detected in Manaus, Amazonas, Brazil, and the protocol we designed to generate high-quality SARS-CoV-2 full genome data. The isolate was obtained from an asymptomatic carrier returning from Madrid, Spain. Nucleotide sequence analysis showed a total of nine mutations in comparison with the original human case in Wuhan, China, and support this case as belonging to the recently proposed lineage A.2. Phylogeographic analysis further confirmed the likely European origin of this case. To our knowledge, this is the first SARS-CoV-2 genome obtained from the North Brazilian Region. We believe that the information generated in this study may contribute to the ongoing efforts toward the SARS-CoV-2 emergence.
C1 [do Nascimento, Valdinete Alves; Guerra Corado, Andre de Lima; do Nascimento, Fernanda Oliveira; Araujo da Costa, Agatha Kelly; Gomes Duarte, Debora Camila; Bessa Luz, Sergio Luiz; de Jesus, Michele Silva; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [do Nascimento, Valdinete Alves; Guerra Corado, Andre de Lima; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Biol Celular & Mol, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [do Nascimento, Fernanda Oliveira; Araujo da Costa, Agatha Kelly; Bessa Luz, Sergio Luiz; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Biol Interacao Patogeno Hosp, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Fe Goncalves, Luciana Mara; da Costa, Cristiano Fernandes] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [Delatorre, Edson] Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Vitoria, ES, Brazil.
   [Naveca, Felipe Gomes] Rede Genom Vigilancia Saude Estado Amazonas, Manaus, Amazonas, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Biol Celular & Mol, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.; Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Biol Interacao Patogeno Hosp, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Rede Genom Vigilancia Saude Estado Amazonas, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Delatorre, Edson/J-8330-2015
OI Delatorre, Edson/0000-0002-5746-0820; Fe-Goncalves, Luciana
   Mara/0000-0002-9240-9975
FU FAPEAM [005/2020]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440856/2016-7, 403276/2020-9]; CAPESCAPES
   [88881.130825/201601, 88887.130823/2016-00]; Inova Fiocruz/FIOCRUZ
   [VPPCB007-FIO-18-2-30]
FX FGN is funded by FAPEAM (PCTI-EmergeSaude/AM call No 005/2020 and Rede
   Genomica de Vigilancia em Saude -REGESAM), CNPq (Grants 440856/2016-7
   and 403276/2020-9), CAPES (Grants 88881.130825/201601 and
   88887.130823/2016-00), Inova Fiocruz/FIOCRUZ (Grant VPPCB007-FIO-18-2-30
   -Geracao de conhecimento).
CR Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   BOND CW, 1979, VIROLOGY, V94, P371, DOI 10.1016/0042-6822(79)90468-9
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   FVS/AM-Fundacao de Vigilancia em Saude do Amazonas, 2020, SIT EP COVID 19 SIND
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li RY, 2020, SCIENCE, V368, P489, DOI 10.1126/science.abb3221
   MS/SVE-Ministerio da Saude/Secretaria de Vigilancia Epide- miologica, 2020, B EP DOENC PEL COR 2
   MS/SVE-Ministerio da Saude/Secretaria de Vigilancia Epidemio- logica, 2020, B EP B ESP DOENC PEL, V15
   Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Rambaut Andrew, 2020, Nat Microbiol, V5, P1403, DOI 10.1038/s41564-020-0770-5
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Resende PC, PREPRINT, DOI [10.1101/2020.06.17.158006v1.full.pdf, DOI 10.1101/2020.06.17.158006V1.FULL.PDF]
   Shu Y, 2017, EUROSURVEILLANCE, V22, P957
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 29
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e200310
DI 10.1590/0074-02760200310
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA NZ0HZ
UT WOS:000576774000001
PM 32997001
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU do Nascimento, VA
   Santos, JHA
   Monteiro, DCD
   Pessoa, KP
   Cardoso, AJL
   de Souza, VC
   Abdalla, LF
   Naveca, FG
AF do Nascimento, Valdinete Alves
   Abdalla Santos, Joao Hugo
   da Silva Monteiro, Dana Cristina
   Pessoa, Karina Pinheiro
   Leao Cardoso, Antonio Jose
   de Souza, Victor Costa
   Abdalla, Ligia Fernandes
   Naveca, Felipe Gomes
TI Oropouche virus detection in saliva and urine
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE arboviruses; orthobunyavirus; Oropouche virus; saliva; urine; real-time
   polymerase chain reaction
ID ZIKA VIRUS; FEVER; PATIENT; STATE
AB Oropouche virus (OROV) is an arthropod-borne virus of the Peribunyaviridae family, transmitted to humans primarily by Culicoides paraensis. It is one of the main arboviruses infecting humans in Brazil, primarily in the Amazon Region. Here, we report the detection of OROV in the saliva and urine of a patient whose samples were collected five days after the onset of symptoms. Nucleotide sequencing and phylogenetic analysis further confirmed the results. To our knowledge, this is the first study reporting the detection of OROV in the saliva and urine of an infected patient. In addition, the results of our study expand the current knowledge pertaining to the natural history of Oropouche fever.
C1 [do Nascimento, Valdinete Alves; da Silva Monteiro, Dana Cristina; Pessoa, Karina Pinheiro; Leao Cardoso, Antonio Jose; de Souza, Victor Costa; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Inst Oswald Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, RJ, Brazil.
   [Abdalla Santos, Joao Hugo] Univ Fed Amazonas, Manaus, AM, Brazil.
   [Abdalla Santos, Joao Hugo] Hosp Adventista Manaus, Manaus, AM, Brazil.
   [Pessoa, Karina Pinheiro; Leao Cardoso, Antonio Jose; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogeno Hospedei, Manaus, AM, Brazil.
   [Abdalla, Ligia Fernandes] Univ Estado Amazonas, Manaus, AM, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.; Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswald Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, RJ, Brazil.; Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogeno Hospedei, Manaus, AM, Brazil.
EM felipe.naveca@fiocruz.br
RI Nascimento, Valdinete Alves do/AAV-1879-2020; Naveca, Felipe/H-1130-2012
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Naveca,
   Felipe/0000-0002-2888-1060
CR Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2
   Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Luna LKD, 2017, J MED VIROL, V89, P1108, DOI 10.1002/jmv.24722
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2018, PLOS CURR, V10
   Romero-Alvarez D, 2018, MICROBES INFECT, V20, P135, DOI 10.1016/j.micinf.2017.11.013
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Nunes MRT, 2019, INFECT GENET EVOL, V68, P16, DOI 10.1016/j.meegid.2018.11.020
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Wise EL, 2018, EMERG INFECT DIS, V24, P935, DOI 10.3201/eid2405.171569
NR 29
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e190338
DI 10.1590/0074-02760190338
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KT1YW
UT WOS:000518810200001
PM 32130368
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   Joshua, Q
   Claro, IM
   Xavier, J
   Hill, SC
   Renato, S
   Paz, P
   Lourenco, J
   Dellicour, S
   Sabino, E
   Loman, NJ
   Naveca, F
   Pybus, OG
   Faria, NR
   Alcantara, LCJ
AF Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Joshua, Quick
   Claro, Ingra Morales
   Xavier Junior, Joilson
   Hill, Sarah C.
   Renato, Souza
   Paz, Paola
   Lourenco, Jose
   Dellicour, Simon
   Sabino, Esther
   Loman, Nicholas J.
   Naveca, Felipe
   Pybus, Oliver G.
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
TI Genomic surveillance of Zika virus transmission in the Amazonas State,
   Brazil
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier Junior, Joilson; Junior Alcantara, Luiz Carlos] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Joshua, Quick; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, Ingra Morales; Sabino, Esther] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Hill, Sarah C.; Lourenco, Jose; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Renato, Souza; Paz, Paola] Univ Fed Rio de Janeiro, Inst Pasteur, Lab Clin & Epidemiol Virol, Rio De Janeiro, Brazil.
   [Dellicour, Simon] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
   [Naveca, Felipe] Fiocruz MS, Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
RI Dellicour, Simon/AAE-9054-2020; Faria, Nuno R/I-2975-2012; Giovanetti,
   Marta/AAK-7408-2020; Pybus, Oliver G/B-2640-2012
OI Dellicour, Simon/0000-0001-9558-1052; Faria, Nuno R/0000-0001-8839-2798;
   Pybus, Oliver G/0000-0002-8797-2667
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A32
BP S10
EP S10
DI 10.1093/ve/vez002.031
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600033
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Naveca, FG
   Claro, I
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Iani, FCD
   do Nascimento, VA
   de Souza, VC
   Silveira, PP
   Lourenco, J
   Santillana, M
   Kraemer, MUG
   Quick, J
   Hill, SC
   Theze, J
   Carvalho, RDD
   Azevedo, V
   Salles, FCD
   Nunes, MRT
   Lemos, PD
   Candido, DD
   Pereira, GD
   Oliveira, MAA
   Meneses, CAR
   Maito, RM
   Cunha, CRS
   Campos, DPD
   Castilho, MD
   Siqueira, TCD
   Terra, TM
   de Albuquerque, CFC
   da Cruz, LN
   de Abreu, AL
   Martins, DV
   Simoes, DSDV
   de Aguiar, RS
   Luz, SLB
   Loman, N
   Pybus, OG
   Sabino, EC
   Okumoto, O
   Alcantara, LCJ
   Faria, NR
AF Naveca, Felipe Gomes
   Claro, Ingra
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   de Melo Iani, Felipe Campos
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Silveira, Paola Paz
   Lourenco, Jose
   Santillana, Mauricio
   Kraemer, Moritz U. G.
   Quick, Josh
   Hill, Sarah C.
   Theze, Julien
   de Oliveira Carvalho, Rodrigo Dias
   Azevedo, Vasco
   da Silva Salles, Flavia Cristina
   Teixeira Nunes, Marcio Roberto
   Lemos, Poliana da Silva
   Candido, Darlan da Silva
   Pereira, Glauco de Carvalho
   Assuncao Oliveira, Marluce Aparecida
   Ribeiro Meneses, Catia Alexandra
   Maito, Rodrigo Melo
   Santa Brigida Cunha, Claudeth Rocha
   de Sousa Campos, Daniela Palha
   Castilho, Marcia da Costa
   da Silva Siqueira, Thalita Caroline
   Terra, Tiza Matos
   Campelo de Albuquerque, Carlos F.
   da Cruz, Laura Nogueira
   de Abreu, Andre Luis
   Martins, Divino Valerio
   de Moraes Vanlume Simoes, Daniele Silva
   de Aguiar, Renato Santana
   Bessa Luz, Sergio Luiz
   Loman, Nicholas
   Pybus, Oliver G.
   Sabino, Ester C.
   Okumoto, Osnei
   Junior Alcantara, Luiz Carlos
   Faria, Nuno Rodrigues
TI Genomic, epidemiological and digital surveillance of Chikungunya virus
   in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAYARO VIRUS; POPULATION-DYNAMICS; MATO-GROSSO; ZIKA VIRUS; OUTBREAK;
   INFERENCE; EMERGENCE; OROPOUCHE; DISEASE; ILLNESS
AB Background Since its first detection in the Caribbean in late 2013, chikungunya virus (CHIKV) has affected 51 countries in the Americas. The CHIKV epidemic in the Americas was caused by the CHIKV-Asian genotype. In August 2014, local transmission of the CHIKV-Asian genotype was detected in the Brazilian Amazon region. However, a distinct lineage, the CHIKV-East-Central-South-America (ECSA)-genotype, was detected nearly simultaneously in Feira de Santana, Bahia state, northeast Brazil. The genomic diversity and the dynamics of CHIKV in the Brazilian Amazon region remains poorly understood despite its importance to better understand the epidemiological spread and public health impact of CHIKV in the country.
   Methodology/Principal findings We report a large CHIKV outbreak (5,928 notified cases between August 2014 and August 2018) in Boa vista municipality, capital city of Roraima's state, located in the Brazilian Amazon region. We generated 20 novel CHIKV-ECSA genomes from the Brazilian Amazon region using MinION portable genome sequencing. Phylogenetic analyses revealed that despite an early introduction of the Asian genotype in 2015 in Roraima, the large CHIKV outbreak in 2017 in Boa Vista was caused by an ECSA-lineage most likely introduced from northeastern Brazil. Epidemiological analyses suggest a basic reproductive number of R-0 of 1.66, which translates in an estimated 39 (95% CI: 36 to 45) % of Roraima's population infected with CHIKV-ECSA. Finally, we find a strong association between Google search activity and the local laboratory-confirmed CHIKV cases in Roraima.
   Conclusions/Significance This study highlights the potential of combining traditional surveillance with portable genome sequencing technologies and digital epidemiology to inform public health surveillance in the Amazon region. Our data reveal a large CHIKV-ECSA outbreak in Boa Vista, limited potential for future CHIKV outbreaks, and indicate a replacement of the Asian genotype by the ECSA genotype in the Amazon region.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa; Bessa Luz, Sergio Luiz] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; de Melo Iani, Felipe Campos; de Oliveira Carvalho, Rodrigo Dias; Azevedo, Vasco; Pereira, Glauco de Carvalho; Assuncao Oliveira, Marluce Aparecida; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [de Jesus, Jaqueline Goes; Xavier, Joilson] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [de Melo Iani, Felipe Campos] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Silveira, Paola Paz; de Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Lourenco, Jose; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
   [Santillana, Mauricio] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Santillana, Mauricio] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Quick, Josh; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Teixeira Nunes, Marcio Roberto; Lemos, Poliana da Silva] Brazilian Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Ribeiro Meneses, Catia Alexandra; Maito, Rodrigo Melo; Santa Brigida Cunha, Claudeth Rocha] Lab Cent Saude Publ, Boa Vista, Roraima, Brazil.
   [de Sousa Campos, Daniela Palha; da Silva Siqueira, Thalita Caroline] Secretaria Municipal Saude Boa Vista, Superintendencia Vigilancia Saude, Roraima, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tiza Matos] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [da Cruz, Laura Nogueira; de Abreu, Andre Luis; Martins, Divino Valerio; de Moraes Vanlume Simoes, Daniele Silva; Okumoto, Osnei] MS, SVS, Brasilia, DF, Brazil.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
EM luiz.alcantara@ioc.fiocruz.br; nuno.faria@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; Aguiar, Renato
   S/G-3542-2015; Sabino, Ester Cerdeira/F-7750-2010; Azevedo, Vasco
   A/B-1556-2019; Giovanetti, Marta/AAK-7408-2020; Nascimento, Valdinete
   Alves do/AAV-1879-2020; Loman, Nicholas/Z-1573-2019
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Aguiar, Renato S/0000-0001-5180-3717; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Azevedo, Vasco A/0000-0002-4775-2280;
   Nascimento, Valdinete Alves do/0000-0002-7786-4718; Hill,
   Sarah/0000-0002-2995-2596; Luz, Sergio Luiz Bessa/0000-0001-5887-7372;
   Souza, Victor Costa de/0000-0002-3869-1519; Alcantara,
   Luiz/0000-0002-6769-9931; Xavier, Joilson/0000-0003-3916-2018; Lourenco,
   Jose/0000-0002-9318-2581; da Silva Candido, Darlan/0000-0002-5080-3130;
   /0000-0002-8529-4022; Carvalho, Rodrigo/0000-0003-0216-7173; da Silva
   Sales, Flavia Cristina/0000-0002-9048-0030; Theze,
   Julien/0000-0001-8188-9494; Iani, Felipe/0000-0002-3629-8529
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440685/2016-8, 440856/2016-7]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88887.130716/2016-00,
   88881.130825/2016-00, 88887.130823/2016-00]; EU's Horizon 2020 Programme
   through ZIKAlliance [PRES-005-FEX-17-4-2-33]; Royal SocietyRoyal Society
   of London; Wellcome Trust Sir Henry Dale Fellowship [204311/Z/16/Z];
   John Fell Research Fund [005166]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN]; National Institute of General Medical Sciences of
   the NIH (USA) [R01GM130668]; internal GCRF grant [005073]; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM130668] Funding
   Source: NIH RePORTER
FX The ZIBRA-2 project is funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 440685/2016-8) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   88887.130716/2016-00). FGN is funded by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br, grant
   440856/2016-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br, grants 88881.130825/2016-00 and
   88887.130823/2016-00). L.C.J.A. is supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant PRES-005-FEX-17-4-2-33). N.R.F. is
   funded by a Royal Society and Wellcome Trust Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN). MS was partially supported by the
   National Institute of General Medical Sciences of the NIH (USA) under
   award number R01GM130668. The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR [Anonymous], 2015, PUBMED, V7, pe141
   [Anonymous], 2017, EMERGING INFECTIOUS, V23, ps6
   [Anonymous], 2015, PUBMED, V31, P43
   [Anonymous], 2016, PLOS CURRENTS OUTBRE, V39, pS1, DOI 10.2337/dc16-S001
   [Anonymous], 2015, PUBMED, V4, pA1
   [Anonymous], 2010, EURO SURVEILLANCE, V15, pe1936
   [Anonymous], 2016, PUBMED, V44, pD7
   [Anonymous], 2016, EVOLUTION, V2, pA49
   [Anonymous], 2016, PUBMED, V21, piii
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrillo FB, 2019, J VIROL, V93, DOI 10.1128/JVI.01622-18
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Freitas Andre Ricardo Ribas, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.14608e586cd321d8d5088652d7a0d884
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Obolski U, 2018, MVSE R PACKAGE ESTIM, DOI [10.1101/360701, DOI 10.1101/360701]
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Organization PAWH, 2017, NUMB REP CAS CHIK FE
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Receveur M. C., 2010, EUROSURVEILLANCE, V15, P18
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TM, 2017, PLOS CURRENTS, V9, DOI [10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727, DOI 10.1371/CURRENTS.OUTBREAKS.4200119978D62CCAA454599CD27357]
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Team RC, 2014, R LANG ENV COMP
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 79
TC 17
Z9 17
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007065
DI 10.1371/journal.pntd.0007065
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300007
PM 30845267
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Costa, MCD
   Maia, LMS
   de Souza, VC
   Gonzaga, AM
   de Azevedo, VC
   Martins, LR
   Pavoni, JHC
   Naveca, FG
   Slhessarenko, RD
AF de Souza Costa, M. C.
   Siqueira Maia, L. M.
   Costa de Souza, V.
   Gonzaga, A. M.
   Correa de Azevedo, V.
   Ramos Martins, L.
   Chavez Pavoni, J. H.
   Games Naveca, F.
   Dezengrini Slhessarenko, R.
TI Arbovirus investigation in patients from Mato Grosso during Zika and
   Chikungunya virus introdution in Brazil, 2015-2016
SO ACTA TROPICA
LA English
DT Article
DE Zika virus; Dengue virus; Chikungunya virus; Mayaro virus; Public
   health; Epidemiology
ID YELLOW-FEVER-VIRUS; INFECTION; STATE
AB Arboviruses have become a major public health concern in Brazil, especially after Zika virus (ZIKV) and Chikungunya virus (CHIKV) introduction, leading to massive epidemics. We conducted an investigation of arboviruses in patients with acute febrile illness for less than five days in Mato Grosso state (MT) during the period of ZIKV and CHIKV dissemination in Brazil. To achieve that, 453 human serum samples of patients suspected of Dengue (DENY), Yellow Fever (YFV), ZIKV or CHIKV collected in health units of 31 cities of MT were subjected to RT-PCR protocols for 10 flaviviruses, 5 alphaviruses and orthobunyaviruses from Simbu serogroup, nucleotide sequencing and viral isolation. Regarding flaviviruses, five (1.1%) patients were infected with DENV-1 genotype V, 22 (4.4%) with DENV-4 genotype II, 3 (0.7%) with YFV South American genotype It and five (1.1%) with ZIKV Asian genotype. The first human case of ZIKV in MT was detected in this study during August, 2015 in Tapurah. Alphaviruses were detected in 2 (0.4%) patients infected with CHIKV genotype ECSA, 1 (0.2%) with Madariaga (EEEV) lineage III and 34 (7.5%) with Mayaro (MAYV) genotype L. Four (11.4%) patients presented dual infections with DENV-1/ZIKV, DENV-1/DENV4, DENV-4/MAYV and ZIKV/MAYV. The majority- 13/34 positive for MAYV, one for Madariaga virus - are residents in Varzea Grande (VG), metropolitan region of Cuiaba, capital of MT. The first CH1KV infection in MT was detected in this study in Mirassol D'Oeste, during July, 2015. In addition, 20 (4.4%) patients were positive for OROV Segment S genotype IA. These results reinforce the variation in arboviruses frequency and distribution during outbreaks, highlinghing the importance of differential diagnosis to identify agents silently co-circulating with major health problem arboviruses.
C1 [de Souza Costa, M. C.; Siqueira Maia, L. M.; Dezengrini Slhessarenko, R.] Univ Fed Moro Grosso, Fac Med, Dept Ciencias Basicas Saude, Programa Posgrad Ciencias Saude, Ave Fernando Correa da Costa,2367,CCBS 1,Solo 82, BR-78060900 Cuiaba, Mato Grosso, Brazil.
   [Costa de Souza, V.; Games Naveca, F.] Fiocruz MS, Inst Leonidas & Maria Deane, Rua Terezina 476, BR-69057070 Manaus, Amazonas, Brazil.
   [Gonzaga, A. M.; Correa de Azevedo, V.] LACEN MT, Seeretaria Estadual Saude, Travessa Thogo da Silva Pereira 63, BR-78020500 Cuiaba, Mato Grosso, Brazil.
   [Ramos Martins, L.] Univ Fed Mato Grosso, Fac Med Vet, Grad Med Vet, Cuiaba, Mato Grosso, Brazil.
   [Chavez Pavoni, J. H.] Univ Fed Mato Grosso, Fac Med, Ave Estudantes 5005,Vila Aurora 1, BR-78735901 Rondonopolis, Mato Grosso, Brazil.
RP Slhessarenko, RD (corresponding author), Univ Fed Moro Grosso, Fac Med, Dept Ciencias Basicas Saude, Programa Posgrad Ciencias Saude, Ave Fernando Correa da Costa,2367,CCBS 1,Solo 82, BR-78060900 Cuiaba, Mato Grosso, Brazil.
EM renatadezengrini@yahoo.com.br
RI Slhessarenko, Renata Dezengrini/R-2390-2019; Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
FU FAPEMAT grant [FAPEMAT.0132298/2017]
FX We are very thankful for Michellen S. Carvalho, Otacilia P. Serra and
   Andressa Z. Pinto for their assistance in RT-PCR testing, and to Ana
   Elisa Viniski for her fundamental assistance on sampling. This study was
   supported by a FAPEMAT grant (FAPEMAT.0132298/2017). MCSC and LMSM are
   CAPES (001) fellows, LRM is a FAPEMAT fellow. We are very thankfull. for
   PDTIS-FIOCRUZ for nucleotide sequencing facilities at ILMD-Fiocruz
   Amazonia.
CR Aguiar D. M., 2008, Brazilian Journal of Veterinary Research and Animal Science, V45, P269
   Alice F., 1956, B I BIOL BAHIA, V3, P3
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Costa A.C., 2017, EMERGENCE PERSISTENC
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O., 2009, J CLIN MICROBIOL, V43, P96
   Figueiredo L. T.M., 2015, SOC BRASILEIRA MED T, V48, P1
   Fiocruz Fundacao Oswaldo Cruz, 2017, ARB DES DIAGN DIF PR
   HEINEN LBS, 2015, REV INST MED TROP SP, V57, P1
   IBGE Institute Brasileiro de Geografia e estatistica, MAT GROSS
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Maia L.M.S., 2018, MED VET ENTOMOL
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Ministerio da Saude, 2015, SIT EP FEBR AM REC I
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Pimentel IR, 2011, REV BRASILEIRA MED F, V6, P175
   Secretaria Municipal de Satide dc MT - SES-MT, 2016, B EP DENG CHIK ZIK, V18
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MLCR, 2017, TRANSBOUND EMERG DIS, V64, P990, DOI 10.1111/tbed.12441
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P19
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 35
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2019
VL 190
BP 395
EP 402
DI 10.1016/j.actatropica.2018.12.019
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HJ9HV
UT WOS:000457510400059
PM 30552880
DA 2020-12-17
ER

PT J
AU de Figueiredo, RMP
   de Souza, VC
   do Nascimento, VA
   Naveca, FG
AF Pinto de Figueiredo, Regina Maria
   de Souza, Victor Costa
   do Nascimento, Valdinete Alves
   Naveca, Felipe Gomes
TI Human parvovirus B19 genotype 1 in suspected dengue patients of Tefe,
   Amazonas State, Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Acute febrile syndrome; Human parvovirus B19; Molecular detection;
   Amazonas State; Brazil
ID RIO-DE-JANEIRO; HUMAN ERYTHROVIRUSES; GENETIC DIVERSITY; INFECTION; DNA;
   VARIABILITY; MAYARO; MANAUS; FEVER
AB Introduction: Human parvovirus B19 (B19V) is a common pathogen, which on infection causes variety of clinical conditions from benign self-limiting exanthematous disease and other similar pathologies to fetal death. Methods: We collected 341 scrum samples between the first and fourth day after the onset of symptoms from all patients suspected of dengue fever who were attended at Regional Hospital of Tefe. Initially, patients were screened for malaria by blood smear test and negative samples were sent to Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD) situated in Manaus (AM) for dengue testing using semi-nested multiplex PCR. Further, we investigated 44 malaria and dengue-negative samples of children for B19V DNA by nested-PCR. Positive samples were analyzed by BLAST against entire public non-redundant nucleotide database and genotyped by phylogenetic analyses using neighbor-joining clustering method. Results: Eight samples (18.2%) were found to be PCR positive. Fever, headache, ocular pain, and/or muscle pain were reported as the most frequent symptoms by the patients and none were diagnosed with rash at the time of sample collection. Phylogenetic analysis of major capsid protein 2 (VP2) and VP3 coding region showed high similarity with B19V genotype 1. Conclusions: Our results reveal the spread of B19V genotype 1 in Tefe. Moreover, our results emphasize the significance of laboratorial differential diagnosis using molecular techniques in patients with acute febrile, and thereby aid the health surveillance system in improving patient care even in the remote areas of Amazon.
C1 [Pinto de Figueiredo, Regina Maria] Fundacao Med Trop Doutor Heitor Vieira Dourado, Gerencia Virol, Manaus, Amazonas, Brazil.
   [de Souza, Victor Costa; do Nascimento, Valdinete Alves; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP de Figueiredo, RMP (corresponding author), Fundacao Med Trop Doutor Heitor Vieira Dourado, Gerencia Virol, Manaus, Amazonas, Brazil.
EM figueiredormp@yahoo.com.br
RI Nascimento, Valdinete Alves do/AAV-1879-2020
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Souza, Victor Costa
   de/0000-0002-3869-1519
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [475740/2011-4, 440856/2016-7]; Fundacao de Amparo a Pesquisa do Estado
   do Amazonas FAPEAM [PPSUS/062.00656/2014, PROEP/062.01939/2014];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [88881.130825/2016-01, 88887.130823/2016-00]
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (http://www.cnpq.br, grant 475740/2011-4,
   edital Universal 2011). FGN thanks Fundacao de Amparo a Pesquisa do
   Estado do Amazonas FAPEAM (www.fapeam.am.gov.br, call 001/2013
   -PPSUS/062.00656/2014 and call 001/2014 - PROEP/062.01939/2014);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://www.cnpq.br, grant 440856/2016-7) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br,
   grants 88881.130825/2016-01 and 88887.130823/2016-00) call MCTIC/FNDCT
   -CNPq/MECCAPES/MS-Decit 14/2016 - Prevencao e Combate ao virus Zika. FGN
   is a CNPq fellow.
CR ANDERSON MJ, 1983, LANCET, V1, P1378
   Bonvicini F, 2017, CURR OPIN VIROL, V27, P8, DOI 10.1016/j.coviro.2017.10.003
   Conteville LC, 2015, MEM I OSWALDO CRUZ, V110, P820, DOI 10.1590/0074-02760150261
   COSSART YE, 1975, LANCET, V1, P72
   Cubel R C, 1997, Rev Soc Bras Med Trop, V30, P15, DOI 10.1590/S0037-86821997000100004
   Cubel RCN, 1996, MEM I OSWALDO CRUZ, V91, P147, DOI 10.1590/S0074-02761996000200003
   da Costa AC, 2013, CLIN MICROBIOL INFEC, V19, pE31, DOI 10.1111/1469-0691.12058
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   de Figueiredo RMP, 2005, REV SOC BRAS MED TRO, V38, P396, DOI 10.1590/S0037-86822005000500006
   Erdman DD, 1996, J GEN VIROL, V77, P2767, DOI 10.1099/0022-1317-77-11-2767
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Kang JH, 2015, INFECT CHEMOTHER, V47, P155, DOI 10.3947/ic.2015.47.3.155
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   de Mendonga MCL, 2008, J VIROL METHODS, V148, P40, DOI 10.1016/j.jviromet.2007.10.004
   Linhares AC, 1991, AN B RAS DERM, V66, P281
   LIS JT, 1975, NUCLEIC ACIDS RES, V2, P383, DOI 10.1093/nar/2.3.383
   Magalhaes BML, 2012, AM J TROP MED HYG, V87, P1119, DOI 10.4269/ajtmh.2012.12-0210
   MOLENAARDEBACKE.MW, 2012, PLOS ONE, V7
   Morris U, 2015, MALARIA J, V14, P1
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Norja P, 2006, P NATL ACAD SCI USA, V103, P7450, DOI 10.1073/pnas.0602259103
   Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16
   Sanabani S, 2006, J CLIN MICROBIOL, V44, P604, DOI 10.1128/JCM.44.2.604-606.2006
   Servant A, 2002, J VIROL, V76, P9124, DOI 10.1128/JVI.76.18.9124-9134.2002
   Weir E, 2005, CAN MED ASSOC J, V172, P743, DOI 10.1503/cmaj.045293
   Wermelinger MCD, 2002, J CLIN VIROL, V25, P223, DOI 10.1016/S1386-6532(02)00014-8
   Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478
NR 29
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e20190304
DI 10.1590/0037-8682-0304-2019
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IX5EC
UT WOS:000485706500001
PM 31508787
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Meneses, CAR
   do Nascimento, VA
   de Souza, VC
   Maito, RM
   Comes, MA
   Cunha, CRS
   Antony, ID
   Silva, MEOE
   Campos, DPD
   Corado, ADG
   Pessoa, KP
   Monteiro, DCD
   Okumoto, O
   Cunha, MC
   Pacheco, FC
   Naveca, FC
AF Ribeiro Meneses, Catia Alexandra
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Maito, Rodrigo Melo
   Comes, Marconi Aragao
   Santa Brigida Cunha, Claudeth Rocha
   Antony, Ilma de Aguiar
   Oliveira e Silva, Maria Eliane
   de Souza Campos, Daniela Palha
   Guerra Corado, Andre de Lima
   Pessoa, Karina Pinheiro
   da Silva Monteiro, Dana Cristina
   Okumoto, Osnei
   Cunha, Marilia Coelho
   Pacheco, Flavia Caselli
   Naveca, Felipe Comes
TI Molecular characterisation of the emerging measles virus from Roraima
   state, Brazil, 2018
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE measles virus; Brazil; genotype; virus genome
ID SAO-PAULO; PERFORMANCE; OUTBREAK
AB Measles is a human infectious disease of global concern that is caused by the measles virus. In this study, we report the complete genome sequencing of one measles virus isolate, genotype D8, that was obtained directly from a urine sample in Boa Vista city, the capital of Roraima state in Brazil. Phylogenetic reconstruction grouped the genome described in this study with that of samples from Australia, South Korea, and Italy. To our knowledge, this is the first complete genome sequence of a wild-type measles virus reported from Latin America. Therefore, the present data strengthen the current knowledge on the molecular epidemiology of measles worldwide.
C1 [Ribeiro Meneses, Catia Alexandra; Maito, Rodrigo Melo; Comes, Marconi Aragao; Santa Brigida Cunha, Claudeth Rocha; Antony, Ilma de Aguiar; Oliveira e Silva, Maria Eliane] Secretaria Estado Saude Roraima, Lab Cent Saude Publ Roraima, Boa Vista, RR, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Guerra Corado, Andre de Lima; Pessoa, Karina Pinheiro; da Silva Monteiro, Dana Cristina; Naveca, Felipe Comes] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [de Souza Campos, Daniela Palha] Secretaria Estado Saude Roraima, Coordenadoria Geral Vigilancia Saude, Boa Vista, RR, Brazil.
   [Okumoto, Osnei] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Cunha, Marilia Coelho; Pacheco, Flavia Caselli] Minist Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
RP Naveca, FC (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Nascimento, Valdinete Alves do/AAV-1879-2020; Naveca, Felipe/H-1130-2012
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Naveca,
   Felipe/0000-0002-2888-1060; Souza, Victor Costa de/0000-0002-3869-1519
FU FIOCRUZ; FAPEAM [001/2013-PPSUS/062.00656/2014,
   001/2014-PROEP/062.01939/2014]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [440856/2016-7]; CAPESCAPES
   [88881.130825/2016-01, 88887.130823/2016-00]
FX FIOCRUZ, FAPEAM (call 001/2013-PPSUS/062.00656/2014,
   001/2014-PROEP/062.01939/2014), CNPq (grant 440856/2016-7), CAPES
   (grants 88881.130825/2016-01, 88887.130823/2016-00, call
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit 14/2016-Prevencao e Combate ao virus
   Zika). CARM, VAN and VCS contributed equally to this work.
CR de Oliveira MI, 2014, REV INST MED TROP SP, V56, P366, DOI 10.1590/S0036-46652014000400018
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Fernandes EG, 2013, REV SAUDE PUBL, V47, P1213, DOI 10.1590/S0034-8910.2013047004788
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Moss WJ, 2017, LANCET, V390, P2490, DOI 10.1016/S0140-6736(17)31463-0
   MS-Ministerio da Saude, 2019, 362019 MS MIN SAUD
   Oliveira MI, 2002, EMERG INFECT DIS, V8, P808, DOI 10.3201/eid0808.020040
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Rota PA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.49
   STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205
NR 14
TC 1
Z9 1
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e180545
DI 10.1590/0074-02760180545
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HP7YQ
UT WOS:000461906900001
PM 30892375
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU da Costa, CF
   da Silva, AV
   do Nascimento, VA
   de Souza, VC
   Monteiro, DCD
   Terrazas, WCM
   dos Passos, RA
   Nascimento, S
   Lima, JBP
   Naveca, FG
AF da Costa, Cristiano Fernandes
   da Silva, Arlesson Viana
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   da Silva Monteiro, Dana Cristina
   Morhy Terrazas, Wagner Cosme
   dos Passos, Ricardo Augusto
   Nascimento, Suzete
   Pereira Lima, Jose Bento
   Naveca, Felipe Gomes
TI Evidence of vertical transmission of Zika virus in field- collected eggs
   of Aedes aegypti in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; DENGUE VIRUS; TRANSOVARIAL
   TRANSMISSION; CHIKUNGUNYA VIRUS; RNA; INFECTION; MOSQUITOS; CELLS; INDIA
AB Background
   Arboviruses are viruses transmitted to humans and other animals by the bite of hematophagous arthropods. Infections caused by chikungunya virus (CHIKV), dengue virus (DENV), Zika virus (ZIKV), and the deadlier yellow fever virus (YFV) are current public health problems in several countries, mainly those located in tropical and subtropical regions. One of the main prevention strategies continues to be vector control, with the elimination of breeding sites and surveillance of infested areas. The use of ovitraps for Aedes mosquitos monitoring has already demonstrated promising results, and maybe be also useful for arboviral surveillance.
   Methods
   This work aimed to detect natural vertical transmission of arboviruses in Aedes aegypti and Aedes albopictus. Mosquito egg collection was carried out using ovitraps in Itacoatiara, a mid-size city in Amazonas state, Brazil. Collected eggs were allowed to hatch and larvae were tested for CHIKV, DENV, and ZIKV RNA by RT-qPCR.
   Results
   A total of 2,057 specimens (1,793 Ae. aegypti and 264 Ae. albopictus), in 154 larvae pools were processed. Results showed one positive pool for CHIKV and one positive pool for ZIKV. The active ZIKV infection was further confirmed by the detection of the negative-strand viral RNA and nucleotide sequencing which confirmed the Asian genotype. The Infection Rate per 1,000 mosquitoes tested was assessed by Maximum Likelihood Estimation (MLE) with 0.45 and 0.44 for CHIKV and ZIKV, respectively, and by Minimum Infection Rate (MIR) with 0.45 for both viruses.
   Conclusion
   To our knowledge, this is the first detection of ZIKV in natural vertical transmission in the Ae. aegypti, a fact that may contribute to ZIKV maintenance in nature during epidemics periods. Furthermore, our results highlight that the use of ovitraps and the molecular detection of arbovirus may contribute to health surveillance, directing the efforts to more efficient transmission blockade.
C1 [da Costa, Cristiano Fernandes; Morhy Terrazas, Wagner Cosme; dos Passos, Ricardo Augusto; Nascimento, Suzete] Hlth Surveillance Fdn Amazonas State FVS, Dept Environm Surveillance, Manaus, Amazonas, Brazil.
   [da Silva, Arlesson Viana; do Nascimento, Valdinete Alves; de Souza, Victor Costa; da Silva Monteiro, Dana Cristina; Naveca, Felipe Gomes] Fiocruz Amazonia, Lab Ecol Doencas Transmiss Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [da Silva, Arlesson Viana] Fiocruz Amazonia, Programa Iniciacao Cient, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.
   [da Silva Monteiro, Dana Cristina] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [dos Passos, Ricardo Augusto; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil.
   [Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.
RP Naveca, FG (corresponding author), Fiocruz Amazonia, Lab Ecol Doencas Transmiss Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.; Lima, JBP (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil.; Naveca, FG (corresponding author), Fiocruz Amazonia, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.
EM jbento@ioc.fiocruz.br; felipe.naveca@fiocruz.br
RI Naveca, Felipe/H-1130-2012; Nascimento, Valdinete Alves do/AAV-1879-2020
OI Naveca, Felipe/0000-0002-2888-1060; Nascimento, Valdinete Alves
   do/0000-0002-7786-4718; Souza, Victor Costa de/0000-0002-3869-1519;
   Lima, Jose/0000-0002-5015-3019; Dos Passos/0000-0002-2155-9351
FU Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM [001/2013 -
   PPSUS / 062.00656/2014, 001/2014 - PROEP / 062.01939/2014]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [440856/2016-7];
   Coordenaca o de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [88881.130825/2016-01, 88887.130823/2016-00]
FX JBPL has a visiting senior researcher fellow PVS PECTI-SAUDE (Amazonas
   State Research Support Foundation - FAPEAM). FGN is funded by Fundacao
   de Amparo a Pesquisa do Estado do Amazonas - FAPEAM
   (www.fapeam.am.gov.br, call 001/2013 - PPSUS / 062.00656/2014 and call
   001/2014 - PROEP / 062.01939/2014); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (http://www.cnpq.br, grant 440856/2016-7) and
   Coordenaca o de Aperfeicoamento de Pessoal de Nivel Superior
   (http://www.capes.gov.br, grants 88881.130825/2016-01 and
   88887.130823/2016-00) call MCTIC/FNDCT-CNPq / MEC-CAPES/ MS-Decit
   14/2016 - Prevencao e Combate ao virus Zika. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Angel A, 2016, ACTA TROP, V155, P20, DOI 10.1016/j.actatropica.2015.11.018
   Arunachalam N, 2008, INDIAN J MED RES, V127, P395
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil. Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chivero ET, 2014, J GEN VIROL, V95, P1307, DOI 10.1099/vir.0.063016-0
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Cruz LCTA, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   Diaz LA, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00493
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Gutierrez-Bugallo G, 2017, ACTA TROP, V174, P146, DOI 10.1016/j.actatropica.2017.07.012
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Jain J, 2016, ACTA TROP, V162, P46, DOI 10.1016/j.actatropica.2016.06.004
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Longatti A, 2015, J VIROL, V89, P2956, DOI 10.1128/JVI.02721-14
   Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Raquin V, 2017, VIROLOGY, V507, P75, DOI 10.1016/j.virol.2017.04.009
   Rio DC, 2010, COLD SPRING HARB PRO, V2010, P5439, DOI DOI 10.1101/PDB.PROT5439
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Undurraga EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003547
   Vaughan G, 2002, CLIN DIAGN LAB IMMUN, V9, P198, DOI 10.1128/CDLI.9.1.198-200.2002
NR 46
TC 13
Z9 13
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006594
DI 10.1371/journal.pntd.0006594
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700017
PM 30011278
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Barletta-Naveca, RH
   Naveca, FG
   de Almeide, VA
   Porto, JIR
   da Silva, GAV
   Ogusku, MM
   Sadahiro, A
   Ramasawmy, R
   Boechat, AL
AF Barletta-Naveca, Raphaela Honorato
   Naveca, Felipe Gomes
   de Almeide, Vanessa Alves
   Rebelo Porto, Jorge Ivan
   Villarouco da Silva, George Allan
   Ogusku, Mauricio Morishi
   Sadahiro, Aya
   Ramasawmy, Rajendranath
   Boechat, Antonio Luiz
TI Toll-Like Receptor-1 Single-Nucleotide Polymorphism 1805T/G Is
   Associated With Predisposition to Multibacillary Tuberculosis
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE tuberculosis; immunogenetics; single-nucleotide polymorphism; toll-like
   receptors; Brazil
ID CELL-SURFACE TRAFFICKING; SUSCEPTIBILITY; TLR1; VARIANTS; RISK; DNA;
   IDENTIFICATION; PRECIPITATION; MYCOBACTERIA; PATHWAY
AB Tuberculosis (TB), caused by mycobacterial species of the Mycobacterium tuberculosis complex, is a serious global health issue. Brazil is among the 22 countries with the highest number of TB cases, and the state of Amazonas has the highest incidence of TB cases in the country. Toll-like receptors (TLRs) are important pattern recognition receptors of the innate immunity and play a key role in orchestrating an effective immune response. We investigated whether the single-nucleotide polymorphisms (SNPs) 1805T/G TLR1, 2258G/A TLR2, 896A/G and 1196C/T of TLR4, 745T/C TLR6, and -1237A/G and -1486A/G of TLR9 are associated with the predisposition to TB and/or bacillary load. The SNPs genotyping was performed by nucleotide sequencing in 263 TB patients and 232 healthy controls residing in the state of Amazonas. Alleles and genotypes frequencies were similar between patients and healthy individuals for most of the investigated SNPs. Stratification of the TB patients according to their bacillary load showed that the genotype 1805TT TLR1 (rs5743618) was prevalent among paucibacillary patients [odds ratio (OR) = 0.38; 95% confidence interval (CI) = 0.19-0.76; p = 0.009] while the genotype 1805TG was common among multibacillary patients (OR = 3.72; CI = 1.65-8.4; p = 0.004). Comparison of demographic characteristics of patients to controls showed that TB is strongly associated with smoking (OR = 6.55; 95% CI = 3.2-13.6; p < 0.0001); alcohol use disorder (OR = 7.14; 95% CI = 3.7-13.9; p < 0.0001); and male gender (OR = 3.66; 95% CI = 2.52-5.3; p < 0.0001). Multivariate logistic regression demonstrated that alcoholism (OR = 2.93; 95% CI = 1.05-8.16; p = 0.03) and the 1805G allele (OR = 2.75; 95% CI = 1.33-5.7; p = 0.006) are predictive variables for multibacillary TB. Altogether, we suggest that the TLR1 1805G allele may be a relevant immunogenetic factor for the epidemiology of TB together with environmental, sociodemographic, and behavioral factors.
C1 [Barletta-Naveca, Raphaela Honorato; de Almeide, Vanessa Alves; Ogusku, Mauricio Morishi; Sadahiro, Aya] INPA, Lab Micobacteriol, Manaus, Amazonas, Brazil.
   [Barletta-Naveca, Raphaela Honorato; Rebelo Porto, Jorge Ivan] INPA, Programa Posgrad Genet Conservacao & Biol Evolut, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Fiocruz Amazonia, Lab Ecol Doencas Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patagenohospedeir, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes; de Almeide, Vanessa Alves; Villarouco da Silva, George Allan; Sadahiro, Aya; Ramasawmy, Rajendranath; Boechat, Antonio Luiz] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.
   [Rebelo Porto, Jorge Ivan] INPA CPBA, Lab Genet Anim, Manaus, Amazonas, Brazil.
   [Sadahiro, Aya] Univ Fed Amazonas, Inst Ciencias Biol, Lab Imunol Mol, Manaus, Amazonas, Brazil.
   [Ramasawmy, Rajendranath] Univ Nilton Lins, Fac Med, Manaus, Amazonas, Brazil.
   [Ramasawmy, Rajendranath] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.
   [Boechat, Antonio Luiz] Univ Fed Amazonas, Inst Ciencias Biol, Lab Imunoquim, Manaus, Amazonas, Brazil.
RP Barletta-Naveca, RH (corresponding author), INPA, Lab Micobacteriol, Manaus, Amazonas, Brazil.; Barletta-Naveca, RH (corresponding author), INPA, Programa Posgrad Genet Conservacao & Biol Evolut, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Fiocruz Amazonia, Lab Ecol Doencas Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Fiocruz Amazonia, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patagenohospedeir, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.
EM raphaelanaveca@gmail.com; felipe.naveca@fiocruz.br
RI Ramasawmy, Rajendranath/V-4926-2019; Naveca, Felipe/H-1130-2012; Porto,
   Jorge/T-4694-2019; Boechat, A.L./H-8484-2019
OI Naveca, Felipe/0000-0002-2888-1060; Boechat, A.L./0000-0001-5597-7343
FU FAPEAM; SUSAM; DECIT; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPEAM Call: UNIVERSAL AMAZONAS [472/
   2012]
FX This work was supported by FAPEAM, SUSAM, DECIT, CNPq (Call: Programa de
   Pesquisa para o SUS: Gestao compartilhada em Saude-PPSUS 2009), and
   FAPEAM Call: UNIVERSAL AMAZONAS (grant number: 472/ 2012).
CR Boechat AL, 2013, INFECT GENET EVOL, V16, P310, DOI 10.1016/j.meegid.2013.02.019
   Boechat ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041588
   Brasil, 2017, IND PRIOR MON PLAN N
   BRASIL, 2008, MAN NAC VIG LAB TUB
   BRASIL. Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Carregaro F, 2010, MEM I OSWALDO CRUZ, V105, P649, DOI 10.1590/S0074-02762010000500008
   Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335
   Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577
   Costa AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183840
   Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda
   Ferwerda B, 2007, AIDS, V21, P1375, DOI 10.1097/QAD.0b013e32814e6b2d
   Hart BE, 2012, J IMMUNOL, V189, P5347, DOI 10.4049/jimmunol.1201545
   Hart BE, 2012, J BIOL CHEM, V287, P16550, DOI 10.1074/jbc.M112.342717
   Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034
   Tong HV, 2017, TROP MED INT HEALTH, V22, P1063, DOI 10.1111/tmi.12923
   Jahantigh D, 2013, SCI WORLD J, DOI 10.1155/2013/534053
   Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Leao SC, 2004, PRACTICAL HDB PHENOT
   Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440
   Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020
   Lis J T, 1980, Methods Enzymol, V65, P347
   LIS JT, 1975, NUCLEIC ACIDS RES, V2, P383, DOI 10.1093/nar/2.3.383
   Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318
   Marques CD, 2013, J INFECT DIS, V208, P120, DOI 10.1093/infdis/jit133
   Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214
   PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346
   Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499
   Qi H, 2015, TUBERCULOSIS, V95, P197, DOI 10.1016/j.tube.2014.12.001
   Ramasawmy R, 2009, J INFECT DIS, V199, P1838, DOI 10.1086/599212
   Salem Julia Ignez, 2007, Acta Amaz., V37, P419, DOI 10.1590/S0044-59672007000300013
   Sanchez D, 2012, INT J IMMUNOGENET, V39, P216, DOI 10.1111/j.1744-313X.2011.01077.x
   Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711
   Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001
   Shaler CR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/628293
   Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803
   Souza de Lima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147543
   Stein Catherine M, 2017, Curr Genet Med Rep, V5, P149, DOI 10.1007/s40142-017-0130-9
   TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993
   Torres-Garcia D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-220
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993
   Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7
   Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339
   Wang Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00309
   World Health Organization, 2017, GLOB TUB REP 2017
NR 46
TC 3
Z9 3
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUN 25
PY 2018
VL 9
AR 1455
DI 10.3389/fimmu.2018.01455
PG 7
WC Immunology
SC Immunology
GA GK4OG
UT WOS:000436140200002
PM 29988507
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Abdalla, LF
   Santos, JHA
   Barreto, RTJ
   Souza, EME
   D'Assuncao, FF
   Borges, MA
   Nascimento, VA
   da Silva, GAV
   de Souza, VC
   Ramasawmy, R
   Campi-Azevedo, AC
   Coelho-dos-Reis, JG
   Antonelli, LRD
   Teixeira-Carvalho, A
   Martins, OA
   Naveca, FG
AF Abdalla, Ligia Fernandes
   Abdalla Santos, Joao Hugo
   Jales Barreto, Renata Teodora
   Martins e Souza, Erick
   D'Assuncao, Fabricio Fonseca
   Borges, Marcio Aurelio
   Nascimento, Valdinete Alves
   Villarouco da Silva, George Allan
   de Souza, Victor Costa
   Ramasawmy, Rajendranath
   Campi-Azevedo, Ana Carolina
   Coelho-dos-Reis, Jordana Graziela
   do Vale Antonelli, Lis Ribeiro
   Teixeira-Carvalho, Andrea
   Martins-Filho, Olindo Assis
   Naveca, Felipe Gomes
TI Atrial fibrillation in a patient with Zika virus infection
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Arboviruses; Atrial fibrillation; Cardiac disorders
ID JANUARY 2016; TRANSMISSION; CHIKUNGUNYA; EPIDEMIC; MICRONESIA; OUTBREAK;
   DISEASE; SALIVA; STATES; BRAZIL
AB Background: Zika virus is an emerging arbovirus of the family Flaviviridae and genus Flavivirus that until 2007 was restricted to a few cases of mild illness in Africa and Asia.
   Case presentation: We report a case of atrial fibrillation disclosed during an acute Zika virus infection in a 49-year-old man. Different biological samples were analyzed for the molecular diagnosis of Zika by real-time PCR, however only the saliva specimen was positive. The patient's wife tested positive in the serum sample, although she was an asymptomatic carrier. Moreover, a complete overview of patient's biomarkers, including cytokines, chemokines, and growth-factors levels, was analyzed and compared to gender and age matching non-infected controls, as well as other Zika infected patients, considering the 95% CI of the mean values. Elevated levels of CXCL8, CCL11, CCL2, CXCL10, IL-1 beta, IL-6, TNF-alpha, IFN-gamma, IL-17, IL-1Ra, IL-4, IL-9, FGF-basic, PDGF, G-CSF, and GM-CSF were observed in the Atrial fibrillation patient, in contrast to uninfected controls. Furthermore, increased levels of CCL5, IL-1 beta, TNF-alpha, IFN-gamma, IL-9, G-CSF, and GM-CSF were observed only in the atrial fibrillation patient, when compared to other Zika patients.
   Conclusions: To our knowledge, this is the first description of this type of cardiac disorder in Zika patients which may be considered another atypical manifestation during Zika virus infection.
C1 [Abdalla, Ligia Fernandes; Villarouco da Silva, George Allan; Ramasawmy, Rajendranath; Naveca, Felipe Gomes] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Abdalla, Ligia Fernandes; D'Assuncao, Fabricio Fonseca] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Abdalla Santos, Joao Hugo; Martins e Souza, Erick] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Abdalla Santos, Joao Hugo; Jales Barreto, Renata Teodora; Borges, Marcio Aurelio] Hosp Adventista Manaus, Manaus, Amazonas, Brazil.
   [Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Diane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.
   [Villarouco da Silva, George Allan; Ramasawmy, Rajendranath] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Ramasawmy, Rajendranath] Univ Nilton Lins, Manaus, Amazonas, Brazil.
   [Campi-Azevedo, Ana Carolina; Coelho-dos-Reis, Jordana Graziela; do Vale Antonelli, Lis Ribeiro; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Diane, Programa Posgrad Biol Int Patogenohospediro, Manaus, Amazonas, Brazil.
RP Naveca, FG (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Fiocruz Amazonia, Inst Leonidas & Maria Diane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Nascimento, Valdinete Alves do/AAV-1879-2020; Antonelli,
   Lis/R-4910-2019; Ramasawmy, Rajendranath/V-4926-2019; Naveca,
   Felipe/H-1130-2012
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Antonelli,
   Lis/0000-0002-4969-8812; Naveca, Felipe/0000-0002-2888-1060;
   Campi-Azevedo, Ana Carolina/0000-0001-6306-3605; Souza, Victor Costa
   de/0000-0002-3869-1519
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440856/2016-7, 440682/2016-9]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88881.130825/2016-00,
   88887.130823/2016-00, 88881.130829/2016-01]; Financiadora de Estudos e
   ProjetosCiencia Tecnologia e Inovacao (FINEP) [TED264/16]
FX FGN is funded by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (http://www.cnpq.br, grant 440856/2016-7) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br,
   grants 88881.130825/2016-00 and 88887.130823/2016-00). OAMF is funded by
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://www.cnpq.br, grant 440682/2016-9); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br,
   grant 88881.130829/2016-01) and Financiadora de Estudos e Projetos
   (http://www.finep.gov.br, grant TED264/16). The funders had no role in
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hadi HAR, 2010, J INFLAMM RES, V3, P75, DOI 10.2147/JIR.S10095
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuo HJ, 2017, J MICROBIOL IMMUNOL
   Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2017, BIORXIV
   OBEYESEKERE I, 1972, BRIT HEART J, V34, P821
   PAHO, 2015, 17 PAHO, P1
   Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282X20160138, 10.1590/0004-282x20160138]
   Ratanacharoensiri A, 2017, J RES PHARM PRACT, V6, P1, DOI 10.4103/2279-042X.200984
   Saldarriaga G. Clara, 2013, Rev. Colomb. Cardiol., V20, P366
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 9
Z9 9
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JAN 25
PY 2018
VL 15
AR 23
DI 10.1186/s12985-018-0938-2
PG 6
WC Virology
SC Virology
GA FU2LY
UT WOS:000423682900001
PM 29370812
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Naveca, FG
   Pontes, GS
   Chang, AYH
   da Silva, GAV
   do Nascimento, VA
   Monteiro, DCD
   da Silva, MS
   Abdalla, LF
   Santos, JHA
   de Almeida, TAP
   Mejia, MDC
   de Mesquita, TGR
   Encarnacao, HVD
   Gomes, MD
   Amaral, LR
   Campi-Azevedo, AC
   Coelho-dos-Reis, JG
   Antonelli, LRD
   Teixeira-Carvalho, A
   Martins, OA
   Ramasawmy, R
AF Naveca, Felipe Gomes
   Pontes, Gemilson Soares
   Chang, Aileen Yu-hen
   Villarouco da Silva, George Allan
   do Nascimento, Valdinete Alves
   da Silva Monteiro, Dana Cristina
   da Silva, Marineide Souza
   Abdalla, Ligia Fernandes
   Abdalla Santos, Joao Hugo
   Pires de Almeida, Tatiana Amaral
   Contreras Mejia, Matilde del Carmen
   Ramos de Mesquita, Tirza Gabrielle
   de Souza Encarnacao, Helia Valeria
   Gomes, Matheus de Souza
   Amaral, Laurence Rodrigues
   Campi-Azevedo, Ana Carolina
   Coelho-dos-Reis, Jordana Graziela
   do Vale Antonelli, Lis Ribeiro
   Teixeira-Carvalho, Andrea
   Martins-Filho, Olindo Assis
   Ramasawmy, Rajendranath
TI Analysis of the Immunological biomarker profile during acute Zika virus
   Infection reveals the overexpression of CXCL10, a chemokine linked to
   neuronal damage
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; CXCL10; biomarkers; chemokines; cytokines
ID VIRAL-INFECTIONS; INFLAMMATION; ACTIVATION; CHILDREN
AB BACKGROUND Infection with Zika virus (ZIKV) manifests in a broad spectrum of disease ranging from mild illness to severe neurological complications and little is known about Zika immunopathogenesis.
   OBJECTIVES To define the immunologic biomarkers that correlate with acute ZIKV infection.
   METHODS We characterized the levels of circulating cytokines, chemokines, and grow th factors in 54 infected patients of both genders at five different time points after symptom onset using microbeads multiplex immunoassay; comparison to 100 agematched controls was performed for statistical analysis and data mining.
   FINDINGS ZIKV-infected patients present a striking systemic inflammatory response with high levels of pro-inflammatory mediators. Despite the strong inflammatory pattern, IL-1Ra and IL-4 are also induced during the acute infection. Interestingly, the inflammatory cytokines IL-1 beta, IL-13, IL,-17, TNF-alpha, and IFN-gamma; chemokines CXCL8, CCL2. CCL5; and the growth factor G-CSF, displaced a bimodal distribution accompanying viremia. While this is the first manuscript to document bimodal distributions of viremia in ZIKV infection, this has been documented in other viral infections, with a primary viremia peak during mild systemic disease and a secondary peak associated with distribution of the virus to organs and tissues.
   MAIN CONCLUSIONS Biomarker network analysis demonstrated distinct dynamics in concurrence with the bimodal viremia profiles at different time points during ZIKV infection. Such a robust cytokine and chemokine response has been associated with blood-brain barrier permeability and neuroinvasiveness in other flaviviral infections. High-dimensional data analysis further identified CXCL10, a chemokine involved in foetal neuron apoptosis and Guillain-Barre syndrome, as the most promising biomarker of acute ZIKV infection for potential clinical application.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; Pires de Almeida, Tatiana Amaral; Contreras Mejia, Matilde del Carmen] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes; Villarouco da Silva, George Allan; da Silva Monteiro, Dana Cristina; da Silva, Marineide Souza; Abdalla, Ligia Fernandes] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Pontes, Gemilson Soares] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.
   [Chang, Aileen Yu-hen] George Washington Univ, Washington, DC USA.
   [Abdalla, Ligia Fernandes] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Abdalla Santos, Joao Hugo] Hosp Adventista Manaus, Manaus, Amazonas, Brazil.
   [Villarouco da Silva, George Allan; Ramos de Mesquita, Tirza Gabrielle; de Souza Encarnacao, Helia Valeria; Ramasawmy, Rajendranath] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Gomes, Matheus de Souza; Amaral, Laurence Rodrigues] Univ Fed Uberlandia, Patos De Minas, MG, Brazil.
   [Campi-Azevedo, Ana Carolina; Coelho-dos-Reis, Jordana Graziela; do Vale Antonelli, Lis Ribeiro; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fundacao Oswald Cruz, FIOCRUZ, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Ramasawmy, Rajendranath] Univ Nilton Lins, Manaus, Amazonas, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Antonelli, Lis/R-4910-2019; Amaral, Laurence/G-5905-2012; Nascimento,
   Valdinete Alves do/AAV-1879-2020; Ramasawmy, Rajendranath/V-4926-2019;
   Amaral, Laurence Rodrigues do/R-2209-2019; Pontes, Gemilson/B-6103-2016;
   Naveca, Felipe/H-1130-2012
OI Antonelli, Lis/0000-0002-4969-8812; Amaral,
   Laurence/0000-0003-4681-5451; Nascimento, Valdinete Alves
   do/0000-0002-7786-4718; Amaral, Laurence Rodrigues
   do/0000-0003-4681-5451; Pontes, Gemilson/0000-0001-9001-7954; Naveca,
   Felipe/0000-0002-2888-1060; Almeida, Tatiana Amaral Pires
   de/0000-0003-2369-6306; Campi-Azevedo, Ana Carolina/0000-0001-6306-3605;
   Martins-Filho, Olindo Assis/0000-0002-5494-4889
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FINEPCiencia Tecnologia e Inovacao (FINEP);
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [440856/2016-7, 440682/2016-9]; CAPESCAPES [88881.130825/2016-00,
   88887.130823/2016-00, 88881.130829/2016-01]; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [TED264/16]
FX CNPq, CAPES, FINEP.; FGN and OAMF were supported by CNPq (Grants
   440856/2016-7, 440682/2016-9) and CAPES (Grants 88881.130825/2016-00,
   88887.130823/2016-00, 88881.130829/2016-01); OAMF is also funded by
   FINEP (Grant TED264/16).
CR Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chiang S, 2013, MUSCLE NERVE, V48, P320, DOI 10.1002/mus.23829
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Edwards MR, 2017, J ALLERGY CLIN IMMUN, V140, P909, DOI 10.1016/j.jaci.2017.07.025
   FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298
   Grip O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005263
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Klein SL, 2012, BIOESSAYS, V34, P1050, DOI 10.1002/bies.201200099
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439
   Melchjorsen J, 2003, J LEUKOCYTE BIOL, V74, P331, DOI 10.1189/jlb.1102577
   Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Sathupan P, 2007, ANN TROP PAEDIATR, V27, P179, DOI 10.1179/146532807X220280
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008
NR 30
TC 18
Z9 19
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 6
AR e170542
DI 10.1590/0074-02760170542
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GF9VE
UT WOS:000432326300001
PM 29768624
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Sousa, DD
   Silva, CRD
   Lima, WP
   Barros, JD
   Nascimento, IAD
   de Souza, VC
   Naveca, FG
   Granja, F
AF de Sousa, Debora Dinelly
   de Sousa Silva, Claudiane Raquel
   Lima Junior, Wilson Pereira
   Barros, Jacqueline de Aguiar
   da Silva Nascimento, Ismael Alexandre
   de Souza, Victor Costa
   Naveca, Felipe Gomes
   Granja, Fabiana
TI Phylogenetic analysis and genotype distribution of Hepatitis B Virus
   (HBV) in Roraima, Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Hepatitis B; Genotypes; Roraima State; Phylogeny
ID GENETIC DIVERSITY; HIGH PREVALENCE; MOLECULAR CHARACTERIZATION;
   SUBGENOTYPES; INFECTION; AFRICAN; EPIDEMIOLOGY; CHILDREN; A1; D4
AB Hepatitis B virus (HBV) infection is a serious global health problem. HBV has a high viral genetic diversity, with 10 genotypes recognized. In Brazil, the Roraima State is the third in the Northern region regarding the number of hepatitis B cases. On the other hand, few data on HBV genotyping and phylogenetic analysis are available. The purpose of this study is to characterize the HBV genotypes circulating in Roraima State. Of the 113 chronic hepatitis B patients enrolled in this study, 40 were HBV-DNA positive. A fragment of 280 bp (S gene) was amplified by PCR and submitted to nucleotide sequencing. A dataset containing the viral sequences obtained in this study, plus 130 obtained from GenBank was used for genotyping by phylogenetic analysis. The HBV subgenotype distribution found was A1 (62.5%), A2 (7.5%), D2, D3, D4 (2.5%), F2a (12.5%), and F3 (10%). We characterized the genotypes and subgenotypes of HBV circulating among patients in the State of Roraima. In addition, our study shows for the first time the HBV/F3 genotype circulating in Brazil. In conclusion, our findings showed a high diversity of HBV genotypes in Roraima, which is also found in other Brazilian geographical regions.
C1 [de Sousa, Debora Dinelly; de Sousa Silva, Claudiane Raquel; Lima Junior, Wilson Pereira; da Silva Nascimento, Ismael Alexandre; Granja, Fabiana] Univ Fed Roraima, Ctr Estudos Biodiversidade, Lab Biol Mol, Ave Capitao Ene Garcez 2413, BR-69310000 Boa Vista, Roraima, Brazil.
   [Barros, Jacqueline de Aguiar] SESAU RR, Coordenacao Geral Vigilancia Saude, Dept Vigilancia Epidemiol, Boa Vista, Roraima, Brazil.
   [de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP de Sousa, DD (corresponding author), Univ Fed Roraima, Ctr Estudos Biodiversidade, Lab Biol Mol, Ave Capitao Ene Garcez 2413, BR-69310000 Boa Vista, Roraima, Brazil.
EM debora_dinelly@yahoo.com.br; fabi.granja@yahoo.com.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa
   de/0000-0002-3869-1519
FU  [CNPq 476688/2013-2]
FX This work was supported by grants from Universal (CNPq 476688/2013-2)
   and we are thankful to FIOCRUZ for the use of the nucleotide sequencing
   facilities at ILMD - Fiocruz Amazonia.
CR Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003
   Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599
   Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642
   Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059
   Dias ALB, 2012, REV SOC BRAS MED TRO, V45, P9, DOI 10.1590/S0037-86822012000100003
   Becker Carlos Eduardo, 2010, Arq. Gastroenterol., V47, P13, DOI 10.1590/S0004-28032010000100003
   Bottecchia M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-11
   Brasil. Ministerio da Saude, 2017, HEP VIR 2017
   Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0
   Castilho MD, 2012, AM J TROP MED HYG, V87, P768, DOI 10.4269/ajtmh.2012.12-0083
   Chang MH, 2010, ANTIVIR THER, V15, P463, DOI 10.3851/IMP1555
   Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107
   Cruz-Santos MD, 2018, ANN HEPATOL, V17, P54, DOI 10.5604/01.3001.0010.7535
   Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024
   Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004
   Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94
   Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007
   Gomes-Gouvea MS, 2009, J GEN VIROL, V90, P2638, DOI 10.1099/vir.0.013615-0
   Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0
   Jaspe RC, 2014, J MED MICROBIOL, V63, P1099, DOI 10.1099/jmm.0.067496-0
   Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982
   Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105317
   Lampe E, 2017, J GEN VIROL, V98, P1389, DOI 10.1099/jgv.0.000789
   Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103
   Mello FCA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-236
   Mendy M, 2008, J MED VIROL, V80, P1537, DOI 10.1002/jmv.21221
   Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0
   Nakano T, 2001, J GEN VIROL, V82, P359, DOI 10.1099/0022-1317-82-2-359
   Norder H, 2003, J GEN VIROL, V84, P2083, DOI 10.1099/vir.0.19034-0
   Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872
   Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0
   Roman S, 2014, WORLD J GASTROENTERO, V20, P7181, DOI 10.3748/wjg.v20.i23.7181
   Roraima. Secretaria de Saude. Departamento de Vigilancia Epidemiologica, 2018, DAD HEP B ROR 2010 2
   Sant' Anna CD, 2018, J MED VIROL, V90, P1063, DOI 10.1002/jmv.25051
   Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315
   Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09
   Valaydon ZS, 2017, BEST PRACT RES CL GA, V31, P257, DOI 10.1016/j.bpg.2017.04.013
   Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808
   YU H, 2010, PLOS ONE, V5
   Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126
NR 40
TC 1
Z9 2
U1 0
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
AR e35
DI 10.1590/S1678-9946201860035
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GO2FA
UT WOS:000439782700005
PM 30043939
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Silva, LA
   Coronato, B
   Schlackman, J
   Marsh, JW
   Ezeonwuka, C
   Fernandes, ACL
   Souza, VC
   da Silva, LS
   de Amorim, EFQ
   Naveca, FG
   de Albuquerque, BC
   Amaral, A
   Souza, ALS
   Carvalho-Costa, FA
   Mustapha, MM
   Harrison, LH
   Barroso, DE
AF Silva, Luciete A.
   Coronato, Beatriz
   Schlackman, Jessica
   Marsh, Jane W.
   Ezeonwuka, Chinelo
   Fernandes, Andreia C. L.
   Souza, Victor C.
   da Silva, Lirna S.
   de Amorim, Elaine F. Q.
   Naveca, Felipe G.
   de Albuquerque, Bernardino C.
   Amaral, Alcirene
   Souza, Ana L. S.
   Carvalho-Costa, Filipe A.
   Mustapha, Mustapha M.
   Harrison, Lee H.
   Barroso, David E.
TI Neisseria meningitidis disease-associated clones in Amazonas State,
   Brazil
SO INFECTIOUS DISEASES
LA English
DT Article
DE Neisseria meningitidis; Meningococcal disease; Serogroup C conjugate
   vaccine; MLST clones; Amazonas
ID RIO-DE-JANEIRO; MENINGOCOCCAL DISEASE; STRAINS; SEROGROUP;
   SUSCEPTIBILITY; EPIDEMIC; VACCINE
AB Background: The aim of this study is to describe the molecular epidemiology of Neisseria meningitidis invasive disease before the introduction of serogroup C conjugate vaccine in Amazonas State in 2010.
   Methods: Meningococcal disease reported cases were investigated in Amazonas State during the period 2000-2010. N. meningitidis isolates (n = 196) recovered from patients were genotyped by multilocus sequence typing (MLST) and sequencing of porB, porA, fetA, fHbp and penA. Antimicrobial susceptibility was determined using E-test.
   Results: In the study period, 948 cases were reported; the incidence was 2.8 for the entire state and 4.8 per 100,000 in the capital of Manaus. Most meningococcal disease was caused by N. meningitidis belonging to ST-32 (72%; 141/196) or ST-103 (21%; 41/196) clonal complexes. Capsular switching (B -> C) was suggested within clonal complex (cc) 32. There were 6 (3%; 6/196) strains with intermediate susceptibility to penicillin and a single strain was resistant to rifampicin. Since 2007, serogroup C strains belonging to the cc103 have predominated and case-fatality has increased.
   Conclusion: We demonstrate a high rate of meningococcal disease in Amazonas State, where, like other parts of Brazil, serogroup C replaced serogroup B during 2000s. These data serve as a baseline to measure impact of serogroup C conjugate vaccine introduction in 2010. This study emphasizes the need for enhanced surveillance to monitor changes in meningococcal disease trends following the introduction of meningococcal vaccines.
C1 [Silva, Luciete A.; Fernandes, Andreia C. L.; Souza, Victor C.; da Silva, Lirna S.; de Amorim, Elaine F. Q.; Naveca, Felipe G.] Fiocruz MS, Leonidas & Maria Deane Inst, Lab Microbial Divers Importance Hlth, Manaus, Amazonas, Brazil.
   [Silva, Luciete A.; Fernandes, Andreia C. L.; Souza, Victor C.; da Silva, Lirna S.; de Amorim, Elaine F. Q.; Naveca, Felipe G.] Fiocruz MS, Leonidas & Maria Deane Inst, Lab Communicable Dis Ecol, Manaus, Amazonas, Brazil.
   [Coronato, Beatriz; Ezeonwuka, Chinelo; Carvalho-Costa, Filipe A.; Barroso, David E.] Fiocruz MS, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Schlackman, Jessica; Marsh, Jane W.; Mustapha, Mustapha M.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA USA.
   [Schlackman, Jessica; Marsh, Jane W.; Mustapha, Mustapha M.; Harrison, Lee H.] Grad Sch Publ Hlth, Pittsburgh, PA USA.
   [de Albuquerque, Bernardino C.; Amaral, Alcirene; Souza, Ana L. S.] Fdn Hlth Surveillance Amazonas, Dept Epidemiol Surveillance, Manaus, Amazonas, Brazil.
   [de Albuquerque, Bernardino C.; Amaral, Alcirene; Souza, Ana L. S.] Fdn Hlth Surveillance Amazonas, Cent Lab, Manaus, Amazonas, Brazil.
   [Carvalho-Costa, Filipe A.] Fiocruz MS, Reg Tech Off, Teresina, Brazil.
RP Barroso, DE (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM barroso@ioc.fiocruz.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa
   de/0000-0002-3869-1519
FU Fogarty International Center Global Infectious Diseases Research
   Training Program grant; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [D43TW006592]; Fundacao de Amparoa Pesquisa do Estado do Amazonas
   - FAPEAM [Foundation for Research Support of the State of Amazonas]
   [021/2011]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [D43TW006592, D43TW006592,
   D43TW006592, D43TW006592, D43TW006592, D43TW006592, D43TW006592,
   D43TW006592, D43TW006592, D43TW006592] Funding Source: NIH RePORTER
FX This work was supported in part by a Fogarty International Center Global
   Infectious Diseases Research Training Program grant, National Institutes
   of Health, to the University of Pittsburgh [D43TW006592], and by the
   Fundacao de Amparoa Pesquisa do Estado do Amazonas - FAPEAM [Foundation
   for Research Support of the State of Amazonas], to the Leonidas & Maria
   Deane Institute (021/2011).
CR Alcala B, 2002, EMERG INFECT DIS, V8, P1512, DOI 10.3201/eid0812.020081
   Almeida G., 1921, REV MED CIRURG BRASI, V29, P449
   Barroso DE, 2007, BRAZ J INFECT DIS, V11, P598, DOI 10.1590/S1413-86702007000600014
   Barroso DE, 2013, EMERG INFECT DIS, V19, P1847, DOI [10.3201/eid1911.130610, 10.3201/13-0610]
   Barroso DE, 2010, BRAZ J INFECT DIS, V14, P242, DOI 10.1590/S1413-86702010000300008
   Castineiras TMPP, 2012, EMERG INFECT DIS, V18, P1336, DOI 10.3201/eid1808.111344
   CLSI, 2010, M100S20 CLSI
   de Filippis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033016
   Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505
   Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799
   Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P194, DOI 10.1128/CVI.00401-10
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Ministry of Health of Brazil, 2015, MEN DIS SER
   Mustapha MM, 2016, GENOME BIOL EVOL, V8, P2065, DOI 10.1093/gbe/evw122
   NORONHA CP, 1995, INT J EPIDEMIOL, V24, P1050, DOI 10.1093/ije/24.5.1050
   Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027
   Pavan MG, 2016, ABSTRACTS OF 20TH IN, P214
   Pedro LGF, 2007, SCAND J INFECT DIS, V39, P28, DOI 10.1080/00365540600904761
   SACCHI CT, 1992, J CLIN MICROBIOL, V30, P1734, DOI 10.1128/JCM.30.7.1734-1738.1992
   Safadi MAP, 2013, EPIDEMIOL INFECT, V141, P447, DOI 10.1017/S0950268812001689
   Santos Magda Levantezi, 2005, Cad. Saúde Pública, V21, P823, DOI 10.1590/S0102-311X2005000300016
   Stefanelli P, 2003, J CLIN MICROBIOL, V41, P5783, DOI 10.1128/JCM.41.12.5783-5786.2003
   Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271
   Taha MK, 2007, ANTIMICROB AGENTS CH, V51, P2784, DOI 10.1128/AAC.00412-07
   Taha MK, 2010, ANTIMICROB AGENTS CH, V54, P3651, DOI 10.1128/AAC.00315-10
   Tsang Raymond Sw, 2005, Can J Infect Dis Med Microbiol, V16, P171
   Wang QA, 2010, INFECT IMMUN, V78, P3883, DOI 10.1128/IAI.00363-10
   Zhu BQ, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01019-16
NR 28
TC 3
Z9 3
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2374-4235
EI 2374-4243
J9 INFECT DIS-NOR
JI Infect. Dis.
PY 2018
VL 50
IS 9
BP 697
EP 704
DI 10.1080/23744235.2018.1459829
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA GS7JH
UT WOS:000443876300007
PM 29623748
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Pereira-Silva, JW
   do Nascimento, VA
   Belchior, HCM
   Almeida, JF
   Pessoa, FAC
   Naveca, FG
   Rios-Velasquez, CM
AF Pereira-Silva, Jordam William
   do Nascimento, Valdinete Alves
   Matos Belchior, Heliana Christy
   Almeida, Jessica Feijo
   Costa Pessoa, Felipe Arley
   Naveca, Felipe Gomes
   Rios-Velasquez, Claudia Maria
TI First evidence of Zika virus venereal transmission in Aedes aegypti
   mosquitoes
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; sexual transmission; mosquito vectors; mating; Flavivirus
ID VERTICAL TRANSMISSION; SEXUAL TRANSMISSION; DIPTERA-CULICIDAE;
   CHIKUNGUNYA-VIRUS; INFECTION; BRAZIL; EPIDEMIC; AMERICA
AB BACKGROUND Aedes aegypti is considered the main Zika virus (ZIKV) vector, and is thought to be responsible for the 20152016 outbreak in Brazil. Zika positive Ae. aegypti males collected in the field suggest that vertical and/or venereal transmission of ZIKV may occur.
   OBJECTIVES In this study, we aimed to demonstrate that venereal transmission of ZIKV by Ae. aegypti can occur under laboratory conditions.
   METHODS Ae. aegypti collected in the city of Manaus, confirmed as negative for Zika, Dengue and Chikungunya virus by reverse transcription real-time polymerase chain reaction (RT-qPCR) (AaM3V-strain), were reared under laboratory conditions and used for the experiments. The ZIKV used in this study was isolated from a patient presenting with symptoms; ZIKV was confirmed by RT-qPCR. Experiment 1: virgin male mosquitoes of AaM3V-strain were intrathoracically inoculated with a ZIKV suspension; four days after injection, they were transferred to a cage containing virgin females of AaM3V-strain and left to copulate for five days. Experiment 2: virgin female mosquitoes of AaM3V-strain were orally infected with a ZIKV suspension by blood feeding membrane assay; nine days after blood feeding, they were placed in cages with Ae. aegypti AaM3V-virgin males and left to copulate for four days. After copulation, all mosquitoes were individually evaluated for viral infection by RT-qPCR.
   FINDINGS The mean infection rate in Experiment 1 and Experiment 2 was 45% and 35%, respectively. In both experiments, cycle threshold values ranged from 13 to 35, indicating the presence of viral genomes.
   MAIN CONCLUSION Ae. aegypti males intrathoracically inoculated with a ZIKV suspension are infected and can transmit the virus to uninfected females by mating. Moreover, Ae. aegypti females orally infected with a ZIKV suspension can transmit the virus to uninfected males by copulation. This study shows that ZIKV infection of Ae. aegypti mosquitoes occurs not only during blood feeding, but also during copulation.
C1 [Pereira-Silva, Jordam William; do Nascimento, Valdinete Alves; Matos Belchior, Heliana Christy; Almeida, Jessica Feijo; Costa Pessoa, Felipe Arley; Naveca, Felipe Gomes; Rios-Velasquez, Claudia Maria] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Pereira-Silva, Jordam William; Almeida, Jessica Feijo] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Programa Posgrad Condicoes Vida & Situacoes Saude, Manaus, Amazonas, Brazil.
RP Rios-Velasquez, CM (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
EM claudia.rios@fiocruz.br
RI Nascimento, Valdinete Alves do/AAV-1879-2020; Naveca,
   Felipe/H-1130-2012; Velasquez, Claudia Maria Rios/ABD-5579-2020; pessoa,
   Felipe Arley Costa/P-2956-2017
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Naveca,
   Felipe/0000-0002-2888-1060; Velasquez, Claudia Maria
   Rios/0000-0002-2684-2981; pessoa, Felipe Arley
   Costa/0000-0002-6318-1887; FEIJO, JESSICA/0000-0002-7288-9799
FU FAPEAM/FIOCRUZ; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440856/2016-7]; CAPESCAPES [88881.130825/2016-01,
   88887.130823/2016-00]; FAPEAM; CNPqNational Council for Scientific and
   Technological Development (CNPq); ILMD/FIOCRUZAM (PAT-Program)
FX FAPEAM/FIOCRUZ (call 001/2014 PROEP), CNPq (grant 440856/2016-7), CAPES
   [grants 88881.130825/2016-01 and 88887.130823/2016-00 (call MCTIC/FNDCT
   - CNPq/MEC - CAPES/MS - Decit 14/2016 - Prevencao e Combate ao virus
   Zika)].; JWPS and HCMB received scholarship from FAPEAM; JFA received
   scholarship from CNPq; VAN received scholarship from ILMD/FIOCRUZAM
   (PAT-Program).
CR [Anonymous], 2016, 5 M EM COMM INT HLTH
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Burkhalter KL, 2017, EMERG INFECT DIS, V23, P680, DOI 10.3201/eid2304.161772
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEA AO, 1968, J INSECT PHYSIOL, V14, P305, DOI 10.1016/0022-1910(68)90072-3
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MS/ SVS-Ministerio da Saude/ Secretaria de Vigilancia em Saude, 2017, MON CAS DENG FEBR CH, V4
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Pang X, 2001, BMC Microbiol, V1, P18, DOI 10.1186/1471-2180-1-18
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   WHO World Health Organization, 2016, ZIK VIR MICR GUILL B
NR 34
TC 11
Z9 11
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JAN
PY 2018
VL 113
IS 1
BP 56
EP 61
DI 10.1590/0074-02760170329
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FO8XA
UT WOS:000417170300009
PM 29185595
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Naveca, FG
   do Nascimento, VA
   de Souza, VC
   Nunes, BTD
   Rodrigues, DSG
   Vasconcelos, PFD
AF Naveca, Felipe Gomes
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Diniz Nunes, Bruno Tardelli
   Guerreiro Rodrigues, Daniela Sueli
   da Costa Vasconcelos, Pedro Fernando
TI Multiplexed reverse transcription real-time polymerase chain reaction
   for simultaneous detection of Mayaro, Oropouche, and Oropouche-like
   viruses
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE real-time PCR; Mayaro virus; Oropouche virus; Amazon
ID FAMILY BUNYAVIRIDAE; BRAZIL; ORTHOBUNYAVIRUS; FEVER; IDENTIFICATION;
   EPIDEMIOLOGY; REASSORTANT; SEQUENCE; MANAUS
AB We describe a sensitive method for simultaneous detection of Oropouche and Oropouche-like viruses carrying the Oropouche S segment, as well as the Mayaro virus, using a multiplexed one-step reverse transcription real-time polymerase chain reaction (RT-qPCR). A chimeric plasmid containing both Mayaro and Oropouche targets was designed and evaluated for the in vitro production of transcribed RNA, which could be easily used as a non-infectious external control. To track false-negative results due to PCR inhibition or equipment malfunction, the MS2 bacteriophage was also included in the multiplex assay as an internal positive control. The specificity of the multiplex assay was evaluated by Primer-Blast analysis against the entire GenBank database, and further against a panel of 17 RNA arboviruses. The results indicated an accurate and highly sensitive assay with amplification efficiency greater than 98% for both targets, and a limit of detection between two and 20 copies per reaction. We believe that the assay described here will provide a tool for Mayaro and Oropouche virus detection, especially in areas where differential diagnosis of Dengue, Zika and Chikungunya viruses should be performed.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Diniz Nunes, Bruno Tardelli; Guerreiro Rodrigues, Daniela Sueli; da Costa Vasconcelos, Pedro Fernando] Minist Saude, Secretaria Vigilancia Saude, Inst Evandro Chagas, Ananindeua, PA, Brazil.
   [da Costa Vasconcelos, Pedro Fernando] Unversidade Estado Para, Belem, Para, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Naveca, Felipe/H-1130-2012; Vasconcelos, Pedro/AAH-3142-2019;
   Nascimento, Valdinete Alves do/AAV-1879-2020
OI Naveca, Felipe/0000-0002-2888-1060; Nascimento, Valdinete Alves
   do/0000-0002-7786-4718; Souza, Victor Costa de/0000-0002-3869-1519
FU FAPEAM PPP; DECIT/FAPEAM PPSUS; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX FAPEAM PPP, DECIT/FAPEAM PPSUS, CNPq.
CR Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Ladner JT, 2014, J GEN VIROL, V95, P1055, DOI 10.1099/vir.0.061309-0
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 17
TC 20
Z9 20
U1 0
U2 13
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL
PY 2017
VL 112
IS 7
BP 510
EP 513
DI 10.1590/0074-02760160062
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EX5HL
UT WOS:000403270100007
PM 28591313
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Corado, ADG
   Bello, G
   Leao, RAC
   Granja, F
   Naveca, FG
AF Guerra Corado, Andre de Lima
   Bello, Gonzalo
   Carvalho Leao, Renato Augusto
   Granja, Fabiana
   Naveca, Felipe Gomes
TI HIV-1 genetic diversity and antiretroviral drug resistance among
   individuals from Roraima state, northern Brazil
SO PLOS ONE
LA English
DT Article
ID SUBTYPE-C; TREATMENT-NAIVE; MUTATIONS; PREVALENCE; SURVEILLANCE;
   AMAZONAS; THERAPY; NETWORK
AB The HIV-1 epidemic in Brazil has spread towards the Northern country region, but little is known about HIV-1 subtypes and prevalence of HIV strains with resistance mutations to antiretrovirals in some of the Northern states. HIV-1 protease (PR) and reverse transcriptase (RT) sequences were obtained from 73 treatment-naive and -experienced subjects followed between 2013 and 2014 at a public health reference unit from Roraima, the northernmost Brazilian state. The most prevalent HIV-1 clade observed in the study population was the subtype B (91%), followed by subtype C (9%). Among 12 HIV-1 strains from treatment-naive patients, only one had a transmitted drug resistance mutation for NNRTI. Among 59 treatment-experienced patients, 12 (20%) harbored HIV-1 strains with acquired drug resistance mutations (ADRM) that reduce the susceptibility to two classes of antiretroviral drugs (NRTI and NNRTI or NRTI and PI), and five (8%) harbored HIV-1 strains with ADRM that reduced susceptibility to only one class of antiretroviral drugs (NNRTI or PI). No patients harboring HIV strains with reduced susceptibility to all three classes of antiretroviral drugs were detected. A substantial fraction of treatment-experienced patients with (63%) and without (70%) ADRM had undetectable plasma viral loads (<40 copies/ml) at the time of sampling. Among treatment-experienced with plasma viral loads above 2,000 copies/ml, 44% displayed no ADRM. This data showed that the HIV-1 epidemic in Roraima displayed a much lower level of genetic diversity and a lower prevalence of ADRM than that described in other Brazilian states.
C1 [Guerra Corado, Andre de Lima; Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas Maria Deane, Manaus, Amazonas, Brazil.
   [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS Imunol Mol, Rio De Janeiro, Brazil.
   [Carvalho Leao, Renato Augusto] LACEN RR, Lab Cent Saude Publ Roraima, Roraima, Brazil.
   [Granja, Fabiana] Univ Fed Roraima UFRR, Lab Biol Mol, Roraima, Brazil.
RP Corado, ADG; Naveca, FG (corresponding author), Fiocruz MS, Inst Leonidas Maria Deane, Manaus, Amazonas, Brazil.
EM andrecorado@gmail.com; felipe.naveca@fiocruz.br
RI Naveca, Felipe/H-1130-2012; Bentancor, Gonzalo Jose Bello/N-7377-2019;
   Bello, Gonzalo/E-6842-2013
OI Naveca, Felipe/0000-0002-2888-1060; Bentancor, Gonzalo Jose
   Bello/0000-0002-2724-2793; 
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) -
   Fundacao Oswaldo Cruz/ILMD - POM
FX ALGC was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) (www.capes.gov.br), financial supported was provided by
   Fundacao Oswaldo Cruz/ILMD (www.amazonia.fiocruz.br) - POM 2014-15. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Bahia Fabianna, 2004, Braz J Infect Dis, V8, P281, DOI 10.1590/S1413-86702004000400003
   Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa
   Brazilian, 2015, AIDS EP B
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]
   Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014
   Cunha LKH, 2012, BRAZ J MED BIOL RES, V45, P104, DOI 10.1590/S0100-879X2012007500003
   da Costa CM, 2016, AIDS RES HUM RETROV, V32, P918, DOI [10.1089/AID.2016.0044, 10.1089/aid.2016.0044]
   Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   Delgado E, 2001, AIDS RES HUM RETROV, V17, P753, DOI 10.1089/088922201750237022
   Diaz RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139677
   Diniz AMA, 2005, CAD GEOGR, V15, P23
   Divino F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162112
   Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hacker MA, 2007, CAD SAUDE PUBLICA, V23, pS345, DOI 10.1590/S0102-311X2007001500003
   Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20
   Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914
   Lopes CAF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/738528
   MACEDO O, 2012, REV PAN-AMAZ SAUDE, V3, P11, DOI DOI 10.5123/S2176-62232012000200002
   Machado LFA, 2009, AIDS RES HUM RETROV, V25, P961, DOI 10.1089/aid.2009.0027
   Toledo PV, 2010, BRAZ J INFECT DIS, V14, P360, DOI 10.1590/S1413-86702010000400009
   Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499
   Rangel HR, 2009, MEM I OSWALDO CRUZ, V104, P522, DOI 10.1590/S0074-02762009000300020
   Saad FF, 2010, INT J MOL MED, V26, P585, DOI 10.3892/ijmm_00000503
   Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785
   Silva LD, 2016, AIDS RES HUM RETROV, V32, P373, DOI [10.1089/aid.2015.0280, 10.1089/AID.2015.0280]
   Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012
   Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012
   Tanuri A, 2002, J CLIN VIROL, V25, P39, DOI 10.1016/S1386-6532(01)00249-9
   Cardoso LPV, 2009, AIDS RES HUM RETROV, V25, P943, DOI 10.1089/aid.2009.0060
NR 35
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2017
VL 12
IS 3
AR e0173894
DI 10.1371/journal.pone.0173894
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN9KE
UT WOS:000396318300090
PM 28301548
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Divino, F
   Corado, ADG
   Naveca, FG
   Stefani, MMA
   Bello, G
AF Divino, Flavia
   Guerra Corado, Andre de Lima
   Naveca, Felipe Gomes
   Stefani, Mariane M. A.
   Bello, Gonzalo
TI High Prevalence and Onward Transmission of Non-Pandemic HIV-1 Subtype B
   Clades in Northern and Northeastern Brazilian Regions
SO PLOS ONE
LA English
DT Article
ID POPULATION-DYNAMICS; GENETIC DIVERSITY; DRUG-RESISTANCE; ALGORITHMS
AB The Human immunodeficiency virus type-1 (HIV-1) epidemic in Brazil is mainly driven by the subtype B pandemic lineage (B-PANDEMIC), while Caribbean non-pandemic subtype B clades (B-CAR) seem to account for a very low fraction of HIV-infections in this country. The molecular characteristics of the HIV-1 subtype B strains disseminated in the Northern and Northeastern Brazilian regions, however, have not been explored so far. In this study, we estimate the prevalence of the HIV-1 B-PANDEMIC and B-CAR clades across different Brazilian regions and we reconstruct the spatiotemporal dynamics of dissemination of the major Brazilian B-CAR clades. A total of 2,682 HIV-1 subtype B pol sequences collected from 21 different Brazilian states from the five country regions between 1998 and 2013 were analyzed. Maximum Likelihood phylogenetic analyses revealed that the B-CAR strains reached 16 out 21 Brazilian states here analyzed. The B-CAR clades comprise a low fraction (< 10%) of subtype B infections in most Brazilian states analyzed, with exception of Roraima (41%), Amazonas (14%) and Maranhao (14%). Bayesian phylogeographic analyses indicate that B-CAR strains originally from the Hispaniola and Trinidad and Tobago were introduced at multiple times into different states from all Brazilian regions and a few of those strains, probably introduced into Roraima, Maranhao and Sao Paulo between the late 1970s and the early 1980s, established secondary outbreaks in the Brazilian population. These results support that the HIV-1 subtype B epidemics in some Brazilian states from the Northern and Northeastern regions display a unique molecular pattern characterized by the high prevalence of B-CAR lineages, which probably reflects a strong epidemiological link with the HIV-1 epidemics in the Caribbean region.
C1 [Divino, Flavia; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
   [Guerra Corado, Andre de Lima; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Stefani, Mariane M. A.] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil.
RP Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
EM gbellobr@gmail.com
RI Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019;
   Naveca, Felipe/H-1130-2012
OI Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Naveca,
   Felipe/0000-0002-2888-1060
FU Public Health Service from the "Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro" (FAPERJ) [E-26/110.439/2014];
   "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [472896/2012-1]; Instituto Oswaldo Cruz-FIOCRUZ
FX GB was supported by Public Health Service grants E-26/110.439/2014 from
   the "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio
   de Janeiro" (FAPERJ) and 472896/2012-1 from the "Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico" (CNPq). FD was funded by a
   fellowship from Instituto Oswaldo Cruz- FIOCRUZ. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amaral EF, 2005, ONLINE J MIGRATION P
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Arouck R, 2000, LUSOTOPIE, P67
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Brazilian (2015) Ministry of Health, 2015, AIDS EP B
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Cabello M, 2015, AIDS, V29, P483, DOI 10.1097/QAD.0000000000000552
   Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045
   Chen J.J., 2011, MODEL SIMUL ENG, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0025286
   Corbin H.P, 2007, BRAZILIAN MIGRATION
   da Costa CM, 2016, AIDS RES HUM RETROVI
   Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   De Theije Marjo, 2009, EUR REV LATIN AM CAR, V87, P5
   Diniz AMA, 2005, CAD GEOGR, V15, P23
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2002, GENETICS, V161, P1307
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104
   Guimaraes ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141372
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Heemskerk M, 2014, SURINAME MIGRATION P
   Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Leonardi V., 2000, FRONTEIRAS AMAZONICA
   Martins CC, 2011, AN 3 S POS GRAD REL
   Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095360
   Pereira Mariana Cunha, 2006, Estud. av., V20, P209, DOI 10.1590/S0103-40142006000200016
   Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A., 2007, TRACER V1 6, P6
   Rambaut A, 2009, FIGTREE V1 4 TREE FI
   Silva LD, 2016, AIDS RES HUM RETROV, V32, P373, DOI [10.1089/aid.2015.0280, 10.1089/AID.2015.0280]
   Soares CL, 2011, PRACS REV HUMANIDADE, V4, P129
   Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Vale Ana Lia Farias, 2006, Estud. av., V20, P255, DOI 10.1590/S0103-40142006000200019
   Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002
NR 42
TC 8
Z9 8
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 7
PY 2016
VL 11
IS 9
AR e0162112
DI 10.1371/journal.pone.0162112
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV9IX
UT WOS:000383255200042
PM 27603317
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Dulgheroff, ACB
   Pereira, WAB
   Sarmento, RR
   Silva, GAV
   Naveca, FG
   Domingues, ALS
AF Dulgheroff, A. C. B.
   Pereira, W. A. B.
   Sarmento, R. R.
   Silva, G. A. V.
   Naveca, F. G.
   Domingues, A. L. S.
TI Analysis of bovine rotavirus strains circulating in diarrheic dairy
   calves in Uberaba, Minas Gerais, Brazil, during 2008-2009
SO ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA
LA English
DT Article
ID IDENTIFICATION; GENOTYPES; VACCINE; CATTLE; PCR
C1 [Dulgheroff, A. C. B.; Domingues, A. L. S.] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil.
   [Dulgheroff, A. C. B.; Sarmento, R. R.] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Pereira, W. A. B.] Inst Fed Catarinense, Concordia, SC, Brazil.
   [Silva, G. A. V.; Naveca, F. G.] Inst Leonidas & Maria Deane Fiocruz, Manaus, Amazonas, Brazil.
RP Domingues, ALS (corresponding author), Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil.
EM alsdomingues@gmail.com
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES-REUNI)
FX We thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES-REUNI) for the support of a PhD fellowship to ACB Dulgheroff and
   the Program for Technological Development in Tools for Health (PDTIS
   FIOCRUZ) for the use of its facilities (Instituto Leonidas and Maria
   Deane sequencing platform).
CR Alferi AF, 2004, VET MICROBIOL, V99, P167, DOI 10.1016/j.vetmic.2003.10.029
   Banyai K, 2003, J MED VIROL, V71, P124, DOI 10.1002/jmv.10462
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Domingues ALS, 2008, J CLIN VIROL, V43, P298, DOI 10.1016/j.jcv.2008.07.008
   Dulgheroff ACB, 2012, J CLIN VIROL, V55, P67, DOI 10.1016/j.jcv.2012.06.003
   GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1338, DOI 10.1128/JCM.32.5.1338-1340.1994
   GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1333, DOI 10.1128/JCM.32.5.1333-1337.1994
   Kaplon J, 2013, VACCINE, V31, P2433, DOI 10.1016/j.vaccine.2013.03.039
   Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020
   Silva FDF, 2012, PESQUI VET BRASIL, V32, P237, DOI 10.1590/S0100-736X2012000300010
   Swiatek DL, 2010, VET MICROBIOL, V140, P56, DOI 10.1016/j.vetmic.2009.07.020
NR 11
TC 1
Z9 1
U1 0
U2 2
PU ARQUIVO BRASILEIRO MEDICINA VETERINARIA ZOOTECNIA
PI MINAS GERAIS
PA FEDERAL MINAS GERAIS CAIXA POSTAL 567-BELO HORIZ, MINAS GERAIS, BRAZIL
SN 0102-0935
EI 1678-4162
J9 ARQ BRAS MED VET ZOO
JI Arq. Bras. Med. Vet. Zootec.
PD JUL-AUG
PY 2016
VL 68
IS 4
BP 1090
EP 1094
DI 10.1590/1678-4162-8737
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA DU3ZY
UT WOS:000382152500037
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Dulgheroff, ACB
   da Silva, GAV
   Naveca, FG
   de Oliveira, AG
   Domingues, ALD
AF Bernardes Dulgheroff, Ana Carolina
   Villarouco da Silva, George Allan
   Naveca, Felipe Gomes
   de Oliveira, Adriana Goncalves
   da Silva Domingues, Andre Luiz
TI Diversity of group A rotavirus genes detected in the Triangulo Mineiro
   region, Minas Gerais, Brazil
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Rotavirus; Infantile diarrhea; Genotype; Genetic variation
ID MOLECULAR CHARACTERIZATION; INTERSPECIES TRANSMISSION; MULTIPLE
   REASSORTMENT; ACUTE GASTROENTERITIS; GLOBAL SPREAD; STRAINS;
   CLASSIFICATION; EVOLUTION; GENOTYPE; DS-1-LIKE
AB Group A rotaviruses are the main causative agent of infantile gastroenteritis. The segmented nature of the viral genome allows reassortment of genome segments, which can generate genetic variants. In this study, we characterized the diversity of the VP7, VP4 (VP8*), VP6, NSP4, and NSP5 genes of the rotaviruses that circulated from 2005 to 2011 in the Trifingulo Mineiro (TM) region of Brazil. Samples with genotypes G2 (sublineages IVa-1 and IVa-3), G1 (sublineage I-A), G9 (lineage III), G12 (lineages II and III), G8 (lineage II), G3 (lineage III), P[4] (sublineages IVa and IVb), P[8] (sublineages P[8]-3.6, P[8]-3.3, and P[8]-3.1), 12 (lineage VII), E2 (lineages VI, XII, and X), and H2 (lineage III) were identified. The associations found in the samples were G1, G9, or G12 with P[8]-I1-E1-H1; G2 or G8 with P[4]-I2-E2-H2; G12 with I3-E3 H6; and G3 with P[4]-I2-E3-H3 (previously unreported combination). Reassortment events in G2P[4] strains and an apparent pattern of temporal segregation within the lineages were observed. Five TM samples contained genes that exhibited high nucleotide and amino acid identities with strains of animal origin. The present study includes a period of pre- and post introduction of rotavirus vaccination in all Brazilian territories, thereby serving as a basis for monitoring changes in the genetic constitution of rotaviruses. The results also contribute to the understanding of the diversity and evolution of rotaviruses in a global context. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license
C1 [Bernardes Dulgheroff, Ana Carolina; de Oliveira, Adriana Goncalves; da Silva Domingues, Andre Luiz] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Microbiol Lab, Uberaba, MG, Brazil.
   [Bernardes Dulgheroff, Ana Carolina] Univ Fed Paraiba, Hlth Sci Ctr, Hlth Tech Sch, Joao Pessoa, Paraiba, Brazil.
   [Villarouco da Silva, George Allan; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Lab Infect Dis Ecol Amazon, Leonidas & Maria Deane Inst, Manaus, Amazonas, Brazil.
RP Dulgheroff, ACB (corresponding author), Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Microbiol Lab, Uberaba, MG, Brazil.; Dulgheroff, ACB (corresponding author), Univ Fed Paraiba, Hlth Sci Ctr, Hlth Tech Sch, Joao Pessoa, Paraiba, Brazil.
EM anadulgheroff@gmail.com
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrazilCAPES; Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU); Federal
   University of Triangulo Mineiro, Brazil
FX We acknowledge Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Brazil for granting a PhD fellowship to ACB
   Dulgheroff; Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU), Federal
   University of Triangulo Mineiro, Brazil for the partial financial
   support and Programa de Desenvolvimento Tecnologico em Insumos para
   Saude (PDTIS) Amazonian Oswaldo Cruz Foundation (FIOCRUZ), Brazil for
   permitting the use of their sequencing platform (Leonidas e Maria Deane
   Institute).
CR Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Cunliffe NA, 1997, J MED VIROL, V53, P41, DOI 10.1002/(SICI)1096-9071(199709)53:1<41::AID-JMV8>3.3.CO;2-N
   Dennis AF, 2014, J VIROL, V88, P3789, DOI 10.1128/JVI.03516-13
   Doan YH, 2011, ARCH VIROL, V156, P1969, DOI 10.1007/s00705-011-1083-z
   Domingues ALS, 2008, J CLIN VIROL, V43, P298, DOI 10.1016/j.jcv.2008.07.008
   Doro R, 2014, INFECT GENET EVOL, V28, P446, DOI 10.1016/j.meegid.2014.08.017
   Dulgheroff ACB, 2014, BRAZ J MED BIOL RES, V47, P1091, DOI 10.1590/1414-431X20144156
   Dulgheroff ACB, 2012, J CLIN VIROL, V55, P67, DOI 10.1016/j.jcv.2012.06.003
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   ESTES MK, 2007, FIELDS VIROLOGY, P1917
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0
   Gomara MI, 2002, J VIROL, V76, P6596, DOI 10.1128/JVI.76.13.6596-6601.2002
   Gomara MI, 2001, J CLIN MICROBIOL, V39, P3796, DOI 10.1128/JCM.39.10.3796-3798.2001
   Gomez MM, 2014, INFECT GENET EVOL, V28, P385, DOI 10.1016/j.meegid.2014.04.007
   Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071
   Ianiro G, 2014, INFECT GENET EVOL, V21, P129, DOI 10.1016/j.meegid.2013.10.029
   Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810
   Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P898
   Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040
   Lappalainen S, 2014, HUM VACC IMMUNOTHER, V10, P2039, DOI 10.4161/hv.28858
   Luchs A, 2014, J GEN VIROL 3, V95, P627
   Luchs A, 2015, J MED VIROL, V87, P1881, DOI 10.1002/jmv.24241
   Maestri RP, 2012, J MED VIROL, V84, P1993, DOI 10.1002/jmv.23364
   da Silva MFM, 2015, INFECT GENET EVOL, V30, P206, DOI 10.1016/j.meegid.2014.12.030
   da Silva MFM, 2013, INFECT GENET EVOL, V16, P200, DOI 10.1016/j.meegid.2013.01.004
   Matthijnssens J, 2006, J VIROL, V80, P3801, DOI 10.1128/JVI.80.8.3801-3810.2006
   Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   Matthijnssens J, 2011, INFECT GENET EVOL, V11, P1396, DOI 10.1016/j.meegid.2011.05.007
   Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137
   Ndze VN, 2014, INFECT GENET EVOL, V28, P537, DOI 10.1016/j.meegid.2014.10.009
   Phan TG, 2007, INFECT GENET EVOL, V7, P656, DOI 10.1016/j.meegid.2007.05.001
   Phan TG, 2007, J VIROL, V81, P4645, DOI 10.1128/JVI.02342-06
   Pietsch C, 2009, J CLIN MICROBIOL, V47, P3569, DOI 10.1128/JCM.01471-09
   Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06
   Rosa E, 2002, J CLIN MICROBIOL, V40, P2837
   Simmonds MK, 2008, J CLIN VIROL, V42, P368, DOI 10.1016/j.jcv.2008.02.011
   Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5
   Tran T N Hoa, 2013, Trop Med Health, V41, P13, DOI 10.2149/tmh.2012-29
NR 43
TC 5
Z9 5
U1 0
U2 0
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD JUL-SEP
PY 2016
VL 47
IS 3
BP 731
EP 740
DI 10.1016/j.bjm.2016.04.012
PG 10
WC Microbiology
SC Microbiology
GA DS9KI
UT WOS:000381101200028
PM 27266629
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Corado, ADG
   da Silva, GAV
   Leao, RAC
   Granja, F
   Naveca, FG
AF Guerra Corado, Andre de Lima
   Villarouco da Silva, George Allan
   Carvalho Leao, Renato Augusto
   Granja, Fabiana
   Naveca, Felipe Gomes
TI Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
C1 [Guerra Corado, Andre de Lima; Villarouco da Silva, George Allan; Naveca, Felipe Gomes] Fiocruz Amazonas, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Carvalho Leao, Renato Augusto] Lab Cent Saude Publ Roraima LACEN RR, Boa Vista, RR, Brazil.
   [Granja, Fabiana] Univ Fed Roraima UFRR, Mol Biol Lab, Boa Vista, RR, Brazil.
RP Corado, ADG (corresponding author), Fiocruz Amazonas, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
EM andrecorado@gmail.com
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
CR Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec
   de Farias JD, 2012, GENET MOL BIOL, V35, P27, DOI 10.1590/S1415-47572012005000003
   Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
   Magno A, 2005, CAD GEOGR, V15, P23
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD MAY-JUN
PY 2016
VL 20
IS 3
BP 314
EP 315
DI 10.1016/S0092-8674(00)80110-5
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DM6ER
UT WOS:000376443900019
PM 26944723
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU do Nascimento, VA
   de Souza, VC
   Naveca, FG
AF do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Naveca, Felipe Gomes
TI Complete genome of a dengue virus serotype 4 strain from Amazonas,
   Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Brazilian Amazon; dengue virus; DENV-4; viral genome; next-generation
   sequencing
AB Dengue virus (DENV) infections represent a significant concern for public health worldwide, being considered as the most prevalent arthropod-borne virus regarding the number of reported cases. In this study, we report the complete genome sequencing of a DENV serotype 4 isolate, genotype II, obtained in the city of Manaus, directly from the serum sample, applying Ion Torrent sequencing technology. The use of a massive sequencing technology allowed the detection of two variable sites, one in the coding region for the viral envelope protein and the other in the nonstructural 1 coding region within viral populations.
C1 [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.
   [do Nascimento, Valdinete Alves] Univ Fed Amazonas, Programa Posgrad Saude, Soc & Endemias Amazonia, Manaus, AM, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.
EM fnaveca@amazonia.fiocruz.br
RI Nascimento, Valdinete Alves do/AAV-1879-2020; Naveca, Felipe/H-1130-2012
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Naveca,
   Felipe/0000-0002-2888-1060; Souza, Victor Costa de/0000-0002-3869-1519
FU FIOCRUZ (PAPES VI); CAPESCAPES
FX Financial support: FIOCRUZ (PAPES VI), CAPES (to VAN)
CR Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Travassos da Rosa AP, 1982, B EPIDEMIOLOGICO MIN, V14, P93
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   World Health Organization, 2014, DENG SEV DENG
NR 9
TC 1
Z9 1
U1 1
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD FEB
PY 2016
VL 111
IS 2
BP 141
EP 143
DI 10.1590/0074-02760150416
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DE3IW
UT WOS:000370522900009
PM 26841048
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Cardoso, BF
   Serra, OP
   Heinen, LBD
   Zuchi, N
   de Souza, VC
   Naveca, FG
   dos Santos, MAM
   Slhessarenko, RD
AF Cardoso, Belgath Fernandes
   Serra, Otacilia Pereira
   da Silva Heinen, Leticia Borges
   Zuchi, Nayara
   de Souza, Victor Costa
   Naveca, Felipe Gomes
   Mendes dos Santos, Marcelo Adriano
   Slhessarenko, Renata Dezengrini
TI Detection of Oropouche virus segment S in patients and in Culex
   quinquefasciatus in the state of Mato Grosso, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE OROV; Orthobunyavirus; Mato Grosso; mosquitoes; phylogenetic analysis
ID LOUIS ENCEPHALITIS-VIRUS; ORTHOBUNYAVIRUS; IDENTIFICATION; EPIDEMIOLOGY;
   CULICIDAE; INFECTION; SANTAREM; AREA; TRANSMISSION; REASSORTANT
AB This study aimed to investigate the circulation of Orthobunyavirus species in the state of Mato Grosso (MT) Brazil. During a dengue outbreak in 2011/2012, 529 serum samples were collected from patients with acute febrile illness with symptoms for up to five days and 387 pools of female Culex quinquefasciatus captured in 2013 were subjected to nested-reverse transcription-polymerase chain reaction for segment S of the Simbu serogroup followed by nucleotide sequencing and virus isolation in Vero cells. Patients (5/529; 0.9%) from Cuiaba (n = 3), Varzea Grande (n = 1) and Nova Mutum (n = 1) municipalities were positive for the S segment of Oropouche virus (OROV). Additionally, eight/387 Cx. quinquefasciatus pools were positive for the segment, with a minimum infection rate of 2.3. Phylogenetic analysis indicated that all the samples belong to the subgenotype Ia, presenting high homology with OROV strains obtained from humans and animals in the Brazilian Amazon. The present paper reports the first detection of an Orthobunyavirus, possibly OROV, in patients and in Cx. quinquefasciatus mosquitoes in MT. This finding reinforces the notion that arboviruses frequently reported in the Amazon Region circulate sporadically in MT during dengue outbreaks.
C1 [Cardoso, Belgath Fernandes; Serra, Otacilia Pereira; da Silva Heinen, Leticia Borges; Zuchi, Nayara; Slhessarenko, Renata Dezengrini] Univ Fed Mato Grosso, Fac Med, Programa Posgrad Ciencias Saude, Cuiaba, MT, Brazil.
   [de Souza, Victor Costa; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.
   [Mendes dos Santos, Marcelo Adriano] Cent Lab, Secretaria Estado Saude, Cuiaba, MT, Brazil.
RP Slhessarenko, RD (corresponding author), Univ Fed Mato Grosso, Fac Med, Programa Posgrad Ciencias Saude, Cuiaba, MT, Brazil.
EM renatadezengrini@yahoo.com.br
RI Naveca, Felipe/H-1130-2012; Slhessarenko, Renata Dezengrini/R-2390-2019
OI Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa
   de/0000-0002-3869-1519
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; UFMT
FX CNPq, CAPES, UFMT BFC, OPS, LBSH and NZ were recipients of CAPES Master
   scholarships.
CR Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013
   Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Batista PM, 2012, REV SOC BRAS MED TRO, V45, P168, DOI 10.1590/S0037-86822012000200006
   Becker B, 2001, PARCERIAS ESTRATEGIC, V12, P135
   BORBOREMA C. A. T., 1982, Revista do Instituto de Medicina Tropical de Sao Paulo, V24, P132
   Chowdhary R, 2012, J GEN VIROL, V93, P1023, DOI 10.1099/vir.0.039479-0
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P215, DOI 10.1590/S0036-46652015000300006
   DIXON KE, 1981, AM J TROP MED HYG, V30, P161, DOI 10.4269/ajtmh.1981.30.161
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   FIGUEIREDO LTM, 1986, REV SAUDE PUBL, V20, P204, DOI 10.1590/S0034-89101986000300003
   Figueiredo LTM, 1999, REV MED RIBEIRAO PRE, V32, P154
   Forattini OP, 2002, CULICIDOLOGIA MED CU, VII
   Gauci PJ, 2015, PLOS ONE, V3, P1
   Hang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092114
   Hoch AL, 1987, PAHO B, V21, P51
   Ladner JT, 2014, J GEN VIROL, V95, P1055, DOI 10.1099/vir.0.061309-0
   LeDuc J, 1986, ARBOVIRUSES EPIDEMIO, P1
   Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Moreli ML, 2013, VIROLOGY DISCOVERY, V1, P1
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Murphy FA, 1998, EMERG INFECT DIS, V4, P429, DOI 10.3201/eid0403.980324
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149
   Pinheiro F. P., 1998, OVERVIEW ARBOVIROLOG, P186
   Pinheiro F. P., 1962, REV SERV ESP SAUDE P, V12, P15
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P172, DOI 10.4269/ajtmh.1981.30.172
   PINHEIRO FP, 1976, TROPENMED PARASITOL, V27, P213
   Pinheiro FP, 1997, DOENCAS INFECCIOSAS, P285
   Pinheiro FP, 1986, 50 ANOS CONTRIBUICAO, P375
   Pinheiro FP, 1983, J BRAS MED, V44, P46
   Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Santarem MCA, 2010, REV PAN AMAZONICA SA, V1, P29, DOI DOI 10.5123/S2176-62232010000400005.T
   Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339
   Nunes MRT, 2009, CAD SAUDE PUBLICA, V25, P2583, DOI 10.1590/S0102-311X2009001200006
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   Barbosa MD, 2008, REV SOC BRAS MED TRO, V41, P658, DOI 10.1590/S0037-86822008000600019
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   VASCONCELOS PFD, 1989, REV INST MED TROP SP, V31, P271, DOI 10.1590/S0036-46651989000400011
   Yanase T, 2012, ARCH VIROL, V157, P1611, DOI 10.1007/s00705-012-1341-8
   Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 49
TC 25
Z9 25
U1 1
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2015
VL 110
IS 6
BP 745
EP 754
DI 10.1590/0074-02760150123
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CV7BW
UT WOS:000364428100006
PM 26517653
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bastos, MS
   Coelho-Dos-Reis, JG
   Zauli, DAG
   Naveca, FG
   Monte, RL
   Pimentel, JP
   Macario, VMK
   da Silva, NL
   Peruhype-Magalhaes, V
   Pascoal-Xavier, MA
   Guimaraes, A
   Carvalho, AT
   Malheiro, A
   Martins, OA
   Mourao, MPG
AF Bastos, Michele Souza
   Coelho-dos-Reis, Jordana Grazziela
   Gomes Zauli, Danielle Alves
   Naveca, Felipe Gomes
   Monte, Rossicleia Lins
   Pimentel, Joao Paulo
   Kramer Macario, Valeria Munique
   da Silva, Natalia Lessa
   Peruhype-Magalhaes, Vanessa
   Pascoal-Xavier, Marcelo Antonio
   Guimaraes, Allyson
   Carvalho, Andrea Teixeira
   Malheiro, Adriana
   Martins-Filho, Olindo Assis
   Gomes Mourao, Maria Paula
TI Divergent cerebrospinal fluid cytokine network induced by non-viral and
   different viral infections on the central nervous system
SO BMC INFECTIOUS DISEASES
LA English
DT Article
ID ASEPTIC-MENINGITIS; NESTED-PCR; INTERFERON-GAMMA; MUMPS MENINGITIS;
   ECHOVIRUS 30; INTERLEUKIN-10; CHILDREN; DIAGNOSIS; VIRUS; FREQUENCY
AB Background: Meningoencephalitis is one of the most common disorders of the central nervous system (CNS) worldwide. Viral meningoencephalitis differs from bacterial meningitis in several aspects. In some developing countries, bacterial meningitis has appropriate clinical management and chemotherapy is available. Virus-associated and virus not detected meningoencephalitis are treatable, however, they may cause death in a few cases. The knowledge of how mediators of inflammation can induce disease would contribute for the design of affordable therapeutic strategies, as well as to the diagnosis of virus not detected and viral meningoencephalitis. Cytokine-induced inflammation to CNS requires several factors that are not fully understood yet.
   Methods: Considering this, several cytokines were measured in the cerebrospinal fluid (CSF) of patients with undiagnosed and viral meningoencephalitis, and these were correlated with cellularity in the CSF.
   Results: The results demonstrate that an altered biochemical profile alongside increased cellularity in the cerebrospinal fluid is a feature of patients with meningoencephalitis that are not associated with the detection of virus in the CNS (P < 0.05). Moreover, HIV-positive patients (n = 10) that evolve with meningoencephalitis display a distinct biochemical/cytological profile (P < 0.05) in the cerebrospinal fluid. Meningoencephalitis brings about a prominent intrathecal cytokine storm regardless of the detection of virus as presumable etiological agent. In the case of Enterovirus infection (n = 13), meningoencephalitis elicits robust intrathecal pro-inflammatory cytokine pattern and elevated cellularity when compared to herpesvirus (n = 15) and Arbovirus (n = 5) viral infections (P < 0.05).
   Conclusion: Differences in the cytokine profile of the CSF may be unique if distinct, viral or presumably non-viral pathways initially trigger the inflammatory response in the CNS.
C1 [Bastos, Michele Souza; Monte, Rossicleia Lins; Kramer Macario, Valeria Munique; da Silva, Natalia Lessa; Gomes Mourao, Maria Paula] Trop Med Fdn Dr Heitor Vieira Dourado, Manaus, AM, Brazil.
   [Gomes Mourao, Maria Paula] Amazonas State Univ, Manaus, AM, Brazil.
   [Coelho-dos-Reis, Jordana Grazziela; Gomes Zauli, Danielle Alves; Peruhype-Magalhaes, Vanessa; Carvalho, Andrea Teixeira; Martins-Filho, Olindo Assis] Fiocruz MS, Lab Biomarkers Diag & Monitoring, Rene Rachou Res Ctr, BR-30190002 Belo Horizonte, MG, Brazil.
   [Naveca, Felipe Gomes] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, AM, Brazil.
   [Pimentel, Joao Paulo; Guimaraes, Allyson; Malheiro, Adriana] Hematol & Hemotherap Fdn Amazonas, Manaus, AM, Brazil.
   [Pascoal-Xavier, Marcelo Antonio] Univ Fed Minas Gerais, Sch Med, Dept Anat Pathol, Belo Horizonte, MG, Brazil.
   [Gomes Zauli, Danielle Alves] Inst Hermes Pardini, Belo Horizonte, MG, Brazil.
RP Coelho-Dos-Reis, JG (corresponding author), Fiocruz MS, Lab Biomarkers Diag & Monitoring, Rene Rachou Res Ctr, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM jordana.reis@cpqrr.fiocruz.br
RI Bastos, Michele/AAS-7386-2020; Naveca, Felipe/H-1130-2012
OI Bastos, Michele/0000-0003-3450-666X; Naveca, Felipe/0000-0002-2888-1060;
   Martins-Filho, Olindo Assis/0000-0002-5494-4889; Costa,
   Allyson/0000-0002-7312-6822
FU Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM) [871/2010, 437/2012];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa
   de Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by grants from Fundacao de Amparo a Pesquisa do
   Amazonas (FAPEAM - grant 871/2010 and 437/2012), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao Oswaldo
   Cruz (FIOCRUZ) and Fundacao de Amparo a Pesquisa de Minas Gerais
   (FAPEMIG). The authors thank the program for technological development
   in tools for health-PDTIS-FIOCRUZ for the use of its facilities. ATC,
   OAMF and AM thank CNPq for fellowships (PQ).
CR Vazquez JA, 2012, J EMERG MED, V43, P322, DOI 10.1016/j.jemermed.2011.07.029
   Azuma H, 2000, CYTOKINE, V12, P160, DOI 10.1006/cyto.1999.0534
   Barcena-Panero A, 2014, DIAGN MICR INFEC DIS, V79, P171, DOI 10.1016/j.diagmicrobio.2014.02.017
   Barichello T, 2012, EUR J PHARMACOL, V697, P158, DOI 10.1016/j.ejphar.2012.09.053
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002
   DULKERIAN SJ, 1995, J PEDIATR-US, V126, P872, DOI 10.1016/S0022-3476(95)70199-0
   El Hiar R, INDIAN J VIROL
   Fujimori A, 1996, NEPHRON, V74, P471, DOI 10.1159/000189373
   Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453
   Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012
   Lin M, 2010, EUR J IMMUNOL, V40, P2277, DOI 10.1002/eji.200940094
   LV S, 2014, LIVER TRANSPLANT, V21, P1115, DOI DOI 10.1111/ENE.12441
   Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001
   Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x
   Mladenova Z, 2014, EPIDEMIOL INFECT, V142, P2159, DOI 10.1017/S0950268813003221
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Pastuszczak M, 2013, SEX TRANSM DIS, V40, P808, DOI 10.1097/OLQ.0000000000000024
   Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x
   Putz K, 2013, PRIMARY CARE, V40, P707, DOI 10.1016/j.pop.2013.06.001
   Roohandeh A, 2013, CLIN LAB, V59, P915, DOI 10.7754/Clin.Lab.2012.121123
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Soderquist RG, 2010, J BIOMED MATER RES A, V93A, P1169, DOI 10.1002/jbm.a.32611
   Sulik A, 2008, SCAND J IMMUNOL, V68, P323, DOI 10.1111/j.1365-3083.2008.02137.x
   Sulik A, 2006, SCAND J IMMUNOL, V64, P420, DOI 10.1111/j.1365-3083.2006.01797.x
   Sulik A, 2014, SCAND J IMMUNOL, V79, P68, DOI 10.1111/sji.12131
   VANLOON AM, 1992, EPIDEMIOL INFECT, V108, P165, DOI 10.1017/S095026880004961X
   Wang Hai-Yan, 2014, Bing Du Xue Bao, V30, P180
NR 28
TC 9
Z9 10
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD AUG 19
PY 2015
VL 15
AR 345
DI 10.1186/s12879-015-1035-4
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA CP2ED
UT WOS:000359689400004
PM 26286516
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Falcone-Dias, MF
   Centron, D
   Pavan, F
   Moura, ACDS
   Naveca, FG
   de Souza, VC
   Farache, A
   Leite, CQF
AF Falcone-Dias, Maria Fernanda
   Centron, Daniela
   Pavan, Fernando
   da Silva Moura, Adriana Candido
   Naveca, Felipe Gomes
   de Souza, Victor Costa
   Farache Filho, Adalberto
   Fujimura Leite, Clarice Queico
TI Opportunistic Pathogens and Elements of the Resistome that Are Common in
   Bottled Mineral Water Support the Need for Continuous Surveillance
SO PLOS ONE
LA English
DT Article
ID HETEROTROPHIC PLATE-COUNT; BURKHOLDERIA-CEPACIA COMPLEX;
   ANTIBIOTIC-RESISTANCE; RALSTONIA-PICKETTII; POTENTIAL SOURCE;
   DRINKING-WATER; BACTERIA; POPULATIONS; DIVERSITY; QUALITY
AB Several differences concerning bacterial species, opportunistic pathogens, elements of the resistome as well as variations concerning the CFU/mL counts were identified in some of the five most marketed bottled mineral water from Araraquara city, Sao Paulo, Brazil. Two out of five brands tested were confirmed as potential source of opportunistic pathogens, including Mycobacterium gordonae, Ralstonia picketti and Burkholderia cepacia complex (Bcc). A total of one hundred and six isolates were recovered from four of these bottled mineral water brands. Betaproteobacteria was predominant followed by Alphaproteobacteria, Gammaproteobacteria and Firmicutes. Ninety percent of the bacteria isolated demonstrated resistance to seventeen of the nineteen antimicrobials tested. These antimicrobials included eight different classes, including 3rd and 4th generation cephalosporins, carbapenems and fluoroquinolones. Multidrug resistant bacteria were detected for fifty-nine percent of isolates in three water brands at counts up to 103 CFU/ml. Of major concern, the two bottled mineral water harboring opportunistic pathogens were also source of elements of the resistome that could be directly transferred to humans. All these differences found among brands highlight the need for continuous bacteriological surveillance of bottled mineral water.
C1 [Falcone-Dias, Maria Fernanda; Pavan, Fernando; da Silva Moura, Adriana Candido; Farache Filho, Adalberto; Fujimura Leite, Clarice Queico] Univ Estadual Paulista, Sch Pharmaceut Sci, Araraquara, SP, Brazil.
   [Falcone-Dias, Maria Fernanda; Centron, Daniela] Univ Buenos Aires, Fac Med, Dept Microbiol, Buenos Aires, DF, Argentina.
   [Naveca, Felipe Gomes; de Souza, Victor Costa] Fiocruz MS, ILMD, Manaus, Amazonas, Brazil.
RP Falcone-Dias, MF (corresponding author), Univ Estadual Paulista, Sch Pharmaceut Sci, Araraquara, SP, Brazil.
EM mariafernandafdias@hotmail.com
RI Pavan, Fernando Rogerio/F-6046-2010; Naveca, Felipe/H-1130-2012;
   Falcone-Dias, Maria Fernanda/D-9583-2012
OI Pavan, Fernando Rogerio/0000-0002-6969-3963; Naveca,
   Felipe/0000-0002-2888-1060; Falcone-Dias, Maria
   Fernanda/0000-0002-5836-5112; Souza, Victor Costa
   de/0000-0002-3869-1519; Centron, Daniela/0000-0001-9308-3762
FU CAPESCAPES [18207/12-0]; Programa Recem-Doutor, Pro-Reitoria de
   Pesquisa/UNESP-Univ Estadual Paulista [05/2012]
FX This work has been partially supported by the Brazilian agency CAPES
   (http://www.capes.gov.br); CAPES, Scholarship Grant #18207/12-0 to MFFD;
   Programa Recem-Doutor (05/2012), Pro-Reitoria de Pesquisa/UNESP-Univ
   Estadual Paulista, Scholarship to MFFD (http://www.unesp.br). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ahmed W, 2014, WATER RES, V53, P361, DOI 10.1016/j.watres.2013.12.021
   Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006
   BISCHOFBERGER T, 1990, INT J FOOD MICROBIOL, V11, P51, DOI 10.1016/0168-1605(90)90039-8
   Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631
   Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7
   CAROLI G, 1985, J APPL BACTERIOL, V58, P461, DOI 10.1111/j.1365-2672.1985.tb01486.x
   Casanovas-Massana A, 2012, INT J FOOD MICROBIOL, V153, P38, DOI 10.1016/j.ijfoodmicro.2011.10.012
   Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI
   Codex Alimentarius Commission, 1081981 COD AL COMM
   D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388
   D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800
   Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157
   Eckburg PB, 2000, CHEST, V117, P96, DOI 10.1378/chest.117.1.96
   Falcone-Dias MF, 2013, FOOD CONTROL, V31, P90, DOI 10.1016/j.foodcont.2012.09.038
   Falcone-Dias MF, 2012, WATER RES, V46, P3612, DOI 10.1016/j.watres.2012.04.007
   Ferreira AC, 1996, J APPL BACTERIOL, V80, P479, DOI 10.1111/j.1365-2672.1996.tb03246.x
   Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355
   Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST
   Jorda-Vargas L, 2008, J CLIN MICROBIOL, V46, P1151, DOI 10.1128/JCM.01595-07
   Leao SC, 2004, PRACTICAL HDB PHENOT
   Leclerc H, 2002, FEMS MICROBIOL REV, V26, P207, DOI 10.1016/S0168-6445(02)00097-9
   Lis J T, 1980, Methods Enzymol, V65, P347
   Loy A, 2005, APPL ENVIRON MICROB, V71, P3624, DOI 10.1128/AEM.71.7.3624-3632.2005
   Mahenthiralingam E, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2014.04.006
   Messi P, 2005, SCI TOTAL ENVIRON, V346, P213, DOI 10.1016/j.scitotenv.2004.12.005
   MORAIS PV, 1990, J APPL BACTERIOL, V69, P750, DOI 10.1111/j.1365-2672.1990.tb01572.x
   Moreira BM, 2005, J HOSP INFECT, V60, P51, DOI 10.1016/j.jhin.2004.09.036
   Nardelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039223
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Otterholt E, 2011, INT J FOOD MICROBIOL, V144, P455, DOI 10.1016/j.ijfoodmicro.2010.10.034
   PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346
   Papapetropoulou M, 1997, CAN J MICROBIOL, V43, P499, DOI 10.1139/m97-071
   Pavlov D, 2004, INT J FOOD MICROBIOL, V92, P275, DOI 10.1016/j.ijfoodmicro.2003.08.018
   Rosenberg F. A., 2003, Clinical Microbiology Newsletter, V25, P41, DOI 10.1016/S0196-4399(03)80019-3
   Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015
   Sartory DP, 2004, INT J FOOD MICROBIOL, V92, P297, DOI 10.1016/j.ijfoodmicro.2003.08.006
   Thomson R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-241
   Varga L, 2011, FOOD CONTROL, V22, P591, DOI 10.1016/j.foodcont.2010.10.009
   Wallace RJ, 1998, ANNU REV MICROBIOL, V52, P453, DOI 10.1146/annurev.micro.52.1.453
   Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005
NR 40
TC 3
Z9 3
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 24
PY 2015
VL 10
IS 3
AR e0121284
DI 10.1371/journal.pone.0121284
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH2XV
UT WOS:000353889600144
PM 25803794
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Silva, GAV
   Ramasawmy, R
   Boechat, AL
   Morais, AC
   Carvalho, BKS
   Sousa, KBA
   Souza, VC
   Cunha, MGS
   Barletta-Naveca, RH
   Santos, MP
   Naveca, FG
AF Silva, G. A. V.
   Ramasawmy, R.
   Boechat, A. L.
   Morais, A. C.
   Carvalho, B. K. S.
   Sousa, K. B. A.
   Souza, V. C.
   Cunha, M. G. S.
   Barletta-Naveca, R. H.
   Santos, M. P.
   Naveca, F. G.
TI Association of TNF-1031 C/C as a potential protection marker for leprosy
   development in Amazonas state patients, Brazil
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE TNF; Polymorphism; Leprosy; Genetic marker
ID NECROSIS-FACTOR-ALPHA; SINGLE NUCLEOTIDE POLYMORPHISM; TNF-ALPHA;
   PROMOTER REGION; GENE POLYMORPHISMS; CIRCULATING LEVELS;
   LYMPHOTOXIN-ALPHA; TUBERCULOSIS; RISK; SUSCEPTIBILITY
AB Polymorphisms present in the TNF promoter region has shown to influence the gene transcription. Leprosy displays different clinical manifestations according to the immune responses of the individual infected with Mycobacterium leprae. In this study, we evaluated the single nucleotide polymorphisms (SNPs) -238 G/A (rs361525), -308 G/A (rs1800629), -857 C/T (rs1799724), -863 A/C (rs1800630) and -1031 TIC (rs1799964) in the promoter region of the TNF to see whether these SNPs influence host-susceptibility to leprosy and the different clinical manifestation. Nucleotide sequencing was performed with DNA samples from 108 leprosy patients and 253 control subjects. An association between -1031 C/C genotype and protection from leprosy was observed when leprosy patients were compared to controls (OR 0.11; 95% CI = 0.01-0.82; p = 0.012). The -857 C/T genotype may be associated with susceptibility to leprosy (OR = 1.81; 95% CI = 1.09-3.00; p = 0.028). Similar genotype and allele frequencies for the SNPs -308 G/A and -238 G/A were observed between leprosy patients and control subjects. Altogether, TNF polymorphisms in the promoter region may be predictive of leprosy outcome. (C) 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Silva, G. A. V.; Morais, A. C.; Carvalho, B. K. S.; Sousa, K. B. A.; Souza, V. C.; Naveca, F. G.] FIOCRUZ Amazonia, Inst Leonidas & Maria Deane, BR-69057070 Manaus, Amazonas, Brazil.
   [Ramasawmy, R.] Fundacao Med Trop Doutor Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Ramasawmy, R.] Univ Nilton Lins, Fac Med, Manaus, Amazonas, Brazil.
   [Boechat, A. L.] Univ Fed Amazonas, Inst Ciencias Biol, Dept Parasitol, Immunol Lab, Manaus, Amazonas, Brazil.
   [Cunha, M. G. S.] Fundacao Dermatol & Venereol Alfredo da Matta, Manaus, Amazonas, Brazil.
   [Barletta-Naveca, R. H.; Santos, M. P.] Inst Nacl de Pesquisas da Amazonia, Lab Micobacteriol, Manaus, Amazonas, Brazil.
RP Silva, GAV (corresponding author), FIOCRUZ Amazonia, Inst Leonidas & Maria Deane, Rua Terezina 476, BR-69057070 Manaus, Amazonas, Brazil.
EM georgevillarouco@hotmail.com
RI Boechat, A.L./H-8484-2019; Ramasawmy, Rajendranath/V-4926-2019; Boechat,
   Antonio Luiz/E-6464-2010; Naveca, Felipe/H-1130-2012
OI Boechat, A.L./0000-0001-5597-7343; Boechat, Antonio
   Luiz/0000-0001-5597-7343; Naveca, Felipe/0000-0002-2888-1060; Souza,
   Victor Costa de/0000-0002-3869-1519
FU Instituto Leonidas e Maria Deane (ILMD) - FIOCRUZ Amazonia, Brazil
FX This work was supported by the Instituto Leonidas e Maria Deane (ILMD) -
   FIOCRUZ Amazonia, Brazil.
CR Affandi JS, 2013, HUM IMMUNOL, V74, P1382, DOI 10.1016/j.humimm.2013.06.019
   Affandi JS, 2013, DIS MARKERS, V34, P445, DOI [10.1155/2013/246017, 10.3233/DMA-130991]
   Franceschi DSA, 2009, INT J INFECT DIS, V13, P493, DOI 10.1016/j.ijid.2008.08.019
   Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994
   Ali S, 2012, HUM GENET, V131, P703, DOI 10.1007/s00439-011-1114-6
   [Anonymous], 2014, Wkly Epidemiol Rec, V89, P389
   Anoosheh S, 2011, IRAN RED CRESCENT ME, V13, P243
   Boechat AL, 2013, CYTOKINE, V61, P406, DOI 10.1016/j.cyto.2012.11.020
   Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x
   Cardoso CC, 2011, J INFECT DIS, V204, P1256, DOI 10.1093/infdis/jir521
   Cui GL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-235
   FONG CLW, 1994, NUCLEIC ACIDS RES, V22, P1108, DOI 10.1093/nar/22.6.1108
   Hagge DA, 2009, AM J PATHOL, V174, P1379, DOI 10.2353/ajpath.2009.080550
   Hananantachai H, 2007, TISSUE ANTIGENS, V69, P277, DOI 10.1111/j.1399-0039.2006.00756.x
   Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x
   Hohjoh H, 2001, GENES IMMUN, V2, P105, DOI 10.1038/sj.gene.6363721
   Kumar R, 2007, TISSUE ANTIGENS, V69, P557, DOI 10.1111/j.1399-0039.2007.00817.x
   Lis J T, 1980, Methods Enzymol, V65, P347
   Ma MJ, 2010, HUM IMMUNOL, V71, P1005, DOI 10.1016/j.humimm.2010.07.009
   Mendonca VA, 2008, AN BRAS DERMATOL, V83, P343, DOI 10.1590/S0365-05962008000400010
   Montoya D, 2010, ADV IMMUNOL, V105, P1, DOI 10.1016/S0065-2776(10)05001-7
   Moraes MO, 2006, LEPROSY REV, V77, P189
   PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346
   RHOADES KL, 1992, J BIOL CHEM, V267, P22102
   Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572
   Santos AR, 2002, J INFECT DIS, V186, P1687, DOI 10.1086/345366
   Sapkota BR, 2010, HUM IMMUNOL, V71, P992, DOI 10.1016/j.humimm.2010.07.001
   Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852
   Sharma S, 2006, AM J RESP CELL MOL, V35, P488, DOI 10.1165/rcmb.2006-0084OC
   Sharma S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-165
   Shaw BE, 2004, TISSUE ANTIGENS, V63, P401, DOI 10.1111/j.0001-2815.2004.00218.x
   Silva GAV, 2014, HUM IMMUNOL, V75, P592, DOI 10.1016/j.humimm.2014.01.009
   Silva GAV, 2012, CYTOKINE, V60, P493, DOI 10.1016/j.cyto.2012.04.043
   Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443
   Sohail M, 2008, MOL IMMUNOL, V45, P1682, DOI 10.1016/j.molimm.2007.10.002
   Tan JH, 2011, TISSUE ANTIGENS, V77, P100, DOI 10.1111/j.1399-0039.2010.01582.x
   Tarrago AM, 2014, HUM IMMUNOL, V75, P1075, DOI 10.1016/j.humimm.2014.08.198
   Valente FP, 2009, TISSUE ANTIGENS, V74, P57, DOI 10.1111/j.1399-0039.2009.01258.x
   Vejbaesya Sasijit, 2007, Journal of the Medical Association of Thailand, V90, P1188
   Felix JSV, 2012, LEPROSY REV, V83, P34
   Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195
   WILSON AG, 1993, J EXP MED, V177, P557, DOI 10.1084/jem.177.2.557
   Zhu H, 2012, GENE, V509, P206, DOI 10.1016/j.gene.2012.08.027
NR 43
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD MAR
PY 2015
VL 76
IS 2-3
BP 137
EP 141
DI 10.1016/j.humimm.2015.01.011
PG 5
WC Immunology
SC Immunology
GA CC7EP
UT WOS:000350530800012
PM 25636570
DA 2020-12-17
ER

PT J
AU Mejia, MDC
   Dos Santos, MP
   da Silva, GAV
   Passos, ID
   Naveca, FG
   Cunha, MDS
   Moraes, MO
   de Paula, L
AF Contreras Mejia, Matilde del Carmen
   Dos Santos, Maisa Porto
   Villarouco da Silva, George Allan
   Passos, Isabella da Motta
   Naveca, Felipe Gomes
   Souza Cunha, Maria da Graca
   Moraes, Milton Ozorio
   de Paula, Lucia
TI Identification of Primary Drug Resistance to Rifampin in Mycobacterium
   leprae Strains from Leprosy Patients in Amazonas State, Brazil
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID MUTATIONS; OFLOXACIN; DAPSONE
AB The aim of this study was to identify polymorphisms in the folp1, gyrA, and rpoB genes in leprosy patients treated in Amazonas State, Brazil. Among 197 slit-skin smear samples from untreated or relapsed patients, we found three cases of primary resistance to rifampin and one confirmed case of multidrug resistance.
C1 [Contreras Mejia, Matilde del Carmen; Dos Santos, Maisa Porto; Villarouco da Silva, George Allan; Passos, Isabella da Motta; de Paula, Lucia] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Villarouco da Silva, George Allan; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Souza Cunha, Maria da Graca] Fundacao Alfredo da Matta, Manaus, Amazonas, Brazil.
   [Moraes, Milton Ozorio] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, Manaus, Amazonas, Brazil.
   [Dos Santos, Maisa Porto] Inst Nacl de Pesquisas da Amazonia, Lab Micobacteriol, Manaus, Amazonas, Brazil.
   [Passos, Isabella da Motta] Univ Estadual Amazonas, Manaus, Amazonas, Brazil.
   [de Paula, Lucia] Univ Fed Goias, Dept Ciencias Biol, Reg Catalao, Catalao, Go, Brazil.
RP de Paula, L (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
EM lpaula.bio@hotmail.com
RI Naveca, Felipe/H-1130-2012; Moraes, Milton Ozorio/G-9753-2011
OI Naveca, Felipe/0000-0002-2888-1060; Moraes, Milton
   Ozorio/0000-0003-2653-0037
FU National Council for Scientific and Technological Development (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq); Coordination of Improvement of Higher Education Personnel
   (CAPES), BrazilCAPES; Amazonas State Funding Agency (FAPEAM)
FX This study was funded by the National Council for Scientific and
   Technological Development (CNPq), Brazil, the Coordination of
   Improvement of Higher Education Personnel (CAPES), Brazil, and the
   Amazonas State Funding Agency (FAPEAM).
CR Fontes ANB, 2012, MEM I OSWALDO CRUZ, V107, P143, DOI 10.1590/S0074-02762012000900021
   Cambau E, 2002, CLIN INFECT DIS, V34, P39, DOI 10.1086/324623
   Pereira EVE, 2011, AN BRAS DERMATOL, V86, P235, DOI 10.1590/S0365-05962011000200005
   Kai M, 1999, FEMS MICROBIOL LETT, V177, P231, DOI 10.1111/j.1574-6968.1999.tb13737.x
   Kai M, 2011, CLIN INFECT DIS, V52, pE127, DOI 10.1093/cid/ciq217
   Lee SB, 2001, ANN TROP MED PARASIT, V95, P429, DOI 10.1080/000349801300188447
   Maeda S, 2001, ANTIMICROB AGENTS CH, V45, P3635, DOI 10.1128/AAC.45.12.3635-3639.2001
   Matsuoka M, 2000, INT J LEPROSY, V68, P452
   Matsuoka M, 2008, J MED MICROBIOL, V57, P1213, DOI 10.1099/jmm.0.2008/002600-0
   Matsuoka M, 2010, JPN J INFECT DIS, V63, P1
   Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477
   RIDLEY D. S., 1962, LEPROSY REV, V33, P119
   Rocha AD, 2012, J CLIN MICROBIOL, V50, P1912, DOI 10.1128/JCM.06561-11
   Talhari S, 1985, AN BRAS DERMATOL, V60, P175
   WHO, 1982, WHO TECHN REP SER, V675
   Williams DL, 2012, LEPROSY REV, V83, P269
   WILLIAMS DL, 1994, ANTIMICROB AGENTS CH, V38, P2380, DOI 10.1128/AAC.38.10.2380
NR 17
TC 7
Z9 7
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD DEC
PY 2014
VL 52
IS 12
BP 4359
EP 4360
DI 10.1128/JCM.01688-14
PG 2
WC Microbiology
SC Microbiology
GA AT9BM
UT WOS:000345222900039
PM 25274993
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Acosta, POA
   Granja, F
   Meneses, CA
   Nascimento, IAS
   Sousa, DD
   Lima, WP
   Naveca, FG
AF Acosta, Pablo O. A.
   Granja, Fabiana
   Meneses, Catia A.
   Nascimento, Ismael A. S.
   Sousa, Debora D.
   Lima Junior, Wilson P.
   Naveca, Felipe Gomes
TI FALSE-NEGATIVE DENGUE CASES IN RORAIMA, BRAZIL: AN APPROACH REGARDING
   THE HIGH NUMBER OF NEGATIVE RESULTS BY NS1 AG KITS
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Dengue; Serotypes; Diagnosis; NS1 antigen; qRT-PCR
ID VIRUS SEROTYPE 4; PROTEIN NS1; SENSITIVITY; ANTIGEN; SPECIFICITY;
   ASSAYS; ELISA; DIAGNOSIS; DISEASE; TESTS
AB Serum samples from 150 NS1-negative (Platelia ELISA) patients presumptively diagnosed with dengue were analyzed by the TaqMan probed real-time reverse transcription PCR (TaqMan qRT-PCR) method. The qRT-PCR positive samples were tested for serotype by semi-nested RT-PCR and a qualitative immunochromatographic assay for IgG and IgM. Molecular detection methods showed 33 (22%) positive samples out of 150 NS1-antigen negative samples. Of these, 72% were collected up to day 2 after the onset of symptoms, when diagnostic sensitivity of NS1-antigen test assays is significantly enhanced. Most of the cases were not characterized as secondary infection. Twenty-eight samples were successfully serotyped, 75% of which for DENV-4, 14% for DENV-2, 7% for DENV-3 and 4% for DENV-1. These findings reaffirm the hyperendemic situation of the state of Roraima and suggest a lower sensitivity of the NS1 test, mainly when DENV-4 is the predominant serotype. Health care providers should therefore be aware of samples tested negative by NS1 antigen assays, especially when clinical symptoms and other laboratory data results show evidence of dengue infection.
C1 [Acosta, Pablo O. A.; Granja, Fabiana; Nascimento, Ismael A. S.; Sousa, Debora D.; Lima Junior, Wilson P.] Univ Fed Roraima, Ctr Estudos Biodiversidade, Lab Biol Mol, Boa Vista, RR, Brazil.
   [Meneses, Catia A.] Lab Cent Roraima, Boa Vista, RR, Brazil.
   [Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP Acosta, POA (corresponding author), Univ Fed Roraima, Lab Biol Mol CBio, Av Ene Garcez 2413, BR-69304000 Boa Vista, RR, Brazil.
EM amezaga@osite.com.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
FU Instituto Leonidas e Maria Deane; Santander Universidades
FX The authors would like to thank the Federal University of Roraima. This
   work was supported by grants from Instituto Leonidas e Maria Deane and
   Santander Universidades.
CR Acosta P. O. A., 2012, Dengue Bulletin, V36, P50
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Acosta POA, 2011, EMERG INFECT DIS, V17, P1979, DOI 10.3201/eid1710.110776
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Sea VRF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064056
   Felix AC, 2012, CLIN VACCINE IMMUNOL, V19, P1972, DOI 10.1128/CVI.00535-12
   Gubler DJ, 1998, EMERG INFECT DIS, V1, P1
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lapphra K, 2008, DIAGN MICR INFEC DIS, V60, P387, DOI 10.1016/j.diagmicrobio.2007.11.010
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Roraima. Secretaria Estadual de Saude. Departamento Vigilancia Epidemiologica, 2012, REL CAS DENG NOT 201
   Sekaran SD, 2009, AFR J MICROBIOL RES, V3, P105
   de Souza VAUF, 2007, J CLIN VIROL, V39, P230, DOI 10.1016/j.jcv.2007.04.005
NR 22
TC 6
Z9 6
U1 0
U2 4
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD SEP-OCT
PY 2014
VL 56
IS 5
BP 447
EP 450
DI 10.1590/S0036-46652014000500014
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AS5TL
UT WOS:000344332300014
PM 25229228
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bastos, MS
   Lessa, N
   Naveca, FG
   Monte, RL
   Braga, WS
   Figueiredo, LTM
   Ramasawmy, R
   Mourao, MPG
AF Bastos, Michele S.
   Lessa, Natalia
   Naveca, Felipe G.
   Monte, Rossicleia L.
   Braga, Wornei S.
   Figueiredo, Luiz Tadeu M.
   Ramasawmy, Rajendranath
   Mourao, Maria Paula G.
TI Detection of Herpesvirus, Enterovirus, and Arbovirus Infection in
   Patients With Suspected Central Nervous System Viral Infection in the
   Western Brazilian Amazon
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE encephalitis; meningitis; arbovirus; enterovirus; herpesvirus
ID VARICELLA-ZOSTER-VIRUS; EPSTEIN-BARR-VIRUS; CEREBROSPINAL-FLUID;
   NESTED-PCR; NEUROLOGICAL MANIFESTATIONS; ASEPTIC-MENINGITIS; DENGUE
   INFECTION; SIMPLEX-VIRUS; ENCEPHALITIS; DIAGNOSIS
AB Acute infections of the central nervous system (CNS) can be caused by various pathogens. In this study, the presence of herpesviruses (HHV), enteroviruses (EVs), and arboviruses were investigated in CSF samples from 165 patients with suspected CNS viral infection through polymerase chain reaction (PCR) and reverse transcriptase PCR. The genomes of one or more viral agents were detected in 29.7% (49/165) of the CSF samples. EVs were predominant (16/49; 32.6%) followed by Epstein-Barr virus (EBV) (22.4%), Varicella-Zoster virus (VZV) (20.4%), Cytomegalovirus (CMV) (18.4%), herpes simplex virus (HSV-1) (4.1%), (HSV-2) (4.1%), and the arboviruses (14.3%). Four of the arboviruses were of dengue virus (DENV) and three of oropouche virus (OROV). The detection of different viruses in the CNS of patients with meningitis or encephalitis highlight the importance of maintaining an active laboratory monitoring diagnostics with rapid methodology of high sensitivity in areas of viral hyperendemicity that may assist in clinical decisions and in the choice of antiviral therapy. (C) 2014 Wiley Periodicals, Inc.
C1 [Bastos, Michele S.; Lessa, Natalia; Monte, Rossicleia L.; Braga, Wornei S.; Ramasawmy, Rajendranath; Mourao, Maria Paula G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Bastos, Michele S.; Ramasawmy, Rajendranath; Mourao, Maria Paula G.] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Lessa, Natalia] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Naveca, Felipe G.] Fiocruz MS, Ctr Pesquisa Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Figueiredo, Luiz Tadeu M.] Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Ramasawmy, Rajendranath; Mourao, Maria Paula G.] Univ Nilton Lins, Manaus, Amazonas, Brazil.
RP Bastos, MS (corresponding author), Lab Virol FMT HVD, Av Pedro Teixeira,25 Bairro Dom Pedro, BR-69040000 Manaus, Amazonas, Brazil.
EM michelebastos01@gmail.com
RI Naveca, Felipe/H-1130-2012; Ramasawmy, Rajendranath/V-4926-2019; Bastos,
   Michele/AAS-7386-2020
OI Naveca, Felipe/0000-0002-2888-1060; Bastos, Michele/0000-0003-3450-666X
FU Fundacao de Apoio a Pesquisa no Estado do Amazonas (FAPEAM) [871/2010]
FX Grant sponsor: Fundacao de Apoio a Pesquisa no Estado do Amazonas
   (FAPEAM) to Dr. MS Bastos; Grant numbers: 871/2010.
CR Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Borawake K, 2011, INDIAN J CRIT CARE M, V15, P190, DOI 10.4103/0972-5229.84896
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002
   Dimas Luciana Ferreira, 2008, J. Bras. Patol. Med. Lab., V44, P97, DOI 10.1590/S1676-24442008000200006
   Dupuis M, 2011, J MED VIROL, V83, P2172, DOI 10.1002/jmv.22169
   ECHEVARRIA JM, 1994, J MED VIROL, V43, P331, DOI 10.1002/jmv.1890430403
   Frantzidou F, 2008, EUR J NEUROL, V15, P995, DOI 10.1111/j.1468-1331.2008.02233.x
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540
   Ihekwaba UK, 2008, CLIN INFECT DIS, V47, P783, DOI 10.1086/591129
   Jackson ST, 2008, W INDIAN MED J, V57, P373
   Kupila L, 2004, ARCH NEUROL-CHICAGO, V61, P1553, DOI 10.1001/archneur.61.10.1553
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001
   Martelius T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-281
   Maurmann S, 2003, J CLIN MICROBIOL, V41, P5419, DOI 10.1128/JCM.41.12.5419-5428.2003
   Meyding-Lamade U, 2012, THER ADV NEUROL DISO, V5, P279, DOI 10.1177/1756285612456234
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Nahdi I, 2012, J MED VIROL, V84, P282, DOI 10.1002/jmv.23192
   Mendoza LP, 2007, J INFECTION, V54, P589, DOI 10.1016/j.jinf.2006.11.013
   Persson A, 2009, J CLIN VIROL, V46, P249, DOI 10.1016/j.jcv.2009.07.014
   Pinheiro F P, 1982, Rev Inst Med Trop Sao Paulo, V24, P246
   Reimann CA, 2008, AM J TROP MED HYG, V79, P974, DOI 10.4269/ajtmh.2008.79.974
   Vidal LRR, 2011, ARQ NEURO-PSIQUIAT, V69, P475, DOI 10.1590/S0004-282X2011000400013
   Rodrigues AH, 2011, VIRUS RES, V155, P35, DOI 10.1016/j.virusres.2010.08.009
   Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   STUDAHL M, 1995, J MED VIROL, V46, P274, DOI 10.1002/jmv.1890460319
   TAN L, 2010, PLOS NEGL TROP DIS, V0004
   TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059
   Weinberg A, 2005, J INFECT DIS, V191, P234, DOI 10.1086/426402
   ZOLL GJ, 1992, J CLIN MICROBIOL, V30, P160, DOI 10.1128/JCM.30.1.160-165.1992
NR 36
TC 27
Z9 27
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2014
VL 86
IS 9
BP 1522
EP 1527
DI 10.1002/jmv.23953
PG 6
WC Virology
SC Virology
GA AL9UE
UT WOS:000339486600009
PM 24760682
DA 2020-12-17
ER

PT J
AU Martins, VDA
   Bastos, MD
   Ramasawmy, R
   de Figueiredo, RP
   Gimaque, JBL
   Braga, WSM
   Nogueira, ML
   Nozawa, S
   Naveca, FG
   Figueiredo, LTM
   Mourao, MPG
AF Alves Martins, Valquiria do Carmo
   Bastos, Michele de Souza
   Ramasawmy, Rajendranath
   de Figueiredo, Regina Pinto
   Lima Gimaque, Joao Bosco
   Miranda Braga, Wornei Silva
   Nogueira, Mauricio Lacerda
   Nozawa, Sergio
   Naveca, Felipe Gomes
   Moraes Figueiredo, Luiz Tadeu
   Gomes Mourao, Maria Paula
TI Clinical and Virological Descriptive Study in the 2011 Outbreak of
   Dengue in the Amazonas, Brazil
SO PLOS ONE
LA English
DT Article
ID NEUROLOGICAL MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; VIRUS TYPE-2;
   INFECTION; CIRCULATION; SEROTYPES; PARAGUAY; MANAUS; STATE; PCR
AB Background: Dengue is a vector-borne disease in the tropical and subtropical region of the world and is transmitted by the mosquito Aedes aegypti. In the state of Amazonas, Brazil during the 2011 outbreak of dengue all the four Dengue virus (DENV) serotypes circulating simultaneously were observed. The aim of the study was to describe the clinical epidemiology of dengue in Manaus, the capital city of the state of the Amazonas, where all the four DENV serotypes were co-circulating simultaneously.
   Methodology: Patients with acute febrile illness during the 2011 outbreak of dengue, enrolled at the Fundacao de Medicina Tropical Dr. Heitor Viera Dourado (FMT-HVD), a referral centre for tropical and infectious diseases in Manaus, were invited to participate in a clinical and virological descriptive study. Sera from 677 patients were analyzed by RT-nested-PCRs for flaviviruses (DENV 1-4, Saint Louis encephalitis virus-SLEV, Bussuquara virus-BSQV and Ilheus virus-ILHV), alphavirus (Mayaro virus-MAYV) and orthobunyavirus (Oropouche virus-OROV).
   Principal Findings: Only dengue viruses were detected in 260 patients (38.4%). Thirteen patients were co-infected with more than one DENV serotype and six (46.1%) of them had a more severe clinical presentation of the disease. Nucleotide sequencing showed that DENV-1 belonged to genotype V, DENV-2 to the Asian/American genotype, DENV-3 to genotype III and DENV-4 to genotype II.
   Conclusions: Co-infection with more than one DENV serotype was observed. This finding should be warning signs to health authorities in situations of the large dispersal of serotypes that are occurring in the world.
C1 [Bastos, Michele de Souza; Ramasawmy, Rajendranath; de Figueiredo, Regina Pinto; Lima Gimaque, Joao Bosco; Miranda Braga, Wornei Silva; Nogueira, Mauricio Lacerda; Moraes Figueiredo, Luiz Tadeu; Gomes Mourao, Maria Paula] Fundacao Med Trop Dr Heitor Viera Dourado FMT HVD, Manaus, Amazonas, Brazil.
   [Alves Martins, Valquiria do Carmo; Bastos, Michele de Souza; Ramasawmy, Rajendranath; Miranda Braga, Wornei Silva; Gomes Mourao, Maria Paula] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Ramasawmy, Rajendranath; Nozawa, Sergio; Gomes Mourao, Maria Paula] Univ Nilton Lins, Manaus, Amazonas, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto FAMERP, Sao Paulo, Brazil.
   [Naveca, Felipe Gomes] Fundacao Oswaldo Cruz FIOCRUZ, Inst Leonidas & Maria Deane ILMD, Manaus, Amazonas, Brazil.
   [Moraes Figueiredo, Luiz Tadeu] Fac Med Ribeirao Preto FMRP USP, Ctr Pesquisas Virol, Sao Paulo, Brazil.
RP Martins, VDA (corresponding author), Univ Estado Amazonas, Manaus, Amazonas, Brazil.
EM alvesvalquiria@yahoo.com.br; mariapaula.mourao@gmail.com
RI Bastos, Michele/AAS-7386-2020; Nogueira, Mauricio L/B-7599-2012; Naveca,
   Felipe/H-1130-2012; Ramasawmy, Rajendranath/V-4926-2019
OI Bastos, Michele/0000-0003-3450-666X; Nogueira, Mauricio
   L/0000-0003-1102-2419; Naveca, Felipe/0000-0002-2888-1060; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Ampara a Pesquisa do Estado do Amazonas (FAPEAM)
   [887/2010]
FX This research was financed by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Ampara a Pesquisa do
   Estado do Amazonas (FAPEAM) through grant 887/2010. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Alfonso HL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-124
   Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Bona ACD, 2012, REV SOC BRAS MED TRO, V45, P297, DOI 10.1590/S0037-86822012000300003
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, P28
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11, DOI 10.1590/S0036-46652003000100003
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hall TA., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725
   Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011
   Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Peng WM, 2005, J CLIN VIROL, V32, P194, DOI 10.1016/j.jcv.2004.04.010
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Rocco Iray Maria, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P151, DOI 10.1590/S0036-46651998000300004
   Rocha LA, 2009, REV SOC BRAS MED TRO, V42, P18
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   WHO/TDR, 2012, HDB CLIN MAN DENG, P124
   Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322
   Yu Man, 2004, Weishengwu Xuebao, V44, P717
NR 37
TC 18
Z9 19
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 30
PY 2014
VL 9
IS 6
AR e100535
DI 10.1371/journal.pone.0100535
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK5ZO
UT WOS:000338506400033
PM 24978469
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Silva, GAV
   Santos, MP
   Motta-Passos, I
   Boechat, AL
   Malheiro, A
   Ramasawmy, R
   Naveca, FG
   de Paula, L
AF Silva, G. A. V.
   Santos, M. P.
   Motta-Passos, I.
   Boechat, A. L.
   Malheiro, A.
   Ramasawmy, R.
   Naveca, F. G.
   de Paula, L.
TI Polymorphisms assessment in the promoter region of IL12RB2 in Amazon
   leprosy patients
SO HUMAN IMMUNOLOGY
LA English
DT Article
ID 5'-FLANKING REGION; SUSCEPTIBILITY; EXPRESSION; DISEASE; INNATE
AB Leprosy displays a wide clinical spectrum that is dependent of the type of immune response. We investigate here whether polymorphisms in the promoter region of the IL12RB2 gene are associated with susceptibility or resistance to clinical forms of leprosy. Nucleotide sequencing of the promoter region of IL12RB2 encompassing SNPs 71035 A/G, 1033 TIC, 1023 A/G, 650 del/G and 464 A/G was performed on DNA samples from 105 leprosy patients and 108 healthy controls. However, none of the SNPs were associated with susceptibility to the disease or any of its clinical forms. Similarly, haplotype analysis did not show any association. The haplotype -1035A/-1033T/-650G/-464A was prevalent, and homozygosity for this haplotype was associated to a lower distribution of CD4+, T cells (p = 0.041). Our data suggest that polymorphisms present in the promoter region of IL12RB2 may not be associated with susceptibility to leprosy or its clinical forms. (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Silva, G. A. V.; Santos, M. P.; Motta-Passos, I.; Boechat, A. L.; Malheiro, A.; Ramasawmy, R.; Naveca, F. G.; de Paula, L.] Univ Fed Amazonas UFAM, Programa Posgrad Imunol Basica & Aplicada PPGIBA, Manaus, Amazonas, Brazil.
   [Malheiro, A.] Univ Fed Amazonas, Dept Parasitol, Inst Ciencias Biol, Manaus, Amazonas, Brazil.
   [Ramasawmy, R.] Fundacao Med Trop Doutor Heitor Vieira Doura, Manaus, Amazonas, Brazil.
   [Ramasawmy, R.] Univ Nilton Lins, Manaus, Amazonas, Brazil.
   [Naveca, F. G.] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [de Paula, L.] Univ Fed Amazonas, Dept Morfol, Inst Ciencias Biol, Manaus, Amazonas, Brazil.
   [de Paula, L.] Univ Fed Goias, Dept Ciencias Biol, BR-75704020 Goias, GO, Brazil.
RP de Paula, L (corresponding author), Univ Fed Goias, Dept Ciencias Biol, Av Dr Lamartine Pinto de Avelar,1120 Setor Univ, BR-75704020 Goias, GO, Brazil.
EM lpaula.bio@hotmail.com
RI Boechat, A.L./H-8484-2019; Boechat, Antonio Luiz/E-6464-2010; Naveca,
   Felipe/H-1130-2012; Ramasawmy, Rajendranath/V-4926-2019
OI Boechat, A.L./0000-0001-5597-7343; Boechat, Antonio
   Luiz/0000-0001-5597-7343; Naveca, Felipe/0000-0002-2888-1060; 
FU Conselho Nacional de desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo A Pesquisa do Estado do Amazonas (FAPEAM)
FX This study was supported by Conselho Nacional de desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo A Pesquisa do
   Estado do Amazonas (FAPEAM). The funding sources had no role in the
   study design, analysis of the data and the writing or decision to submit
   the manuscript for publication.
CR Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010
   Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/fmb.11.39, 10.2217/FMB.11.39]
   da Motta-Passos I, 2012, EUR J DERMATOL, V22, P488, DOI 10.1684/ejd.2012.1741
   De la Barrera S, 2004, CLIN EXP IMMUNOL, V135, P105, DOI 10.1111/j.1365-2249.2004.02334.x
   Guerini FR, 2012, CLIN IMMUNOL, V143, P203, DOI 10.1016/j.clim.2012.03.003
   Kim J, 2001, J IMMUNOL, V167, P779, DOI 10.4049/jimmunol.167.2.779
   Mendez-Samperio P, 2010, INT J INFECT DIS, V14, pE366, DOI 10.1016/j.ijid.2009.06.022
   Montoya D, 2010, ADV IMMUNOL, V105, P1, DOI 10.1016/S0065-2776(10)05001-7
   Ohyama H, 2005, J CLIN PATHOL, V58, P740, DOI 10.1136/jcp.2004.023903
   Ohyama H, 2008, J INTERF CYTOK RES, V28, P563, DOI 10.1089/jir.2008.0133
   Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8
   Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002
   Qu HQ, 2011, INT J INFECT DIS, V15, pE305, DOI 10.1016/j.ijid.2011.01.004
   Rietschoten JGI, 2001, J BIOL CHEM, V276, P34509
   Rietschoten JGI, 2004, TISS ANT, V63, P538
   Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825
   Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109
   Silva GAV, 2012, CYTOKINE, V60, P493, DOI 10.1016/j.cyto.2012.04.043
   Takeuchi-Hatanaka K, 2008, J CLIN PERIODONTOL, V35, P317, DOI 10.1111/j.1600-051X.2008.01208.x
   Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003
NR 20
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD JUN
PY 2014
VL 75
IS 6
BP 592
EP 596
DI 10.1016/j.humimm.2014.01.009
PG 5
WC Immunology
SC Immunology
GA AH9LY
UT WOS:000336465100015
PM 24486579
DA 2020-12-17
ER

PT J
AU Silva, GAV
   Naveca, FG
   Ramasawmy, R
   Boechat, AL
AF Silva, G. A. V.
   Naveca, F. G.
   Ramasawmy, R.
   Boechat, A. L.
TI Association between the IFNG+874A/T gene polymorphism and leprosy
   resistance: A meta-analysis
SO CYTOKINE
LA English
DT Article
DE IFNG+874; Polymorphism; Leprosy; Meta-analysis; Genetic resistance
ID IFN-GAMMA; TUBERCULOSIS; SUSCEPTIBILITY; VARIANTS
AB Previous studies identified the variant IFNG +874A/T (rs2430561) in the first intron of the gene in association with mycobacterial infection, especially tuberculosis and leprosy. The aim of this investigation was to analyze the protective role of the T allele in relation to leprosy using a meta-analysis evaluation. Thus, 1573 patients and 1914 controls were included and analyzed in fixed effects model. The T allele is associated with a protective effect for leprosy under the dominant model (pooled OR = 0.83, 95% CI = 0.72-0.96, p = 0.011) suggesting that carriers of the IFNG +874T allele may be protected from developing leprosy. The T allele has been suggested to correlate with high interferon-gamma levels. A phenotype with high IFN-gamma producing and an increased inflammatory profile may account for these findings. This meta-analysis suggests that IFNG +874T allele is associated with leprosy resistance. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Silva, G. A. V.; Naveca, F. G.] Fiocruz MS, Inst Leonidas & Maria Deane, BR-69057070 Manaus, Amazonas, Brazil.
   [Ramasawmy, R.] Fundacao Med Trop Doutor Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Ramasawmy, R.] Univ Nilton Lins, Manaus, Amazonas, Brazil.
   [Boechat, A. L.] Univ Fed Amazonas, Inst Ciencias Biol, Dept Parasitol, Lab Imunol, Manaus, Amazonas, Brazil.
RP Silva, GAV (corresponding author), Fiocruz MS, Inst Leonidas & Maria Deane, Rua Terezina 476, BR-69057070 Manaus, Amazonas, Brazil.
EM george_silva@amazonia.fiocruz.br
RI Boechat, Antonio Luiz/E-6464-2010; Naveca, Felipe/H-1130-2012;
   Ramasawmy, Rajendranath/V-4926-2019; Boechat, A.L./H-8484-2019
OI Boechat, Antonio Luiz/0000-0001-5597-7343; Naveca,
   Felipe/0000-0002-2888-1060; Boechat, A.L./0000-0001-5597-7343
CR Franceschi DSA, 2009, INT J INFECT DIS, V13, P493, DOI 10.1016/j.ijid.2008.08.019
   Ben Selma W, 2011, DNA CELL BIOL, V30, P379, DOI 10.1089/dna.2010.1157
   Cardoso CC, 2010, HUM GENET, V128, P481, DOI 10.1007/s00439-010-0872-x
   Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851
   COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202
   Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362
   Montoya D, 2010, ADV IMMUNOL, V105, P1, DOI 10.1016/S0065-2776(10)05001-7
   Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5
   Silva GAV, 2012, CYTOKINE, V60, P493, DOI 10.1016/j.cyto.2012.04.043
   Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008
   Vidyarani M, 2006, INDIAN J MED RES, V124, P403
   Wang D, 2012, HUM GENET, V131, P1251, DOI 10.1007/s00439-012-1153-7
   WHO, 2012, WKLY EPIDEMIOL REC, V87, P317
NR 15
TC 12
Z9 12
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD FEB
PY 2014
VL 65
IS 2
BP 130
EP 133
DI 10.1016/j.cyto.2013.12.002
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA AB0RO
UT WOS:000331500000003
PM 24389160
DA 2020-12-17
ER

PT J
AU da Rosa, FB
   de Souza, VC
   de Almeida, TAP
   do Nascimento, VA
   Vasquez, FG
   Cunha, MDS
   Naveca, FG
AF da Rosa, Fernanda Borowsky
   de Souza, Victor Costa
   Pires de Almeida, Tatiana Amaral
   do Nascimento, Valdinete Alves
   Vasquez, Felicien Goncalves
   Souza Cunha, Maria da Graca
   Naveca, Felipe Gomes
TI Detection of Mycobacterium leprae in saliva and the evaluation of oral
   sensitivity in patients with leprosy
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE leprosy; sensation disorders; oral cavity; real-time polymerase chain
   reaction
ID AGREEMENT; NERVE; DNA; PCR
AB The aim of this study was to investigate sensitivity disorders in the oral cavity related to the presence of Mycobacterium leprae in the saliva of treatment-naive patients with leprosy in the state of Amazonas, Brazil. A cross-sectional study was conducted involving 45 subjects with leprosy. The subjects were interviewed to evaluate the sensitivity of the oral cavity. For the detection of M. leprae, saliva and slit-skin smear samples were collected. The samples were analysed using a bacteriological index (BI) protocol and the real-time quantitative polymerase chain reaction (qPCR). The results indicated that 15 of the 45 (33.3%) subjects with leprosy showed decreased oral sensitivity, which confirmed the importance of the oral cavity sensitivity evaluation. There was not a direct relationship between the presence of M. leprae in saliva and changes in oral sensitivity. Positive saliva qPCR results from six (31.6%) of 19 paucibacillary (PB) patients suggested the possibility of a new site for sample collection. Positive results using these diagnostic techniques (BI, slit-skin smear and saliva qPCR) increased to 55.5%, thus opening the possibility of combining these different techniques to increase the rate of positive diagnoses, especially in PB patients.
C1 [da Rosa, Fernanda Borowsky; Naveca, Felipe Gomes] Univ Fed Amazonas, Manaus, AM, Brazil.
   [da Rosa, Fernanda Borowsky] Univ Nilton Lins, Manaus, AM, Brazil.
   [de Souza, Victor Costa; Pires de Almeida, Tatiana Amaral; do Nascimento, Valdinete Alves; Naveca, Felipe Gomes] Inst Leonidas & Maria Deane Fiocruz, Manaus, AM, Brazil.
   [Vasquez, Felicien Goncalves; Souza Cunha, Maria da Graca] Fdn Dermatol Trop & Venereol Alfredo da Matta, Manaus, AM, Brazil.
RP da Rosa, FB (corresponding author), Univ Fed Amazonas, Manaus, AM, Brazil.
EM feborowsky@hotmail.com
RI Naveca, Felipe/H-1130-2012; Nascimento, Valdinete Alves
   do/AAV-1879-2020; Almeida, Tatiana/B-3404-2013
OI Naveca, Felipe/0000-0002-2888-1060; Nascimento, Valdinete Alves
   do/0000-0002-7786-4718; Almeida, Tatiana/0000-0001-7395-3062
FU POM/ILMD-FIOCRUZ; FAPEAM DCTA fellowship; FIOCRUZ/FA-PEAM Tec-Tec
   fellowship; FAPEAM PAIC/FIOCRUZ fellowship
FX POM/ILMD-FIOCRUZ; VCS has a FAPEAM DCTA fellowship, TAPA has a
   FIOCRUZ/FA-PEAM Tec-Tec fellowship and VAN was the recipient of a FAPEAM
   PAIC/FIOCRUZ fellowship.
CR Abdalla Ligia Fernandes, 2010, Rev. odonto ciênc., V25, P148, DOI 10.1590/S1980-65232010000200008
   Abreu Marilda Aparecida Milanez Morgado de, 2006, Rev. Bras. Otorrinolaringol., V72, P312, DOI 10.1590/S0034-72992006000300004
   Banerjee S, 2011, INT J DERMATOL, V50, P1522, DOI 10.1111/j.1365-4632.2011.04994.x
   Goulart IMB, 2008, ARCH DERMATOL RES, V300, P269, DOI 10.1007/s00403-008-0857-y
   Pontes ARB, 2008, REV BRAS ENFERM, V61, P734, DOI 10.1590/S0034-71672008000700013
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Costa A, 2003, Indian J Dermatol Venereol Leprol, V69, P381
   D'Abreu P. C., 2000, Anais Brasileiros de Dermatologia, V75, P339
   FUAM, 2011, B EPIDEMIOLOGICO, VXIII, P5
   Kumar S, 2006, NEUROL INDIA, V54, P283, DOI 10.4103/0028-3886.27154
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Margarido LC, 2005, TRATADO INFECTOLOGIA, V3, P939
   Martinez AN, 2006, J CLIN MICROBIOL, V44, P3154, DOI 10.1128/JCM.02250-05
   Martinez TS, 2011, CLIN MICROBIOL INFEC, V17, P1653, DOI 10.1111/j.1469-0691.2010.03453.x
   MS-Ministerio da Saude, 2002, GUIA CONTR HANS
   MS - Ministerio da Saude, 2010, GUIA PROC TECN BAC H
   Neville B, 2009, PATOLOGIA ORAL MAXIL, P198
   Patrocinio LG, 2005, FEMS IMMUNOL MED MIC, V44, P311, DOI 10.1016/j.femsim.2005.01.002
   Phetsuksiri B, 2006, FEMS IMMUNOL MED MIC, V48, P319, DOI 10.1111/j.1574-695X.2006.00152.x
   REICHART PA, 1982, INT J ORAL MAXILLOF, V11, P14, DOI 10.1016/S0300-9785(82)80043-4
   SCHEEPERS A, 1993, LEPROSY REV, V64, P37
   SONI NK, 1981, J LARYNGOL OTOL, V95, P717, DOI 10.1017/S0022215100091337
   Taheri JB, 2012, MED ORAL PATOL ORAL, V17, pE728, DOI 10.4317/medoral.17718
   Villar VM, 2004, REV CEFAC, V6, P151
   Wani AA, 2009, DERMATOL ONLINE J, V5, P3
   WHO, 2012, WKLY EPIDEMIOL REC, V87, P317
NR 26
TC 11
Z9 11
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2013
VL 108
IS 5
BP 572
EP 577
DI 10.1590/S0074-02762013000500006
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 192XI
UT WOS:000322520800006
PM 23903971
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ferreira, WA
   Ferreira, CM
   Naveca, FG
   Vasconcelos, WD
   Gomes, JD
   da Silva, MDP
   Alecrim, MDC
AF Ferreira, William Antunes
   Ferreira, Cristina Motta
   Naveca, Felipe Gomes
   Vasconcelos, Waldemara de Souza
   Gomes, Jairo de Souza
   Pinto da Silva, Maria de Fatima
   Costa Alecrim, Maria das Gracas
TI Molecular Epidemiology of beta-Lactamase-Producing Neisseria gonorrhoeae
   Strains in Manaus, AM, Brazil
SO SEXUALLY TRANSMITTED DISEASES
LA English
DT Article
ID CEFIXIME; SURVEILLANCE; CEFTRIAXONE
AB We report new sequence types of 14 penicillinase-producing Neisseria gonorrhoeae, isolated from sexually transmitted disease clinic attendees in Manaus, Brazil. They were characterized by WI/WII/WIII groups, susceptibility testing and Multi-Antigen Sequencing Typing/Mutilocus Sequence Typing protocols. Twelve were classified as WII/III and 2 as WI and were presented resistance to penicillin and tetracycline. New alleles for por and AroE genes and novel sequence types were identified, revealing molecular characteristics not described previously. ST1590 is the common ancestor after eBURST analysis, and these findings represent an important contribution of molecular epidemiology approach in gonococci's research in Amazonas.
C1 [Ferreira, William Antunes] Univ Estado Amazonas, Fundaco Alfredo Matta FUAM, Lab Bacteriol, Manaus, Amazonas, Brazil.
   [Ferreira, Cristina Motta] Fundaco Estadual Hematol & Hemoterapia Amazonas, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] FIOCRUZ AM, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Vasconcelos, Waldemara de Souza; Gomes, Jairo de Souza; Pinto da Silva, Maria de Fatima] Fundacao Dermatol Trop & Venereol Alfredo Matta, Manaus, Amazonas, Brazil.
   [Costa Alecrim, Maria das Gracas] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
RP Ferreira, WA (corresponding author), Fundaco Alfredo Matta FUAM, Lab Bacteriol, Clin Rua Codaja 25, BR-69065130 Manaus, Amazonas, Brazil.
EM wianfe@yahoo.com.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
CR Bennett JS, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-35
   Clinical and Laboratory Standards Institute, 2010, M100S20 CLIN LAB STA, V30
   Dillon JAR, 2001, SEX TRANSM DIS, V28, P521, DOI 10.1097/00007435-200109000-00008
   Ferreira WA, 2007, J BRAS DOENCAS SEX T, V19, P65
   Ferreira WA, 2011, MEM I OSWALDO CRUZ, V106, P629, DOI 10.1590/S0074-02762011000500018
   Florindo C, 2010, SEX TRANSM INFECT, V86, P449, DOI 10.1136/sti.2010.044321
   Fundacao Alfredo da Matta, 2012, B EP, V020
   Hjelmevoll SO, 2012, EUR J CLIN MICROBIOL, V31, P1181, DOI 10.1007/s10096-011-1426-4
   Ilina EN, 2010, J CLIN MICROBIOL, V48, P3681, DOI 10.1128/JCM.00565-10
   Khaki P, 2007, Indian J Med Microbiol, V25, P225
   Kulkarni S, 2012, SEX TRANSM DIS, V39, P188, DOI 10.1097/OLQ.0b013e3182389a24
   Martin IMC, 2006, J ANTIMICROB CHEMOTH, V58, P587, DOI 10.1093/jac/dkl265
   Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047
   Martin I, 2012, SEX TRANSM DIS, V39, P316, DOI 10.1097/OLQ.0b013e3182401b69
   Mavroidi A, 2011, J CLIN MICROBIOL, V49, P1196, DOI 10.1128/JCM.02233-10
   Ohnishi M, 2010, ANTIMICROB AGENTS CH, V54, P1060, DOI 10.1128/AAC.01010-09
   Starnino S, 2008, CLIN MICROBIOL INFEC, V14, P949, DOI 10.1111/j.1469-0691.2008.02071.x
   Uehara AA, 2011, J CLIN MICROBIOL, V49, P4208, DOI 10.1128/JCM.01175-11
   Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11
   Van Dick E, 1999, LAB DIAGNOSIS SEXUAL
   Viscidi RP, 2003, J CLIN MICROBIOL, V41, P197, DOI 10.1128/JCM.41.1.197-204.2003
   Whiley DM, 2010, SEX TRANSM INFECT, V86, P51, DOI 10.1136/sti.2009.037689
NR 22
TC 4
Z9 4
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0148-5717
EI 1537-4521
J9 SEX TRANSM DIS
JI Sex. Transm. Dis.
PD JUN
PY 2013
VL 40
IS 6
BP 469
EP 472
DI 10.1097/OLQ.0b013e318286d2ce
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA 147UH
UT WOS:000319192500008
PM 23680903
DA 2020-12-17
ER

PT J
AU Naveca, FG
   Sabido, M
   de Almeida, TAP
   Veras, EA
   Mejia, MDC
   Galban, E
   Benzaken, AS
AF Naveca, Felipe Gomes
   Sabido, Meritxell
   Pires de Almeida, Tatiana Amaral
   Veras, Elaine Araujo
   Contreras Mejia, Matilde del Carmen
   Galban, Enrique
   Benzaken, Adele Schwartz
TI Etiology of Genital Ulcer Disease in a Sexually Transmitted Infection
   Reference Center in Manaus, Brazilian Amazon
SO PLOS ONE
LA English
DT Article
ID REAL-TIME PCR; IMMUNODEFICIENCY-VIRUS-INFECTION;
   POLYMERASE-CHAIN-REACTION; PRIMARY-HEALTH-CARE; SYNDROMIC MANAGEMENT;
   TREPONEMA-PALLIDUM; HAEMOPHILUS-DUCREYI; CLINICAL-DIAGNOSIS; MOLECULAR
   METHODS; HSV-2 INFECTION
AB Objectives: To determine the etiology and factors associated with genital ulcer disease (GUD) among patients presenting to a sexually transmitted infections clinic in Manaus, Brazil; and to compare a multiplex polymerase chain reaction (M-PCR) assay for the diagnosis of GUD with standard methods.
   Methods: Ulcer swabs were collected and used for Tzanck test and processed in an M-PCR to detect herpes simplex virus (HSV-1/2), Treponema pallidum (T. pallidum), and Haemophilus ducreyi (H. ducreyi). Sera were tested for HIV and syphilis antibodies. Multivariable analysis was used to measure the association between clinical aspects and GUD. M-PCR results were compared with syphilis serology and Tzanck tests.
   Results: Overall, 434 GUD samples were evaluated, 84.8% from men. DNA from HSV-2 was detected in 55.3% of GUD samples, T. pallidum in 8.3%, HSV-1 in 3.2%, and 32.5% of GUD specimens were negative for the DNA of all three pathogens. No cases of H. ducreyi were identified. HIV serology among GUD patients was 3.2%. Treponemal antibodies and Tzanck test positivity for genital herpes was detected in 25 (5.8%) and in 125 (30.3%) of GUD patients, respectively. In multivariable analysis genital herpes etiology by M-PCR was associated with the vesicular, multiple and recurrent lesions whereas T. pallidum with non-vesicular, non-recurrent lesions. Compared to M-PCR, syphilis serology was 27.8% sensitive and 96.2% specific whereas Tzanck test was 43.8% sensitive and 88.9% specific.
   Conclusions: The predominance of genital herpes etiology suggests a revision of existing national syndromic treatment guidelines in Brazil to include antiherpetic treatment for all GUD patients. The use of M-PCR can significantly improve the diagnosis of GUD and provide a greater sensitivity than standard diagnostics.
C1 [Naveca, Felipe Gomes; Veras, Elaine Araujo; Contreras Mejia, Matilde del Carmen; Galban, Enrique; Benzaken, Adele Schwartz] Fundacao Alfredo Matta, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes; Pires de Almeida, Tatiana Amaral] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil.
   [Sabido, Meritxell] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.
   [Sabido, Meritxell] Fundacio Sida & Soc, Barcelona, Spain.
   [Pires de Almeida, Tatiana Amaral] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Galban, Enrique] Fac Med Calixto Garcia, Havana, Cuba.
   [Benzaken, Adele Schwartz] UNAIDS, Brasilia, DF, Brazil.
RP Sabido, M (corresponding author), Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.
EM xellsabido@gmail.com
RI Almeida, Tatiana/B-3404-2013; Naveca, Felipe/H-1130-2012
OI Almeida, Tatiana/0000-0001-7395-3062; Naveca, Felipe/0000-0002-2888-1060
FU Regional Scientific Development Program (DCR); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPqNational Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado do Amazonas - FAPEAM; CNPq/FAPEAM; FAPEAM
FX The study was funded by the Regional Scientific Development Program
   (DCR) Call 005/2007 of Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq (www.cnpq.br) and Fundacao de Amparo a Pesquisa do
   Estado do Amazonas - FAPEAM (www.fapeam.am.gov.br). FGN received
   CNPq/FAPEAM fellowship. TAPA, EAV and MCCM received FAPEAM fellowships.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ahmed HJ, 2003, SEX TRANSM DIS, V30, P114, DOI 10.1097/00007435-200302000-00004
   Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007
   Beyrer C, 1998, J INFECT DIS, V178, P243, DOI 10.1086/515603
   Brankin AE, 2009, INT J STD AIDS, V20, P650, DOI 10.1258/ijsa.2009.009067
   Brasil. Ministerio da Saude, 2006, PROGR NAC DST AIDS M
   Bruisten SM, 2001, J CLIN MICROBIOL, V39, P601, DOI 10.1128/JCM.39.2.601-605.2001
   Burris H, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S5
   Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849
   Cheluget B, 2004, SEX TRANSM DIS, V31, P522, DOI 10.1097/01.olq.0000137896.40790.7d
   Chen CY, 2012, METHODS MOL BIOL, V903, P103, DOI 10.1007/978-1-61779-937-2_6
   Clark JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007201
   CONE RW, 1994, JAMA-J AM MED ASSOC, V272, P792, DOI 10.1001/jama.272.10.792
   DANGOR Y, 1990, SEX TRANSM DIS, V17, P184, DOI 10.1097/00007435-199010000-00007
   Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006
   Cavalcante EGF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-595
   FOLKERS E, 1988, GENITOURIN MED, V64, P249
   Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622
   Heymans R, 2010, J CLIN MICROBIOL, V48, P497, DOI 10.1128/JCM.00720-09
   Hope-Rapp E, 2010, SEX TRANSM DIS, V37, P153, DOI 10.1097/OLQ.0b013e3181bf5a98
   Hoyo C, 2005, SEX TRANSM DIS, V32, P231, DOI 10.1097/01.olq.0000149669.98128.ce
   JANIER M, 1990, GENITOURIN MED, V66, P43
   KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305
   Lai W, 2003, SEX TRANSM INFECT, V79, P202, DOI 10.1136/sti.79.3.202
   LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1
   Leslie DE, 2007, J CLIN MICROBIOL, V45, P93, DOI 10.1128/JCM.01578-06
   Lewis DA, 2003, SEX TRANSM INFECT, V79, P68, DOI 10.1136/sti.79.1.68
   Lewis DA, 2012, SEX TRANSM DIS, V39, P880, DOI 10.1097/OLQ.0b013e318269cf90
   Lin HC, 1999, CANCER RES, V59, P807
   Makasa M, 2012, SEX TRANSM DIS, V39, P787, DOI 10.1097/OLQ.0b013e31826ae97d
   Ministerio da Saude do Brasil, 2008, PROGR NAC DST AIDS P
   Ministerio da Saude do Brasil, 2006, MIN SAUD BRAS SER MA, V68
   Moodley P, 2003, SEX TRANSM DIS, V30, P241, DOI 10.1097/00007435-200303000-00013
   Gomes CMM, 2007, BRAZ J INFECT DIS, V11, P254, DOI 10.1590/S1413-86702007000200018
   Morrow RA, 2003, J CLIN MICROBIOL, V41, P5212, DOI 10.1128/JCM.41.11.5212-5214.2003
   Morse SA, 1997, J INFECT DIS, V175, P583, DOI 10.1093/infdis/175.3.583
   Nilsen A, 2007, ACTA DERM-VENEREOL, V87, P355, DOI 10.2340/00015555-0241
   Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996
   Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979
   Paz-Bailey G, 2010, CLIN INFECT DIS, V50, P1060, DOI 10.1086/651115
   Pedrosa VL, 2011, DST J BRAS DOENCAS S, V23, P57
   Prabhakar P, 2012, SEX TRANSM DIS, V39, P906, DOI 10.1097/OLQ.0b013e3182663e22
   Risbud A, 1999, SEX TRANSM DIS, V26, P55, DOI 10.1097/00007435-199901000-00009
   Rottingen JA, 2001, SEX TRANSM DIS, V28, P579
   Suntoke TR, 2009, SEX TRANSM INFECT, V85, P97, DOI 10.1136/sti.2008.034207
   Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881
   Totten PA, 2000, J CLIN MICROBIOL, V38, P268
   Vickerman P, 2008, SEX TRANSM INFECT, V84, P243, DOI 10.1136/sti.2007.027136
   Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3
   Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011
   White BA, 2001, PCR CLONING PROTOCOL, P64
   World Health Organization, 2007, GLOB SURV PREV CONTR
NR 51
TC 12
Z9 12
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2013
VL 8
IS 5
AR e63953
DI 10.1371/journal.pone.0063953
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 149OK
UT WOS:000319330200092
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Andrade, MB
   Silva, GV
   Neto, VC
   Almeida, AP
   Vasquez, FG
   Freitas, LH
   Di Tommaso, GR
   Ferreira, MD
   Moura, JM
   Silva, C
   Lima, RF
   Oliveira, SB
   Malheiro, A
   Naveca, F
   Rocha, CM
AF Andrade, Midia B.
   Silva, George V.
   Neto, Valter C.
   Almeida, Andre P.
   Vasquez, Felicien G.
   Freitas, Ligia H.
   Di Tommaso, Gabriel R.
   Ferreira, Mayara D.
   Moura, Juliana M.
   Silva, Carolina
   Lima, Renata F.
   Oliveira, Sanmya B.
   Malheiro, Adriana
   Naveca, Felipe
   Rocha, Cristina M.
TI Hepatitis C in the Amazon Rainforest
SO GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT Digestive Disease Week / 28th Annual Residents and Fellows Research
   Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT)
CY MAY 18-21, 2013
CL Orlando, FL
SP Soc Surg Alimentary Tract
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD MAY
PY 2013
VL 144
IS 5
SU 1
BP S990
EP S990
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 199LY
UT WOS:000322997205523
DA 2020-12-17
ER

PT J
AU Ferreira, CM
   Naveca, FG
   Ferreira, WA
   de Oliveira, CMC
   Barbosa, MDV
AF Ferreira, Cristina Motta
   Naveca, Felipe Gomes
   Ferreira, William Antunes
   Costa de Oliveira, Cintia Mara
   Vale Barbosa, Maria das Gracas
TI Novel methicillin-resistant coagulase-negative Staphylococcus clone
   isolated from patients with haematological diseases at the Blood Bank
   Centre of Amazon, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE SCCmec; ST clones; coagulase-negative Staphylococcus
ID BIOFILM FORMATION; MULTIPLEX PCR; EPIDERMIDIS; AUREUS; DIVERSITY;
   LINEAGES; ELEMENT
AB Methicillin-resistant Staphylococcus remains a severe public health problem worldwide. This research was intended to identify the presence of methicillin-resistant coagulase-negative staphylococci clones and their staphylococcal cassette chromosome mec (SCCmec)-type isolate from patients with haematologic diseases presenting bacterial infections who were treated at the Blood Bank of the state of Amazonas in Brazil. Phenotypic and genotypic tests, such as SCCmec types and multilocus sequence typing (MLST), were developed to detect and characterise methicillin-resistant isolates. A total of 26 Gram-positive bacteria were isolated, such as: Staphylococcus epidermidis (8/27), Staphylococcus intermedius (4/27) and Staphylococcus aureus (4/27). Ten methicillin-resistant staphylococcal isolates were identified. MLST revealed three different sequence types: S. aureus ST243, S. epidermidis ST2 and a new clone of S. epidermidis, ST365. These findings reinforce the potential of dissemination presented by multiresistant Staphylococcus and they suggest the introduction of monitoring actions to reduce the spread of pathogenic clonal lineages of S. aureus and S. epidermidis to avoid hospital infections and mortality risks.
C1 [Ferreira, Cristina Motta] Fundacao Estadual Hematol & Hemoterapia Amazonas, Manaus, Amazonas, Brazil.
   [Ferreira, Cristina Motta; Vale Barbosa, Maria das Gracas] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Inst Leonidas & Maria Deane Fiocruz, Manaus, Amazonas, Brazil.
   [Ferreira, William Antunes; Vale Barbosa, Maria das Gracas] Fundacao Dermatol Trop & Venereol Alfredo da Matt, Manaus, Amazonas, Brazil.
   [Costa de Oliveira, Cintia Mara] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
RP Ferreira, CM (corresponding author), Fundacao Estadual Hematol & Hemoterapia Amazonas, Manaus, Amazonas, Brazil.
EM cris_motta_ferr@yahoo.com.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
FU FAPEAM; Gestao Compartilhada em Saude [PPSUS-014/2006]
FX FAPEAM, Gestao Compartilhada em Saude (PPSUS-014/2006)
CR Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483
   Carvalho KS, 2010, BRAZ J INFECT DIS, V14, P71, DOI 10.1590/S1413-86702010000100014
   CLSI, 2010, M100S20 CLSI
   de Almeida LM, 2012, ANTIMICROB AGENTS CH, V56, P2792, DOI 10.1128/AAC.06089-11
   de Sousa FC, 2009, REV SOC BRAS MED TRO, V42, P179, DOI 10.1590/S0037-86822009000200017
   Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000
   Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004
   Jonas D, 2002, J CLIN MICROBIOL, V40, P1821, DOI 10.1128/JCM.40.5.1821-1823.2002
   Liakopoulos A, 2010, J ANTIMICROB CHEMOTH, V65, P1070, DOI 10.1093/jac/dkq065
   Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07
   Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722
   Miyoshi T, 2005, APPL ENVIRON MICROB, V71, P1084, DOI 10.1128/AEM.71.2.1084-1088.2005
   Botelho AMN, 2012, J MED MICROBIOL, V61, P1136, DOI 10.1099/jmm.0.035931-0
   Iorio NLP, 2012, DIAGN MICR INFEC DIS, V72, P32, DOI 10.1016/j.diagmicrobio.2011.09.017
   Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08
   Stranden AM, 2009, INFECTION, V37, P44, DOI 10.1007/s15010-008-7430-7
   Strommenger B, 2008, J CLIN MICROBIOL, V46, P582, DOI 10.1128/JCM.01600-07
   Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08
   Weisser M, 2010, J CLIN MICROBIOL, V48, P2407, DOI 10.1128/JCM.00492-10
   Widerstrom M, 2012, EUR J CLIN MICROBIOL, V31, P7, DOI 10.1007/s10096-011-1270-6
   Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9
NR 21
TC 1
Z9 1
U1 0
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2013
VL 108
IS 2
BP 233
EP 238
DI 10.1590/0074-0276108022013017
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 125FS
UT WOS:000317525600017
PM 23579805
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Sousa, KBA
   da Silva, TRR
   Alencar, RB
   Baton, LA
   Naveca, FG
   Shimabukuro, PHF
AF Alves de Sousa, Katianne Barbosa
   Ribeiro da Silva, Tullio Romao
   Alencar, Ronildo Baiatone
   Baton, Luke Anthony
   Naveca, Felipe Gomes
   Fernandes Shimabukuro, Paloma Helena
TI 16S rRNA gene-based identification of microbiota associated with the
   parthenogenetic troglobiont sand fly Deanemyia maruaga (Diptera,
   Psychodidae) from central Amazon, Brazil
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Actinobacteria; bat guano; parthenogensis; sand flies; troglobiont
ID BACTERIAL COMMUNITIES; PHYLOGENETIC DIVERSITY; PALEOLITHIC PAINTINGS;
   COMPLEX; CAVE; POPULATIONS; CULICIDAE; FLORA; WATER; GUT
AB Bacteria associated with the parthenogenetic troglobiont sand fly Deanemyia maruaga were characterized by sequencing cloned 16S rDNA PCR products. Eleven novel partial 16S rDNA sequences, with varying degrees of similarity to Actinobacteria, were identified. None of the sequences identified had homology to those known from parthenogenesis-inducing bacteria.
C1 [Alves de Sousa, Katianne Barbosa; Ribeiro da Silva, Tullio Romao; Naveca, Felipe Gomes; Fernandes Shimabukuro, Paloma Helena] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Alencar, Ronildo Baiatone] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.
   [Baton, Luke Anthony; Fernandes Shimabukuro, Paloma Helena] Fiocruz Minas, Ctr Pesquisas Rene Rachou, BR-31190002 Belo Horizonte, MG, Brazil.
RP Shimabukuro, PHF (corresponding author), Fiocruz Minas, Ctr Pesquisas Rene Rachou, Ave Augusto de Lima 1715, BR-31190002 Belo Horizonte, MG, Brazil.
EM phfs@yahoo.com
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; Baton, Luke/0000-0003-4515-8867;
   Shimabukuro, Paloma Helena Fernandes/0000-0002-5114-953X
FU Programa Integrado de Pesquisa Cientifica e Tecnologica/Fundacao de
   Amparo a Pesquisa do Estado do Amazonas [2216/08]
FX We would like to thank: Programa Integrado de Pesquisa Cientifica e
   Tecnologica/Fundacao de Amparo a Pesquisa do Estado do Amazonas for
   grant no. 2216/08 to PHFS; the Department of Environment and Tourism in
   Presidente Figueiredo for permission to undertake field work at the
   Refugio do Maruaga cave. We are also grateful to Ricardo de Moura Mota
   and Silvio Romero Junior for field work assistance.
CR Alves VR, 2008, MEM I OSWALDO CRUZ, V103, P251, DOI 10.1590/S0074-02762008005000012
   Alves VR, 2011, MEM I OSWALDO CRUZ, V106, P353, DOI 10.1590/S0074-02762011000300016
   Brazil RP, 1999, MED VET ENTOMOL, V13, P463, DOI 10.1046/j.1365-2915.1999.00181.x
   Burke DJ, 2008, FEMS MICROBIOL ECOL, V65, P299, DOI 10.1111/j.1574-6941.2008.00491.x
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102
   GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201
   Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0
   HANSON WILFORD J., 1961, ANN ENT SOC AMER, V54, P317, DOI 10.1093/aesa/54.3.317
   Heard DJ, 1997, J ZOO WILDLIFE MED, V28, P471
   Hill P, 2011, MICROB ECOL, V61, P286, DOI 10.1007/s00248-010-9752-0
   Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881
   Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226
   KILLICKKENDRICK R, 1979, BIOL KINETOPLASTIDA, V2, P395
   KLITE PD, 1965, J BACTERIOL, V90, P375, DOI 10.1128/JB.90.2.375-379.1965
   Konieczna Iwona, 2007, Medycyna Weterynaryjna, V63, P1626
   Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P1025, DOI 10.1128/AEM.68.3.1025-1032.2002
   Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008
   Mirete S, 2007, APPL ENVIRON MICROB, V73, P6001, DOI 10.1128/AEM.00048-07
   Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993
   Muyzer G, 1998, MOL MICROBIAL ECOLOG, V3.4.4, P1
   Normark B. B., 2009, ENCY INSECTS, P688
   Rangel EF, 2011, FLEBOTOMINEOS BRASIL, P291
   Schabereiter-Gurtner C, 2002, ENVIRON MICROBIOL, V4, P392, DOI 10.1046/j.1462-2920.2002.00303.x
   Schabereiter-Gurtner C, 2004, FEMS MICROBIOL ECOL, V47, P235
   Torkko P, 1998, J CLIN MICROBIOL, V36, P499, DOI 10.1128/JCM.36.2.499-505.1998
   Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Yarwood SA, 2009, FEMS MICROBIOL ECOL, V70, P151, DOI 10.1111/j.1574-6941.2009.00733.x
   Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x
   Zhou JP, 2007, J MICROBIOL, V45, P105
NR 34
TC 2
Z9 2
U1 0
U2 6
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PY 2013
VL 44
IS 1
BP 325
EP 328
DI 10.1590/S1517-83822013005000013
PG 4
WC Microbiology
SC Microbiology
GA 207CV
UT WOS:000323575600047
PM 24159323
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Magalhaes, BML
   Alexandre, MAA
   Siqueira, AM
   Melo, GC
   Gimaque, JBL
   Bastos, MS
   Figueiredo, RMP
   Carvalho, RC
   Tavares, MA
   Naveca, FG
   Alonso, P
   Bassat, Q
   Lacerda, MVG
   Mourao, MPG
AF Magalhaes, Belisa M. L.
   Alexandre, Marcia A. A.
   Siqueira, Andre M.
   Melo, Gisely C.
   Gimaque, Joao B. L.
   Bastos, Michele S.
   Figueiredo, Regina M. P.
   Carvalho, Ricardo C.
   Tavares, Michel A.
   Naveca, Felipe G.
   Alonso, Pedro
   Bassat, Quique
   Lacerda, Marcus V. G.
   Mourao, Maria P. G.
TI Case Report: Clinical Profile of Concurrent Dengue Fever and Plasmodium
   vivax Malaria in the Brazilian Amazon: Case Series of 11 Hospitalized
   Patients
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PLATELET TRANSFUSION; INFECTION; THROMBOCYTOPENIA; STATE
AB Malaria and dengue fever are the most prevalent vector-borne diseases worldwide. This study aims to describe the clinical profile of patients with molecular diagnosis of concurrent malaria and dengue fever in a tropical-endemic area. Eleven patients with concurrent dengue virus (DENV) and Plasmodium vivax infection are reported. Similar frequencies of DENV-2, DENV-3, and DENV-4 were found, including DENV-3/DENV-4 co-infection. In eight patients, the World Health Organization (WHO) criteria for severe malaria could be fulfilled (jaundice being the most common). Only one patient met severe dengue criteria, but warning signs were present in 10. Syndromic surveillance systems must be ready to identify this condition to avoid misinterpretation of severity attributed to a single disease.
C1 [Magalhaes, Belisa M. L.; Alexandre, Marcia A. A.; Siqueira, Andre M.; Melo, Gisely C.; Gimaque, Joao B. L.; Bastos, Michele S.; Figueiredo, Regina M. P.; Carvalho, Ricardo C.; Tavares, Michel A.; Naveca, Felipe G.; Lacerda, Marcus V. G.; Mourao, Maria P. G.] Fundacao Med Trop Dr Heitor Vieira Dourado, BR-69040000 Manaus, Amazonas, Brazil.
   Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   Univ Nilton Lins, Manaus, Amazonas, Brazil.
   Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona CRESIB, Barcelona, Spain.
   [Alonso, Pedro; Bassat, Quique] Univ Barcelona, Ctr Int Hlth Res CRESIB, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.
RP Lacerda, MVG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Av Pedro Teixeira 25, BR-69040000 Manaus, Amazonas, Brazil.
EM magalhaesbelisa@gmail.com; marcialexandre@gmail.com;
   amsiqueira@gmail.com; cardosogisely@gmail.com; guimaque@ig.com.br;
   michelebastos01@gmail.com; figueiredormp@hotmail.com;
   riaucarvalho@ig.com.br; micheltavares@hotmail.com;
   fnaveca@amazonia.fiocruz.br; palonso@clinic.ub.es;
   quique.bassat@cresib.cat; marcuslacerda.br@gmail.com;
   mariapaula.mourao@gmail.com
RI Bastos, Michele/AAS-7386-2020; Siqueira, Andre M/G-1340-2010; Bassat,
   Quique/P-2341-2016; Naveca, Felipe/H-1130-2012; Alonso, Pedro
   L/AAZ-3645-2020
OI Bastos, Michele/0000-0003-3450-666X; Siqueira, Andre
   M/0000-0003-2208-0294; Bassat, Quique/0000-0003-0875-7596; Naveca,
   Felipe/0000-0002-2888-1060; Alonso, Pedro L/0000-0003-3292-3443
FU Fundacio Cellex's P. vivax Consortium; National Council for Scientific
   and Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [555.666/2009-3]; Foundation of
   Research Support of the Amazonas State (FAPEAM); Coordination for the
   Improvement of Higher Educational Level Personnel (CAPES); National
   Institute of Science and Technology for Innovation in Neglected Diseases
   (INCT-IDN)
FX This research was funded by Fundacio Cellex's P. vivax Consortium;
   National Council for Scientific and Technological Development (CNPq)
   (grant 555.666/2009-3); Foundation of Research Support of the Amazonas
   State (FAPEAM); Coordination for the Improvement of Higher Educational
   Level Personnel (CAPES); and the National Institute of Science and
   Technology for Innovation in Neglected Diseases (INCT-IDN). MVGL is a
   level 2 productivity fellow from CNPq.
CR Abbasi A, 2009, JCPSP-J COLL PHYSICI, V19, P25, DOI 01.2009/JCPSP.2529
   Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Anand AC, 2005, J GASTROEN HEPATOL, V20, P1322, DOI 10.1111/j.1440-1746.2005.03884.x
   Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13
   [Anonymous], 2009, DENG GUID DIAGN TREA
   [Anonymous], 2010, MAL REP
   Anstey NM, 2007, PLOS MED, V4, P1291, DOI 10.1371/journal.pmed.0040267
   Lanca EFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035406
   Carme B, 2009, EMERG INFECT DIS, V15, P668, DOI 10.3201/eid1504.080891
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1153, DOI 10.3201/eid1107.041352
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   Chagas ECD, 2009, REV PANAM SALUD PUBL, V26, P203
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   Deresinski S, 2006, EMERG INFECT DIS, V12, P1802, DOI 10.3201/eid1211.060341
   Epelboin L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-142
   Gonçalves Maria Jacirema Ferreira, 2004, Rev. salud pública, V6, P156
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170, DOI 10.4269/ajtmh.1985.34.170
   Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007
   Itha S, 2005, NATL MED J INDIA, V18, P127
   Jagdish Chander, 2009, Tropical Medicine and Health, V37, P69, DOI 10.2149/tmh.2009-07
   Kochar D K, 2003, J Assoc Physicians India, V51, P1069
   Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Larreal Yraima, 2005, Invest. clín, V46, P169
   Lomar André V., 2005, Braz J Infect Dis, V9, P425, DOI 10.1590/S1413-86702005000500011
   Lye DC, 2009, CLIN INFECT DIS, V48, P1262, DOI 10.1086/597773
   Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40
   Mourao MPG, 2007, PLATELETS, V18, P605, DOI 10.1080/09537100701426604
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Pancharoen Chitsanu, 2002, Journal of the Medical Association of Thailand, V85, pS298
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Rebulla P, 2001, Rev Clin Exp Hematol, V5, P288, DOI 10.1046/j.1468-0734.2001.00042.x
   Santana VD, 2010, REV SOC BRAS MED TRO, V43, P508, DOI 10.1590/S0037-86822010000500007
   Santos-Ciminera PD, 2007, ACTA TROP, V102, P38, DOI 10.1016/j.actatropica.2007.02.013
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Thaha M, 2008, CLIN NEPHROL, V70, P427
   THAITHUMYANON P, 1994, CLIN INFECT DIS, V18, P248, DOI 10.1093/clinids/18.2.248
   Thomas L, 2009, TRANSFUSION, V49, P1400, DOI 10.1111/j.1537-2995.2009.02132.x
   Torres EM, 2006, REV PANAM SALUD PUBL, V20, P60, DOI 10.1590/S1020-49892006000700013
   Vasconcelos P. F. C., 1990, Revista Latinoamericana de Microbiologia, V32, P291
   Wang Wei-Kung, 2003, Journal of Microbiology Immunology and Infection, V36, P89
NR 46
TC 19
Z9 19
U1 0
U2 10
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2012
VL 87
IS 6
BP 1119
EP 1124
DI 10.4269/ajtmh.2012.12-0210
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 052YG
UT WOS:000312236000027
PM 23033396
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Silva, GAV
   Santos, MP
   Mota-Passos, I
   Boechat, AL
   Malheiro, A
   Naveca, FG
   de Paula, L
AF Silva, G. A. V.
   Santos, M. P.
   Mota-Passos, I.
   Boechat, A. L.
   Malheiro, A.
   Naveca, F. G.
   de Paula, L.
TI IFN-gamma +875 microsatellite polymorphism as a potential protection
   marker for leprosy patients from Amazonas state, Brazil
SO CYTOKINE
LA English
DT Article
DE Leprosy; Cellular immunity; Cytokine; Polymorphism
ID SINGLE NUCLEOTIDE POLYMORPHISM; INTERFERON-GAMMA; GENE POLYMORPHISMS;
   CYTOKINE LEVELS; TUBERCULOSIS; SUSCEPTIBILITY; ASSOCIATION; IFNG+874T/A;
   DISEASE; REGION
AB Polymorphisms present in the first intron of IFN-gamma may have an important role in the regulation of the immune response, which could have functional consequences for gene transcription. Leprosy patients are characterized by different immune responses in different clinical forms. We investigated a possible association of the +874 polymorphism and CA repeats present in the first intron of IFN-gamma with susceptibility to leprosy and with the manifestation of the different clinical forms. Nucleotide sequencing was performed with samples from 108 leprosy patients and 113 controls subjects, as well as immunopheno-typing of CD4+, CD8+ and CD69+ T cells by flow cytometry. The data showed that there were no significant differences between patients and control subjects, as well as according classification of Ridley-jopling. However, the A/A genotype was significantly increased in paucibacillary patients (p = 0.028) and the microsatellite encoding 16 CA repeats were significantly associated with paucibacillary compared to multibacillary patients (p = 0.019). Individuals homozygous for the +874 A allele, the mean level of CD4+ and CD69+ T cells was higher. Our data suggest that polymorphisms present in the first intron of IFN-gamma are not associated with susceptibility to leprosy, nevertheless, the +874 polymorphism and the CA repeats number encoded in IFN-gamma gene may be related to a higher cellular immune response in patients and are consistently more frequently detected in PB patients. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [de Paula, L.] Univ Fed Amazonas, Inst Ciencias Biol, Dept Morfol, BR-69077000 Manaus, AM, Brazil.
   [Silva, G. A. V.; Santos, M. P.; Mota-Passos, I.; Boechat, A. L.; Malheiro, A.; Naveca, F. G.; de Paula, L.] Univ Fed Amazonas, PPGIBA, BR-69077000 Manaus, AM, Brazil.
   [Malheiro, A.] Univ Fed Amazonas, Inst Ciencias Biol, Dept Parasitol, BR-69077000 Manaus, AM, Brazil.
   [Naveca, F. G.] FIOCRUZ Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP de Paula, L (corresponding author), Univ Fed Amazonas, Inst Ciencias Biol, Dept Morfol, Av Gen Rodrigo Octavio Jordao Ramos 3000,Campus U, BR-69077000 Manaus, AM, Brazil.
EM lpaula.bio@hotmail.com
RI Boechat, A.L./H-8484-2019; Boechat, Antonio Luiz/E-6464-2010; Naveca,
   Felipe/H-1130-2012
OI Boechat, A.L./0000-0001-5597-7343; Boechat, Antonio
   Luiz/0000-0001-5597-7343; Naveca, Felipe/0000-0002-2888-1060
FU Conselho Nacional de desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)
FX This study was supported by Conselho Nacional de desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Amazonas (FAPEAM).
CR Franceschi DSA, 2009, INT J INFECT DIS, V13, P493, DOI 10.1016/j.ijid.2008.08.019
   Amim L, 2008, MOL BIOL REP, V35, P563, DOI 10.1007/s11033-007-9123-1
   Anand SP, 2010, CYTOKINE, V49, P130, DOI 10.1016/j.cyto.2009.11.009
   Ben Selma W, 2011, DNA CELL BIOL, V30, P379, DOI 10.1089/dna.2010.1157
   Bozzi A, 2009, CYTOKINE, V48, P212, DOI 10.1016/j.cyto.2009.07.011
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   Cardoso CC, 2010, HUM GENET, V128, P481, DOI 10.1007/s00439-010-0872-x
   Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/fmb.11.39, 10.2217/FMB.11.39]
   de Albuquerque MC, 2009, MEM I OSWALDO CRUZ, V104, P451, DOI 10.1590/S0074-02762009000300009
   Ding SP, 2008, HUM IMMUNOL, V69, P129, DOI 10.1016/j.humimm.2007.11.006
   Goulart Isabela Maria Bernardes, 2002, Rev Soc Bras Med Trop, V35, P365, DOI 10.1590/S0037-86822002000400014
   Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362
   Ito C, 2006, ENDOCR J, V53, P473, DOI 10.1507/endocrj.K06-015
   Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC
   Mendonca VA, 2008, AN BRAS DERMATOL, V83, P343, DOI 10.1590/S0365-05962008000400010
   Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278
   Moraes MO, 2006, LEPROSY REV, V77, P189
   Moran A, 2007, INT J TUBERC LUNG D, V11, P113
   Mosaad YM, 2010, SCAND J IMMUNOL, V72, P358, DOI 10.1111/j.1365-3083.2010.02426.x
   Ohyama H, 2008, J INTERF CYTOK RES, V28, P563, DOI 10.1089/jir.2008.0133
   Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5
   Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1
   Pravica V, 1999, EUR J IMMUNOGENET, V26, P1, DOI 10.1046/j.1365-2370.1999.00122.x
   Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011
   SICA A, 1992, P NATL ACAD SCI USA, V89, P1740, DOI 10.1073/pnas.89.5.1740
   Tso HW, 2005, GENES IMMUN, V6, P358, DOI 10.1038/sj.gene.6364189
   Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008
   Vidyarani M, 2006, INDIAN J MED RES, V124, P403
NR 28
TC 11
Z9 12
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD NOV
PY 2012
VL 60
IS 2
BP 493
EP 497
DI 10.1016/j.cyto.2012.04.043
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 029KL
UT WOS:000310494300026
PM 22683002
OA Bronze
DA 2020-12-17
ER

PT J
AU da Motta-Passos, I
   Malheiro, A
   Naveca, FG
   Passos, LFD
   Cardoso, CRD
   Cunha, MDS
   Dos Santos, MP
   Silva, GAV
   Fraporti, LS
   de Paula, L
AF da Motta-Passos, Isabella
   Malheiro, Adriana
   Naveca, Felipe Gomes
   de Souza Passos, Luiz Fernando
   De Barros Cardoso, Cristina Ribeiro
   Souza Cunha, Maria da Graca
   Dos Santos, Maisa Porto
   Villarouco Silva, George Allan
   Fraporti, Liziara Silva
   de Paula, Lucia
TI Decreased RNA expression of interleukin 17A in skin of leprosy
SO EUROPEAN JOURNAL OF DERMATOLOGY
LA English
DT Article
DE IL-17A mRNA; immunity; inflammatory cytokines; Leprosy; Mycobacterium
   leprae; skin
ID MYCOBACTERIUM-TUBERCULOSIS; T-CELL; CYTOKINE PRODUCTION;
   IMMUNE-RESPONSE; CROHNS-DISEASE; PANETH CELLS; INFECTION; INNATE;
   LEPRAE; IL-23
AB Interleukin-17A (IL-17A) is a proinflamatory cytokine that plays an important role in fighting pathogens at mucosal interfaces, by summoning neutrophils and upregulating cytoplasmatic antimicrobial peptides. So far, the presence of IL-17A in leprosy has not been demonstrated. The expression of IL-17A and related cytokines (IL-6 and IL-23p19) was addressed through RNA extraction and cDNA quantitative amplification in macerated biopsies of active lesions of 48 leprosy patients and 20 fragments of normal skin of individuals. Blood levels of IL-17A, IL-23p19 and IL-6 were determined by ELISA. We found an abrogated mRNA IL-17A response in all biopsies of leprosy patients, as compared with controls. Circulating IL-17A and IL-23p19 were undetectable in both patients and controls, but IL-6 was higher in lepromatous patients. Although at low levels, IL-17A mRNA in lepromatous patients had an inverse linear correlation with bacillary burden. Low expression of IL-17A in patients may be a constitutive genetic feature of leprosy patients or a circumstantial event induced by the local presence of the pathogen, as an escape mechanism.
C1 [da Motta-Passos, Isabella; Malheiro, Adriana; de Souza Passos, Luiz Fernando; Dos Santos, Maisa Porto; Villarouco Silva, George Allan; Fraporti, Liziara Silva; de Paula, Lucia] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Malheiro, Adriana] Fdn Hemoterapia & Hematol Amazonas, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil.
   [De Barros Cardoso, Cristina Ribeiro] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.
   [Souza Cunha, Maria da Graca] Fdn Dermatol & Venereol Alfredo da Matta, Manaus, Amazonas, Brazil.
   [de Paula, Lucia] Univ Fed Amazonas, Inst Ciencias Biol, Dept Morfol, Manaus, Amazonas, Brazil.
RP de Paula, L (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
EM lpaula.bio@hotmail.com
RI de Barros Cardoso, Cristina Ribeiro/L-8396-2017; Naveca,
   Felipe/H-1130-2012
OI de Barros Cardoso, Cristina Ribeiro/0000-0002-6156-3144; Naveca,
   Felipe/0000-0002-2888-1060
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); State of Amazonas Research Foundation (FAPEAM), through DCR
   Program; FAPEAM fellowships
FX Financial support: This work was financially supported by the National
   Council for Scientific and Technological Development (CNPq) and the
   State of Amazonas Research Foundation (FAPEAM), through DCR Program.
   Motta-Passos I, Santos MP and Silva GAV received FAPEAM fellowships. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Conflict of
   Interest: The authors have declared that no conflict of interests
   exists.
CR ARNOLDI J, 1990, AM J PATHOL, V137, P749
   Attia EAS, 2010, INT J DERMATOL, V49, P1152, DOI 10.1111/j.1365-4632.2010.04535.x
   Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783
   Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584
   Belgaumkar VA, 2007, LEPROSY REV, V78, P223
   Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7
   Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/fmb.11.39, 10.2217/FMB.11.39]
   Chen JH, 2010, J CLIN IMMUNOL, V30, P539, DOI 10.1007/s10875-010-9391-8
   Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800
   Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x
   Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456
   Jadhav R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000977
   Job CK, 2008, AM J TROP MED HYG, V78, P518, DOI 10.4269/ajtmh.2008.78.518
   Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449
   Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862
   KLATSER PR, 1993, J CLIN MICROBIOL, V31, P2947, DOI 10.1128/JCM.31.11.2947-2951.1993
   Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018
   Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9
   Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308
   Lim A, 2010, CLIN IMMUNOL, V137, P296, DOI 10.1016/j.clim.2010.07.011
   Lima MCBS, 2000, SCAND J IMMUNOL, V51, P419, DOI 10.1046/j.1365-3083.2000.00703.x
   Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025
   Massone C, 2010, AM J DERMATOPATH, V32, P251, DOI 10.1097/DAD.0b013e3181b7fc56
   MISRA N, 1995, IMMUNOLOGY, V86, P97
   Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001
   Moraes MO, 2006, LEPROSY REV, V77, P189
   Moubasher AEDA, 1998, INT J DERMATOL, V37, P733, DOI 10.1046/j.1365-4362.1998.00381.x
   Murray RA, 2007, J IMMUNOL, V178, P338, DOI 10.4049/jimmunol.178.1.338
   Ochoa MT, 1996, INT J DERMATOL, V35, P786, DOI 10.1111/j.1365-4362.1996.tb02974.x
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006
   Sales AM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001013
   Schurr E, 2009, NEW ENGL J MED, V361, P2666, DOI 10.1056/NEJMe0910690
   Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006
   Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962
   Sinsimer D, 2010, INFECT IMMUN, V78, P293, DOI 10.1128/IAI.00816-09
   Stefani MM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-75
   Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693
   Teixeira-Coelho M, 2011, INT IMMUNOL, V23, P89, DOI 10.1093/intimm/dxq459
   Tilg H, 2009, EUR CYTOKINE NETW, V20, P1, DOI 10.1684/ecn.2009.0141
   Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786
   WHO World Health Organization, 2011, WEEKLY EPIDEMIOLOGIC, V86, P398
   World Health Organization (WHO), 1982, WHO TECHN REP SER, pWHO
   YOO ZB, 1995, J IMMUNOL, V155, P5483
   Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332
   Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753
   Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488
NR 47
TC 7
Z9 7
U1 0
U2 5
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1167-1122
EI 1952-4013
J9 EUR J DERMATOL
JI Eur. J. Dermatol.
PD JUL-AUG
PY 2012
VL 22
IS 4
BP 488
EP 494
DI 10.1684/ejd.2012.1741
PG 7
WC Dermatology
SC Dermatology
GA 000FF
UT WOS:000308371200008
PM 22641009
DA 2020-12-17
ER

PT J
AU Bastos, MD
   Figueiredo, LTM
   Naveca, FG
   Monte, RL
   Lessa, N
   de Figueiredo, RMP
   Gimaque, JBD
   Joao, GP
   Ramasawmy, R
   Mourao, MPG
AF Bastos, Michele de Souza
   Moraes Figueiredo, Luiz Tadeu
   Naveca, Felipe Gomes
   Monte, Rossicleia Lins
   Lessa, Natalia
   Pinto de Figueiredo, Regina Maria
   de Lima Gimaque, Joao Bosco
   Joao, Guilherme Pivoto
   Ramasawmy, Rajendranath
   Gomes Mourao, Maria Paula
TI Short Report: Identification of Oropouche Orthobunyavirus in the
   Cerebrospinal Fluid of Three Patients in the Amazonas, Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; VIRUS; INFECTIONS; DIAGNOSIS; PCR
AB Oropouche fever is the second most frequent arboviral infection in Brazil, surpassed only by dengue. Oropouche virus (OROV) causes large and explosive outbreaks of acute febrile illness in cities and villages in the Amazon and Central-Plateau regions. Cerebrospinal fluid (CSF) samples from 110 meningoencephalitis patients were analyzed. The RNA extracted from fluid was submitted to reverse transcription-polymerase chain reaction and sequencing to identify OROV. Three CSF samples showed the presence of OROV causing infection in the central nervous system (CNS). These patients are adults. Two of the patients had other diseases affecting CNS and immune systems: neurocysticercosis and acquired immunodeficiency syndrome, respectively. Nucleotide sequence analysis showed that the OROV from the CSF of these patients belonged to genotype I. We show here that severe Oropouche disease is occurring during outbreaks of this virus in Brazil
C1 [Bastos, Michele de Souza; Monte, Rossicleia Lins; Lessa, Natalia; Pinto de Figueiredo, Regina Maria; de Lima Gimaque, Joao Bosco; Joao, Guilherme Pivoto; Ramasawmy, Rajendranath; Gomes Mourao, Maria Paula] Univ State Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, BR-69040000 Manaus, Amazonas, Brazil.
   [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Sch Med, BR-14049 Ribeirao Preto, SP, Brazil.
   [Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Ramasawmy, Rajendranath; Gomes Mourao, Maria Paula] Nilton Lins Univ Ctr, Manaus, Amazonas, Brazil.
   [Lessa, Natalia] Univ Fed Amazon, Manaus, Amazonas, Brazil.
RP Bastos, MD (corresponding author), Univ State Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, Av Pedro Teixeira 25, BR-69040000 Manaus, Amazonas, Brazil.
EM Michele@fmt.am.gov.br; ltmfigue@fmrp.usp.br;
   fnaveca@amazonia.fiocruz.br; rossi@fmt.am.gov.br;
   naty_lessa@hotmail.com; figueiredormp@yahoo.com.br; gimaque@ig.com.br;
   guilhermepivoto@hotmail.com; ramasawm@gmail.com;
   mariapaula.mourao@gmail.com
RI Bastos, Michele/AAS-7386-2020; Naveca, Felipe/H-1130-2012; Figueiredo,
   Luiz T/E-3702-2012; Ramasawmy, Rajendranath/V-4926-2019
OI Bastos, Michele/0000-0003-3450-666X; Naveca, Felipe/0000-0002-2888-1060;
   
FU Amazonas Research Supporting Foundation (FAPEAM) [871/10, 887/10]
FX This research was supported by the Amazonas Research Supporting
   Foundation (FAPEAM grant 871/10) to Michele de Souza Bastos and (FAPEAM
   grant 887/10) to Maria Paula Gomes Mourao.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   dos Santos GPL, 2006, J MED VIROL, V78, P98, DOI 10.1002/jmv.20509
   Elliot RM, 2000, VIRUS TAXONOMY, P599
   FIGUEIREDO LTM, 1987, J VIROL METHODS, V17, P191, DOI 10.1016/0166-0934(87)90129-7
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Mendoza LP, 2007, J INFECTION, V54, P589, DOI 10.1016/j.jinf.2006.11.013
   Pinheiro F P, 1982, Rev Inst Med Trop Sao Paulo, V24, P246
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P172, DOI 10.4269/ajtmh.1981.30.172
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Shope RE, 1998, ARBOVIRUSES EPIDEMIO, P37
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
NR 16
TC 32
Z9 33
U1 0
U2 8
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD APR
PY 2012
VL 86
IS 4
BP 732
EP 735
DI 10.4269/ajtmh.2012.11-0485
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 922AR
UT WOS:000302519700029
PM 22492162
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Naveca, FG
   Souza, VC
   Silva, GAV
   Maito, RM
   Granja, F
   Siqueira, T
   Acosta, POA
AF Naveca, Felipe G.
   Souza, Victor C.
   Silva, George A. V.
   Maito, Rodrigo M.
   Granja, Fabiana
   Siqueira, Thalita
   Acosta, Pablo O. A.
TI Complete Genome Sequence of a Dengue Virus Serotype 4 Strain Isolated in
   Roraima, Brazil
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID EVOLUTION; HISTORY; TYPE-4
AB Dengue is the most important arboviral disease worldwide. We report the complete genome sequence of a dengue virus serotype 4, genotype II strain isolated in 2010 from a patient with classical dengue fever in Boa Vista, Roraima, Brazil.
C1 [Naveca, Felipe G.; Souza, Victor C.; Silva, George A. V.] Inst Lenidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Maito, Rodrigo M.] Lab Cent Roraima, Boa Vista, Roraima, Brazil.
   [Granja, Fabiana; Siqueira, Thalita; Acosta, Pablo O. A.] Univ Fed Roraima, Ctr Estudos Biodiversidade, Boa Vista, Roraima, Brazil.
RP Naveca, FG (corresponding author), Inst Lenidas & Maria Deane, Manaus, Amazonas, Brazil.
EM fnaveca@amazonia.fiocruz.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa
   de/0000-0002-3869-1519
FU POM-Fiocruz; PRONEX Rede Dengue (CNPq) [550120/2010-6]; Fundacao de
   Amparo a Pesquisa do Estado do Amazonas (FAPEAM); PPSUS; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX This work was supported by grants from POM-Fiocruz and PRONEX Rede
   Dengue (CNPq 550120/2010-6). V. C. S. and G. A. V. S. received
   fellowship support from the Fundacao de Amparo a Pesquisa do Estado do
   Amazonas (FAPEAM) and the PPSUS program, and T. S. had a CNPq
   fellowship.
CR Acosta POA, 2010, REEMERGENCE DENGUE V
   Drummond A., 2011, GENEIOUS V5 5
   Forshey BM, 2009, EMERG INFECT DIS, V15, P1815, DOI 10.3201/eid1511.090663
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Osanai CA, 1984, THESIS ESCOLA NACL S
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007
NR 14
TC 11
Z9 11
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD FEB
PY 2012
VL 86
IS 3
BP 1897
EP 1898
DI 10.1128/JVI.06731-11
PG 2
WC Virology
SC Virology
GA 879CT
UT WOS:000299308000058
PM 22247521
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Mourao, MPG
   Bastos, MD
   de Figueiredo, RP
   Gimaque, JBL
   Galusso, ED
   Kramer, VM
   de Oliveira, CMC
   Naveca, FG
   Figueiredo, LTM
AF Gomes Mourao, Maria Paula
   Bastos, Michele de Souza
   de Figueiredo, Regina Pinto
   Lima Gimaque, Joao Bosco
   Galusso, Elizabeth dos Santos
   Kramer, Valeria Munique
   Costa de Oliveira, Cintia Mara
   Naveca, Felipe Gomes
   Moraes Figueiredo, Luiz Tadeu
TI Mayaro Fever in the City of Manaus, Brazil, 2007-2008
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Alphavirus; Arbovirus; Brazilian Amazon; Mayaro fever
ID HUMAN DISEASE AGENT; VIRUS-DISEASE; OUTBREAK; BELTERRA; INFECTION
AB Mayaro Alphavirus is an arbovirus that causes outbreaks of acute febrile illness in the Amazon region of South America. We show here the cases of Mayaro fever that occurred in 2007-2008, in Manaus, a large city and capital of the Amazonas State, in Western Brazilian Amazon. IgM antibodies to Mayaro virus (MAYV) were detected by an enzyme immunoassay using infected cell cultures as antigen in the sera of 33 patients from both genera and 6-65 years old. MAYV genome was also detected by RT-PCR in the blood of 1/33 of these patients. The patients presented mainly with headache, arthralgia, myalgia, ocular pain, and rash. These cases of Mayaro fever are likely to represent the tip of an iceberg, and probably a much greater number of cases occurred in Manaus in the study period.
C1 [Gomes Mourao, Maria Paula; Bastos, Michele de Souza; de Figueiredo, Regina Pinto; Lima Gimaque, Joao Bosco; Galusso, Elizabeth dos Santos; Costa de Oliveira, Cintia Mara] Fundacao Med Trop Dr Heitor Viera Dourado FMT HVD, Dept Virol, BR-69040000 Manaus, Amazonas, Brazil.
   [Gomes Mourao, Maria Paula; Bastos, Michele de Souza; Lima Gimaque, Joao Bosco] Univ Estado Amazonas, Trop Med Postgrad Program, Manaus, Amazonas, Brazil.
   [Gomes Mourao, Maria Paula] Univ Nilton Lins, Unictr, Manaus, Amazonas, Brazil.
   [Kramer, Valeria Munique] Univ Fed Amazonas UFAM, Fac Pharm, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Fundacao Oswaldo Cruz FIOCRUZ, Inst Pesquisa Leonidas & Maria Deane ILDM, Manaus, Amazonas, Brazil.
   [Moraes Figueiredo, Luiz Tadeu] Fac Med Ribeirao Preto FMRP USP, Ctr Pesquisas Virol, Sao Paulo, Brazil.
RP Mourao, MPG (corresponding author), Fundacao Med Trop Dr Heitor Viera Dourado FMT HVD, Dept Virol, Av Pedro Teixeira,25 Gerencia Virol, BR-69040000 Manaus, Amazonas, Brazil.
EM mariapaula.mourao@gmail.com
RI Bastos, Michele/AAS-7386-2020; Naveca, Felipe/H-1130-2012; Figueiredo,
   Luiz T/E-3702-2012
OI Bastos, Michele/0000-0003-3450-666X; Naveca, Felipe/0000-0002-2888-1060;
   
FU National Council for Scientific and Technologic Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [484941/2007-0]; Amazonas Research Supporting Foundation (FAPEAM)
FX This research was supported by the National Council for Scientific and
   Technologic Development (CNPq-grant 484941/2007-0) and by Amazonas
   Research Supporting Foundation (FAPEAM).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   dos Santos MC, 2006, EMERG INFECT DIS, V12, P1165
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   FIGUEIREDO LTM, 1989, MEM I OSWALDO CRUZ, V84, P303, DOI 10.1590/S0074-02761989000300003
   GRIFFIN DE, 2007, FIELDS VIROLOGY, P1023
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Luers AJ, 2005, COMP FUNCT GENOM, V6, P217, DOI 10.1002/cfg.478
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Mourao MPG, 2001, BRAZ J INFECT DIS, pS22
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   Tavares-Neto José, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000100001
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Thatcher BD, 2000, REV SOC BRAS MED S1, V33, P203
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 30
TC 64
Z9 64
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JAN
PY 2012
VL 12
IS 1
BP 42
EP 46
DI 10.1089/vbz.2011.0669
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 876MY
UT WOS:000299112800007
PM 21923266
OA Green Published
DA 2020-12-17
ER

PT J
AU de Figueiredo, RMP
   Naveca, FG
   Oliveira, CM
   Bastos, MD
   Mourao, MPG
   Viana, SD
   Melo, MD
   Itapirema, EF
   Saatkamp, CJ
   Farias, IP
AF de Figueiredo, Regina M. P.
   Naveca, Felipe Gomes
   Oliveira, Cintia Mara
   Bastos, Michele de Souza
   Gomes Mourao, Maria Paula
   Viana, Suziane de S.
   Melo, Miriam do N.
   Itapirema, Evaulino F.
   Saatkamp, Cassiano J.
   Farias, Izeni P.
TI CO-INFECTION OF DENGUE VIRUS BY SEROTYPES 3 AND 4 IN PATIENTS FROM
   AMAZONAS, BRAZIL
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Brazil; Dengue; Co-infection; Flavivirus
AB The natural co-infection with dengue virus can occur in highly endemic areas where different serotypes have been observed for many years. We report here four cases of DENV-3/DENV-4 co-infection detected by serological and molecular tests among 674 patients with acute undifferentiated fever from the tropical medicine reference center of Manaus City, Brazil, between 2005 and 2010. Analysis of the sequences obtained indicated the presence of genotype 3 and 1 for DENV-3 and DENV-4 respectively.
C1 [de Figueiredo, Regina M. P.; Oliveira, Cintia Mara; Bastos, Michele de Souza; Gomes Mourao, Maria Paula; Viana, Suziane de S.; Melo, Miriam do N.; Itapirema, Evaulino F.; Saatkamp, Cassiano J.] Fundacao Med Trop Dr Heitor Vieira Dourado, FMTHVD, BR-69040000 Manaus, AM, Brazil.
   [Farias, Izeni P.] Univ Fed Amazonas UFAM, Manaus, Amazonas, Brazil.
RP de Figueiredo, RMP (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, FMTHVD, Av Pedro Teixeira 25, BR-69040000 Manaus, AM, Brazil.
EM figueiredormp@yahoo.com.br
RI Farias, Izeni Pires/J-3069-2014; Bastos, Michele/AAS-7386-2020; Naveca,
   Felipe/H-1130-2012
OI Farias, Izeni Pires/0000-0002-1416-4351; Bastos,
   Michele/0000-0003-3450-666X; Naveca, Felipe/0000-0002-2888-1060
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11, DOI 10.1590/S0036-46652003000100003
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   GUZMAN MG, 1986, IS SEQUENTIAL INFECT, P172
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
NR 12
TC 24
Z9 24
U1 0
U2 4
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD NOV-DEC
PY 2011
VL 53
IS 6
BP 321
EP 323
DI 10.1590/S0036-46652011000600004
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 865GG
UT WOS:000298298400004
PM 22183455
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Acosta, POA
   Maito, RM
   Granja, F
   Cordeiro, JD
   Siqueira, T
   Cardoso, MN
   Corado, AD
   Barletta-Naveca, RH
   Naveca, FG
AF Amezaga Acosta, Pablo Oscar
   Maito, Rodrigo Melo
   Granja, Fabiana
   Cordeiro, Joel da Silva
   Siqueira, Thalita
   Cardoso, Mayara Nunes
   Corado, Andre de Lima
   Barletta-Naveca, Raphaela Honorato
   Naveca, Felipe Gomes
TI Dengue Virus Serotype 4, Roraima State, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Amezaga Acosta, Pablo Oscar] Univ Fed Roraima Biol, BR-69301000 Boa Vista, Roraima, Brazil.
   [Maito, Rodrigo Melo] Lab Cent Roraima, Boa Vista, Brazil.
   [Barletta-Naveca, Raphaela Honorato] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Rio De Janeiro, Brazil.
RP Acosta, POA (corresponding author), Univ Fed Roraima Biol, Campus Paricarana,Av Cap Ene Garcez 2413, BR-69301000 Boa Vista, Roraima, Brazil.
EM amezaga@osite.com.br
RI Naveca, Felipe/H-1130-2012; Azevedo, Raimunda/T-4656-2019
OI Naveca, Felipe/0000-0002-2888-1060; Azevedo,
   Raimunda/0000-0003-1932-9976
CR de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Naveca FG, 2010, 21 NAT M BRAZ SOC VI
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
NR 5
TC 10
Z9 10
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2011
VL 17
IS 10
BP 1979
EP 1980
DI 10.3201/eid1710.110776
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 833PL
UT WOS:000295897300050
PM 22000396
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ferreira, WA
   Ferreira, CM
   Naveca, FG
   Almeida, NCOD
   Vasconcelos, WD
   Gomes, JD
   da Silva, MDP
   Alecrim, MDC
AF Ferreira, William Antunes
   Ferreira, Cristina Motta
   Naveca, Felipe Gomes
   Oliveira da Silva Almeida, Nayanne Cristina
   Vasconcelos, Waldemara de Souza
   Gomes, Jairo de Souza
   Pinto da Silva, Maria de Fatima
   Costa Alecrim, Maria das Gracas
TI Genotyping of two Neisseria gonorrhoeae fluroquinolone-resistant strains
   in the Brazilian Amazon Region
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Neisseria gonorrhoeae; fluroquinolone resistance; gyrA and parC;
   genotyping; MAST
ID SUSCEPTIBILITY; MUTATIONS
AB We report two ciprofloxacin and ofloxacin-resistant Neisseria gonorrhoeae strains that were isolated from the urethral discharge of male patients at the sexually transmitted diseases outpatient clinic of the Alfredo da Matta Foundation (Manaus, state of Amazonas, Brazil). The gonococci displayed minimal inhibitory concentrations (> 32.00 mu g/mL) and three mutations in the quinolone resistance-determining region (S91F and D95G in GyrA and S87R in ParC). Both isolates were genotyped using N. gonorrhoeae multi-antigen sequence typing and the analysis showed that the ST225 which represented an emerging widespread multi-resistant clone that has also been associated with reduced susceptibility to ceftriaxone. We recommend continued surveillance of this pathogen to assess the efficacy of anti-gonococcal antibiotics in Brazil.
C1 [Ferreira, William Antunes; Vasconcelos, Waldemara de Souza; Gomes, Jairo de Souza; Pinto da Silva, Maria de Fatima] Univ Estadual Amazonas, Fundacao Alfredo Matta, Lab Bacteriol Clin, BR-69065130 Manaus, Amazonas, Brazil.
   [Ferreira, Cristina Motta] Fundacao Hematol & Hemoterapia Amazonas, Manaus, Amazonas, Brazil.
   [Oliveira da Silva Almeida, Nayanne Cristina] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Costa Alecrim, Maria das Gracas] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
RP Ferreira, WA (corresponding author), Univ Estadual Amazonas, Fundacao Alfredo Matta, Lab Bacteriol Clin, Rua Codajas 25, BR-69065130 Manaus, Amazonas, Brazil.
EM wianfe@yahoo.com.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
CR [Anonymous], 2003, Commun Dis Intell Q Rep, V27, P488
   BELLAND RJ, 1994, MOL MICROBIOL, V14, P371, DOI 10.1111/j.1365-2958.1994.tb01297.x
   Clinical and Laboratory Standards Institute (CLSI), 2005, M100S15 CLSI
   CLSI, 2010, M100S20 CLSI
   Ferreira WA, 2007, J BRAS DOENCAS SEX T, V19, P65
   Florindo C, 2010, SEX TRANSM INFECT, V86, P449, DOI 10.1136/sti.2010.044321
   *GIPS, 2009, SEX TRANSM DIS SURV
   Ilina EN, 2008, ANTIMICROB AGENTS CH, V52, P2175, DOI 10.1128/AAC.01420-07
   Junior WB, 2007, BRAZ J MICROBIOL, V38, P293, DOI 10.1590/S1517-83822007000200020
   *MAN EP DIS CONTR, 2010, FDN TROP DERM VEN AL
   Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047
   Mavroidi A, 2011, J CLIN MICROBIOL, V49, P1196, DOI 10.1128/JCM.02233-10
   Monfort L, 2009, J CLIN MICROBIOL, V47, P3540, DOI 10.1128/JCM.01236-09
   *MS, 2006, MAN CONTR DOEN SEX T
   Palmer HM, 2008, J ANTIMICROB CHEMOTH, V62, P490, DOI 10.1093/jac/dkn235
   PAUILLAC FV, 2009, ANTIMICROB AGENTS CH, V53, P1264
   Rosen T, 2009, DERMATOL CLIN, V27, P49, DOI 10.1016/j.det.2008.07.002
   Starnino S, 2009, J ANTIMICROB CHEMOTH, V63, P1200, DOI 10.1093/jac/dkp118
   Todd K, 2007, SEX HEALTH, V4, P233, DOI 10.1071/SH07037
   Van Dick E, 1999, LAB DIAGNOSIS SEXUAL
   Whiley DM, 2010, J ANTIMICROB CHEMOTH, V65, P1615, DOI 10.1093/jac/dkq187
   Zhang TJ, 2009, INDIAN J MED RES, V129, P701
NR 22
TC 7
Z9 7
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2011
VL 106
IS 5
BP 629
EP 631
DI 10.1590/S0074-02762011000500018
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 815BT
UT WOS:000294501800018
PM 21894387
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Ferreira, CM
   Ferreira, WA
   Almeida, NCOD
   Naveca, FG
   Barbosa, MDV
AF Ferreira, Cristina Motta
   Ferreira, William Antunes
   Oliveira da Silva Almeida, Nayanne Cristina
   Naveca, Felipe Gomes
   Vale Barbosa, Maria das Gracas
TI EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING BACTERIA ISOLATED FROM
   HEMATOLOGIC PATIENTS IN MANAUS, STATE OF AMAZONAS, BRAZIL
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE ESBL; beta-lactams; nosocomial infection; TEM; SHV; OXA; CTX-M
ID ESCHERICHIA-COLI; CTX-M; ENTEROBACTERIACEAE; PREVALENCE; RESISTANCE;
   STRAINS; CLONES
AB Antibiotic therapy in hematologic patients, often weak and susceptible to a wide range of infections, particularly nosocomial infections derived from long hospitalization periods, is a challenging issue. This paper presents ESBL-producing strains isolated from such hematologic patients treated at the Amazon Hematology and Hemotherapy Foundation (HEMOAM) in the Brazilian Amazon Region to identify the ESBL genes carried by them as well as the susceptibility to 11 antimicrobial agents using the E-test method. A total of 146 clinical samples were obtained from July 2007 to August 2008, when 17 gram-negative strains were isolated in our institution. The most frequent isolates confirmed by biochemical tests and 16S rRNA sequencing were E. coli (8/17), Serratia spp. (3/17) and B. cepacia (2/17).
   All gram-negative strains were tested for extended-spectrum-beta-lactamases (ESBLs), where: (12/17) strains carried ESBL; among these, (8/12) isolates carried bla(TEM), bla(CTX-M), bla(OXA), bla(SHV) genes, (1/12) bla(TEM) gene and (3/12) bla(TEM), bla(CTX-M), bla(OXA) genes. Antibiotic resistance was found in (15/17) of the isolates for tetracycline, (12/17) for ciprofloxacin, (1/17) resistance for cefoxitin and chloramphenicol, (1/17) for amikacin and (3/17) cefepime. This research showed the presence of gram-negative ESBL-producing bacteria infecting hematologic patients in HEMOAM. These strains carried the bla(TEM), bla(SHV), bla(CTX-M) and bla(OXA) genes and were resistant to different antibiotics used in the treatment. This finding was based on a period of 13 months, during which clinical samples from specific populations were obtained. Therefore, caution is required when generalizing the results that must be based on posological orientations and new breakpoints for disk diffusion and microdilution published by CLSI 2010.
C1 [Ferreira, Cristina Motta] Univ Estado Amazonas, Fundacao Med Trop Amazonas, Fundacao Hematol & Hemoterapia Amazonas, Manaus, Amazonas, Brazil.
   [Ferreira, William Antunes] Univ Estado Amazonas, Fundacao Med Trop Amazonas, Fundacao Dermatol Trop & Venereol Alfredo da Matt, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP Ferreira, CM (corresponding author), Fundacao Hematol & Hemoterapia Amazonas HEMOAM, Ave Constantino Nery 4397, BR-69050002 Manaus, Amazonas, Brazil.
EM cris_motta_ferr@yahoo.com.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
FU Amazonas State Research Foundation (Fundacao de Amparo a Pesquisa do
   Estado do Amazonas - FAPEAM)
FX The authors are grateful to acknowledge the support provided by the
   Amazonas State Research Foundation (Fundacao de Amparo a Pesquisa do
   Estado do Amazonas - FAPEAM). Inputs to carry out this research derived
   from a project approved by the Research Program of SUS ( Brazilian
   National Health Care System): Shared Health Management PPSUS- Posting
   014/2006-FAPEAM Manaus, State of Amazonas, Brazil. This paper stems from
   the preliminary findings reported by the author's doctoral thesis at the
   Amazon State University (UEA) and the Amazon Tropical Medicine
   Foundation (FMT-AM) in the field of clinical bacteriology.
CR Ahmed Shaaban H, 2009, BMC Res Notes, V2, P76, DOI 10.1186/1756-0500-2-76
   Al Naiemi N, 2006, J MED MICROBIOL, V55, P1607, DOI 10.1099/jmm.0.46704-0
   Al-Zarouni M, 2008, MED PRIN PRACT, V17, P32, DOI 10.1159/000109587
   ALADAG MO, 2009, WORLD APPL SCI J, V6, P630
   Augusti GR, 2007, SCI MED, V17, P192
   Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001
   Cergole-Novella MC, 2010, MICROB DRUG RESIST, V16, P177, DOI 10.1089/mdr.2010.0008
   Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005
   Clinical and Laboratory Standards Institute, 2010, M100S20 CLIN LAB STA
   Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350
   Cormican MG, 1996, J CLIN MICROBIOL, V34, P1880, DOI 10.1128/JCM.34.8.1880-1884.1996
   DALMARCO EM, 2006, RBAC, V38, P171
   Habeeb KC, 2007, AFR J BIOTECHNOL, V6, P1791
   Hujer AM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-46
   Jeong SH, 2004, J CLIN MICROBIOL, V42, P2902, DOI 10.1128/JCM.42.7.2902-2906.2004
   Lim KT, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/165637
   MACEDO MLA, 2005, CIENC BIOL SADE, V7, P59
   Mansouri M., 2009, Journal of Biological Sciences, V9, P362, DOI 10.3923/jbs.2009.362.366
   Miyoshi T, 2005, APPL ENVIRON MICROB, V71, P1084, DOI 10.1128/AEM.71.2.1084-1088.2005
   MOHAMMAD MF, 2009, MDR, P1
   Monstein HJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-7
   Mshana Stephen E, 2009, BMC Res Notes, V2, P49, DOI 10.1186/1756-0500-2-49
   Mulvey MR, 2004, ANTIMICROB AGENTS CH, V48, P1204, DOI 10.1128/AAC.48.4.1204-1214.2004
   Nurul Atifah M A, 2005, Malays J Pathol, V27, P75
   PASTA AAC, 2008, REV BRAS ANAL CLIN, V40, P137
   Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003
   PICAO RC, 2007, PRATICA HOSPITALAR, V49, P79
   ROMANUS II, 2009, MACED J MED SCI, V2, P1
   Ruppe E, 2009, EMERG INFECT DIS, V15, P741, DOI 10.3201/eid1505.071299
   Schmitt J, 2007, J MED MICROBIOL, V56, P241, DOI 10.1099/jmm.0.46670-0
   Slama T. G., 2008, CRIT CARE, V12, P4
   SMITH BA, 2009, AJIC, V33, pE121
   Song KH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-41
   Superti SV, 2009, REV I MED TROP, V51, P211, DOI 10.1590/S0036-46652009000400006
   THIERRY F, 2006, EMERG INFECT DIS, V12, P863
   Thomson KS, 2001, EMERG INFECT DIS, V7, P333, DOI 10.3201/eid0702.010238
   TOFTELAND S, 2008, ANTIMICROB AGENTS CH, V52, P3244
   VENKATACHALAM KV, 1994, J BIOL CHEM, V269, P23444
   WINN JWC, 2008, MICROBIOLOGICAL DIAG
   Wootton M, 2007, J CLIN MICROBIOL, V45, P329, DOI 10.1128/JCM.01508-06
NR 40
TC 8
Z9 8
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD JUL-SEP
PY 2011
VL 42
IS 3
BP 1075
EP 1083
PG 9
WC Microbiology
SC Microbiology
GA 857XB
UT WOS:000297756800028
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU de Figueiredo, RMP
   Naveca, FG
   Bastos, MD
   Melo, MD
   Viana, SD
   Mourao, MP
   Costa, CA
   Farias, IP
AF Pinto de Figueiredo, Regina Maria
   Naveca, Felipe Gomes
   Bastos, Michele de Souza
   Melo, Miriam do Nascimento
   Viana, Suziane de Souza
   Gomes Mourao, Maria Paula
   Costa, Cristovao Alves
   Farias, Izeni Pires
TI Dengue virus type 4, Manaus, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID HEMORRHAGIC-FEVER
AB We report dengue virus type 4 (DENV-4) in Amazonas, Brazil. This virus was isolated from serum samples of 3 patients treated at a tropical medicine reference center in Manaus. All 3 cases were confirmed by serologic and molecular tests; 1 patient was co-infected with DENV-3 and DENV-4.
C1 [Pinto de Figueiredo, Regina Maria; Bastos, Michele de Souza; Melo, Miriam do Nascimento; Gomes Mourao, Maria Paula] Fundacao Med Trop Amazonas, Gerencia Virol, BR-69040000 Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes] Fundacao Alfredo Matta, Manaus, Amazonas, Brazil.
   [Viana, Suziane de Souza; Costa, Cristovao Alves] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.
   [Farias, Izeni Pires] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
RP de Figueiredo, RMP (corresponding author), Fundacao Med Trop Amazonas, Gerencia Virol, Av Pedro Teixeira 25, BR-69040000 Manaus, Amazonas, Brazil.
EM regina68@ig.com.br
RI Farias, Izeni Pires/J-3069-2014; Bastos, Michele/AAS-7386-2020; Naveca,
   Felipe/H-1130-2012
OI Farias, Izeni Pires/0000-0002-1416-4351; Bastos,
   Michele/0000-0003-3450-666X; Naveca, Felipe/0000-0002-2888-1060
CR BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   FIGUEIREDO RM, 2003, 39 C BRAZ SOC TROP M, P485
   FIGUEIREDO RM, 2002, 38 C BRAZ SOC TROP M, P94
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lorono Pino M A, 1993, Rev Inst Med Trop Sao Paulo, V35, P449, DOI 10.1590/S0036-46651993000500011
   *MIN SAUD, 2000, INF EP SUS 2000 BRAS
   Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004
   Osanai CA, 1984, THESIS ESCOLA NACL S
   WHO. World Health Organization, 2002, DENG DENG HAEM FEV
NR 15
TC 59
Z9 61
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2008
VL 14
IS 4
BP 667
EP 669
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 282VJ
UT WOS:000254595000025
PM 18394292
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Wermelinger, MCD
   Oelemann, WMR
   de Mendonca, MCL
   Naveca, FG
   von Hubinger, MG
AF Wermelinger, MCD
   Oelemann, WMR
   de Mendonca, MCL
   Naveca, FG
   von Hubinger, MG
TI Detection of human parvovirus B19 infection: a study of 212 suspected
   cases in the state of Rio de Janeiro, Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE parvovirus B19; Brazil; exanthema; spontaneous abortion; PCR; ELISA
ID POLYMERASE CHAIN-REACTION; ORGAN TRANSPLANT RECIPIENTS; HYDROPS-FETALIS;
   RHEUMATIC MANIFESTATIONS; DE-JANEIRO; ANEMIA; DIAGNOSIS; PREGNANCY;
   CHILDHOOD; ANTIBODY
AB Background: Parvovirus B19 infections are associated with different clinical manifestations that vary from symptom-less to severe. The main clinical manifestations are erythema infectiosum or fifth disease, transient aplastic crisis in individuals with hemoglobinopathies, chronic anemia in the immunocompromised, acute polyarthralgia syndrome in adults, hydrops fetalis, spontaneous abortion and stillbirth. Although the classical features of B19 and rubella infections are distinct, uncommon presentations can lead to misdiagnosis. Objective: The goal of this study was to assess the occurrence of parvovirus B19 (1319) infection in patients with clinical signs of toxoplasmosis or rubella, both of which were not confirmed by laboratorial techniques. Study design: Serum samples from 214 patients were collected between January 1996 and December 1997 in the state of Rio de Janeiro, Brazil, B19 specific IgG and IgM were detected by using commercial enzyme-linked immunosorbent assays (ELISA), and viral nucleic acid was detected employing a nested polymerase chain reaction (PCR) protocol. Results: Combining the results obtained by IgM ELISA and PCR, 14.5% of the samples were positive in one or both tests, with a concordance of 92.5% between the two techniques. Conclusions: Specimens collected in 16 out of 22 municipalities were positive in at least one out of the three tests employed, indicating that parvovirus B19 circulates in several regions of the state of Rio de Janeiro. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Prof Paulo Goes, BR-21941590 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo Goes, BR-21941590 Rio De Janeiro, RJ, Brazil.
   Escola Natl Saude Publ, Dept Adm & Planejamento Saude, Fundacao Oswaldo Cruz, BR-21041210 Rio De Janeiro, RJ, Brazil.
RP Wermelinger, MCD (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Prof Paulo Goes, POB 68040, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM monicaw@ensp.fiocruz.br; oelemann@micro.ufrj.br; genoveva@micro.ufrj.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; Wermelinger, Monica Carvalho de
   Mesquita Werner/0000-0001-5861-5479
CR AGUIAR FS, 1998, REV RES, V3, P126
   Alger LS, 1997, INFECT DIS CLIN N AM, V11, P55, DOI 10.1016/S0891-5520(05)70341-X
   ANAND A, 1987, NEW ENGL J MED, V316, P183, DOI 10.1056/NEJM198701223160403
   ANDERSON MJ, 1987, LANCET, V1, P738
   Araujo F, 1999, Acta Med Port, V12, P195
   BROWN KE, 1994, LANCET, V343, P895, DOI 10.1016/S0140-6736(94)90011-6
   Calvet A, 1999, J CLIN VIROL, V13, P37, DOI 10.1016/S1386-6532(99)00012-8
   Cameron AD, 1997, AUST NZ J OBSTET GYN, V37, P316, DOI 10.1111/j.1479-828X.1997.tb02419.x
   CASSINOTTI P, 1993, J MED VIROL, V40, P228, DOI 10.1002/jmv.1890400311
   CLEWLEY JP, 1992, FRONTIERS VIROLOGY, V1, P285
   COSSART YE, 1975, LANCET, V1, P72
   COTMORE SF, 1986, J VIROL, V60, P548, DOI 10.1128/JVI.60.2.548-557.1986
   CRUZ AD, 1989, MEM I OSWALDO CRUZ, V84, P279, DOI 10.1590/S0074-02761989000200022
   Cubel R C, 1997, Rev Soc Bras Med Trop, V30, P15, DOI 10.1590/S0037-86821997000100004
   CUBEL RCN, 1992, REV INST MED TROP SP, V34, P479, DOI 10.1590/S0036-46651992000500017
   DAVIDSON JE, 1989, LANCET, V1, P102
   FawazEstrup F, 1996, J RHEUMATOL, V23, P1180
   FEDER HM, 1989, ARCH INTERN MED, V149, P2176, DOI 10.1001/archinte.149.10.2176
   Flunker G, 1998, MED MICROBIOL IMMUN, V186, P189, DOI 10.1007/s004300050063
   FREITAS RB, 1990, J MED VIROL, V32, P203
   Freitas Ronaldo B. De, 1993, Memorias do Instituto Oswaldo Cruz Rio de Janeiro, V88, P497
   Fuller A, 1996, PATHOLOGY, V28, P277, DOI 10.1080/00313029600169154
   Garcia AGP, 1996, TROP DOCT, V26, P78, DOI 10.1177/004947559602600211
   Garcia Aparecida Gomes Pinto, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P145, DOI 10.1590/S0036-46651998000300003
   Gentilomi G, 1998, PRENATAL DIAG, V18, P363
   Heegaard ED, 1999, PEDIATR HEMAT ONCOL, V16, P329, DOI 10.1080/088800199277155
   Keyserling HL, 1997, CLIN PERINATOL, V24, P193
   KIRCHNER JT, 1994, AM FAM PHYSICIAN, V50, P335
   KOCH WC, 1990, J CLIN MICROBIOL, V28, P65, DOI 10.1128/JCM.28.1.65-69.1990
   Kyriazopoulou V, 1997, EUR J OBSTET GYN R B, V74, P157, DOI 10.1016/S0301-2115(97)00107-3
   LOPES DP, 1998, VIRUS REV RES, V3, P126
   Naides SJ, 1998, RHEUM DIS CLIN N AM, V24, P375, DOI 10.1016/S0889-857X(05)70014-4
   NASCIMENTO JP, 1990, REV I MED TROP, V32, P41, DOI 10.1590/S0036-46651990000100007
   NASCIMENTO JP, 1988, 4 C BRAS VIR, P108
   NASCIMENTO JP, 1988, 4 C BRAS VIROL, P107
   OLIVEIRA MI, 1998, VIRUS REV RES, V3, P127
   Oliveira Solange A., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P323
   PATTISON JR, 1981, LANCET, V1, P664
   REID DM, 1985, LANCET, V1, P422
   Schwarz TF, 1997, ZBL BAKT-INT J MED M, V285, P525
   SCHWARZ TF, 1987, LANCET, V1, P739
   Scroggie DA, 2000, J RHEUMATOL, V27, P2444
   Searle K, 1997, INFECTION, V25, P32, DOI 10.1007/BF02113504
   Setubal S, 2000, Rev Soc Bras Med Trop, V33, P477, DOI 10.1590/S0037-86822000000500009
   SEVALL JS, 1990, MOL CELL PROBE, V4, P237, DOI 10.1016/0890-8508(90)90057-7
   Sloots T, 1996, EUR J CLIN MICROBIOL, V15, P758, DOI 10.1007/BF01691968
   Soderlund M, 1997, LANCET, V349, P1063, DOI 10.1016/S0140-6736(96)09110-6
   TAKIMOTO S, 1988, 4 C BRAS VIROL, P109
   Thomas HIJ, 1999, J CLIN VIROL, V14, P107, DOI 10.1016/S1386-6532(99)00051-7
   VONHUBINGER MG, 1998, VIRUS REV RES, V3, P129
   Wattre P, 1998, J MED VIROL, V54, P140, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;140::AID-JMV12&gt;3.0.CO;2-N
   Wicki J, 1997, HEMATOL CELL THER, V39, P199, DOI 10.1007/s00282-997-0199-9
   1993, DIS REP CDR WKLY, V3, P125
   1998, DIS REP CDR WKLY, V8, P93
NR 54
TC 9
Z9 10
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD AUG
PY 2002
VL 25
IS 2
BP 223
EP 230
AR PII S1386-6532(02)00014-8
DI 10.1016/S1386-6532(02)00014-8
PG 8
WC Virology
SC Virology
GA 610PA
UT WOS:000178968100015
PM 12367658
DA 2020-12-17
ER

EF